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General Introduction
Rick H.A. van der Doelen, Tamás Kozicz and Judith R. Homberg
9GENERAL INTRODUCTION
1
1. Depression
Major depressive disorder, commonly referred to as (unipolar) depression, is a psychiatric 
disorder that inflicts a huge personal and societal burden (Schmidt et al., 2011; Morava and 
Kozicz, 2013; Belzung, 2014). The life time prevalence of depression has been reported to 
range between 15% and 20%, with women having a twofold higher risk than men (Kendler 
et al., 2002; Wittchen and Jacobi, 2005). Depression often becomes chronic, shows 
considerable comorbidity with anxiety and other psychiatric disorders, and also somatic 
diseases (Paile-Hyvärinen et al., 2007). Furthermore, according to the World Health 
Organization (WHO, 2008), depression is among the leading causes of disability worldwide, 
in third place in 2008 and predicted to be number one in 2030. In Europe, the financial 
costs associated with depression have been estimated to equal to about 1% of the total 
gross economic product of the European Union (Schmidt et al., 2011).
 Depressed patients are typically treated with selective serotonin reuptake inhibitors 
(SSRIs) or selective noradrenalin reuptake inhibitors (SNRIs). These drugs block the 
transporter proteins that are located on axon terminals of the central nervous system 
(CNS), and are major regulators of serotonin and noradrenalin levels in the synaptic cleft. 
The SSRIs and SNRIs are the refined successors of the antidepressants that were discovered 
serendipitously in the 1950s. Whereas they have considerable less side effects, the SSRIs/
SNRIs have provided little improvement regarding efficacy, remaining sub-optimal with 
regard to latency of onset of effect, remission and recurrence (Kirsch et al., 2008; Fournier 
et al., 2010); only about 50% of all patients demonstrate complete remission, with relapse 
rates of more than 40% (Huynh and McIntyre, 2008). The failure to improve the efficacy of 
pharmacological treatment is mirrored by the failure to provide molecular targets for the 
development of novel antidepressant therapies (Pryce and Seifritz, 2011; Hyman, 2014). At 
the same time, depressed patients can be successfully treated with psychotherapy and 
electroconvulsive shocks, or their combination with pharmacological treatment (UK ECT 
Review Group, 2003; Khan et al., 2012). Nevertheless, it has been urged to improve the 
current pharmacological treatment options, and for this it is necessary to elucidate novel 
molecular targets that are at the core of the biological causes of depression (Nestler et al., 
2002; Pryce and Seifritz, 2011; Schmidt et al., 2011; Hyman, 2014).
 As the knowledge of the pathophysiology of depression is limited, diagnosis is 
entirely based on the symptoms and course of the disease state. The most widely used 
manuals for the diagnosis of psychiatric disorders are the Diagnostic and Statistical Manual 
of Mental Disorders (DSM, 5th Ed 2013) of the American Psychiatric Association and the 
International Classification of Diseases (ICD, 10th Ed 2010) of the WHO. Based on the 
well-described and universally observable symptoms, the categorical approaches of DSM 
and ICD have enabled a standardized, unambiguous diagnostic system. However, patients 
can qualify for the diagnosis of depression by displaying variable sets of symptoms, and 
therefore, patients can vary considerably in clinical presentation (Box 1).
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(Hasler et al., 2004; Hyman, 2007; Miller and Rockstroh, 2013; Pryce and Klaus, 2013; Davis 
and Isles, 2014).
 Endophenotypes and RDoCs can be regarded as equivalent, being biological or 
psychological characteristics that are quantifiable, and that are considered to occupy 
the terrain between etiological factors and disease symptoms. Important advantages of 
the endophenotype approach are the expected improvements in the obtainment of 
homogeneous study samples, and the amenability of animal models for depression. 
Therefore, studying endophenotypes is predicted to stimulate the identification of 
relevant pathophysiological changes, as well as genetic and environmental risk factors 
for depressive symptomatology (Homberg, 2013; Miller and Rockstroh, 2013; Pryce and 
Klaus, 2013).
 The heritability of depression has been estimated to contribute to 30-50% of the risk 
to develop depression (Sullivan et al., 2000; Kendler et al., 2002, 2006), with the remaining 
liability accounted for by non-genetic factors as stress and traumatic events, but also viral 
infections and even stochastic processes during brain development (Sullivan et al., 2000; 
Nestler et al., 2002; Kendler et al., 2003). Despite the considerable levels of heritability for 
depression, the replicability of genetic association studies has been lacking (Bogdan et al., 
2013; MDD Working Group of the Psychiatric GWAS Consortium, 2013). This ‘missing 
heritability’ could be explained by limitations of the current technology, stringent 
statistical approaches, the small effect sizes of genetic variants, and the lack of power to 
detect epistasis (gene x gene – GxG – interaction) (Davis and Isles, 2014). In addition, a 
likely explanation is that the effects of genetic variants are not independent of 
environmental factors, and therefore, epidemiological studies should incorporate the 
interactive nature of genome and environment (Uher, 2010; Bogdan et al., 2013). Indeed, it 
is becoming increasingly clear that vulnerability to depression consists of a complex 
interplay of genome and environment. Gene x environment (GxE) interactions are 
generally referred to as genetic variants that confer differential susceptibility to particular 
environments (Ellis et al., 2011; Pluess and Belsky, 2012). Furthermore, by affecting behaviour 
and personality characteristics, genetic variation is also thought to influence the exposure 
to particular environments (Jaffee and Price, 2007).
 On the other hand, environmental events can affect gene expression by affecting 
epigenetic mechanisms as DNA methylation and hydroxymethylation, histone modifications 
(e.g. acetylation, methylation), and downstream of transcription, the actions of noncoding 
and microRNAs which act by modulating mRNA stability and translation (Mill and Petronis, 
2007; O’Connor et al., 2012; Sun et al., 2013). Moreover, epigenetic programming of gene 
expression is considered to be a key interface for GxE interactions (Bale et al., 2010; Meaney, 
2010; Van IJzendoorn et al., 2010; Bogdan et al., 2013; Zannas and West, 2014). DNA 
methylation, catalyzed by DNA methyltransferases, generally occurs at cytosine- 
phosphate-guanine sites and is associated with repression of gene expression (Moore et 
al., 2013). DNA methylation is a relatively stable epigenetic mark, as exposure to ELS has 
Consequently, depression is not a single disease, but a heterogeneous syndrome of likely 
distinct causes and pathophysiologies (Nestler et al., 2002; Pryce and Seifritz, 2011). 
Furthermore, the all-or-none (qualitative) nature of the diagnosis of depression is 
incompatible with the psychological and neurobiological research (quantitative) that aims 
to elucidate the pathophysiology of depression. Indeed, during the development of 
the 5th edition of DSM (DSM-5, 2013) a conceptual change has been made by the adoption of 
a spectrum of phenotypes for diagnosis of certain disorders, also called the dimensional 
criteria for diagnosis. However, the categorical approach is still dominant over 
symptomatology, and the use of a disorder-specific classification system therefore still 
prevails (Casey et al., 2013). In response, the National Institute for Mental Health (USA) has 
launched a new approach to classification of depression and other psychiatric disorders, 
called the Research Domain Criteria (RDoC) project (Insel et al., 2010). Others have also 
supported the shift in psychiatric research from categorical to dimensional concepts of 
psychopathology; i.e. from the study of binary disease entities to that of endophenotypes 
Box 1   DSM criteria for major depressive episode  
(Nestler and Hyman, 2010; DSM-5, 2013)
A.  At least five of the following are present simultaneously for at least two weeks 
(symptom 1 or 2 is necessary)
 1. Depressed or irritable mood
 2. Markedly diminished interest or pleasure in all, or almost all, daily activities
 3. Substantial weight loss or gain
 4. Insomnia or hypersomnia nearly every day
 5. Psychomotor agitation or retardation nearly every day
 6. Fatigue or loss of energy nearly every day
 7. Feelings of worthlessness or inappropriate guilt nearly every day
 8. Diminished ability to think or concentrate nearly every day
 9. Recurrent thoughts of death or suicide
B.  It cannot be established that an organic factor is the cause, and the disturbance is 
not a normal reaction to the death of a loved one
Subtypes of depression are recognized by opposite directions of symptoms (melancholic, 
atypical depression), catatonia or specific events (postpartum depression, seasonal 
affective disorders), but it should be noted that these subtypes lack evidence for 
differential pathophysiology (Nestler et al., 2002).
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repeated exposure to events that usually involve a breach of trust (De Bellis, 2001). Active 
examples include childhood sexual, physical and various forms of emotional abuse, while 
passive examples include emotional and physical neglect. Teicher and Samson (2013), 
among others, have provided extensive and well-described assessment criteria and 
definitions for the subtypes of childhood maltreatment (Box 2).
been shown to alter the DNA methylation and transcription of stress-related genes in the 
hippocampus of adult mice, rats and humans (Weaver et al., 2004; Mueller and Bale, 2008; 
McGowan et al., 2009; Chen et al., 2012). 
2. Stress
Perhaps the best studied and validated environmental risk factor for depression is the 
experience of stress, particularly the exposure to chronic stress or traumatic events across 
development (Heim et al., 2008; Schmidt et al., 2011). Stress has been defined as any 
disturbance of the physiological as well as the psychological integrity (homeostasis) of an 
individual (Selye, 1936; De Kloet, 2013). Stress involves a stimulus – the stressor – that is 
recognized as a threat to homeostasis and that elicits specific response mechanisms 
(Levine, 2005; Scharf and Schmidt, 2012). A psychological stressor can generate a stress 
response that is clearly distinct from physical stressors, not in the last place because it can 
already occur in anticipation. The most severe psychological condition involves ambiguity 
and uncertainty as this renders the individual unable to predict or control the situation 
(De Kloet, 2013). Depressive patients frequently report hopelessness, helplessness and the 
inability to cope with environmental events (Beck et al., 1974). Although these feelings are 
not diagnostic symptoms of depression, stressors that are (perceived to be) unpredictable 
and uncontrollable appear to be major environmental etiological factors in depression 
(Koolhaas et al., 2011; Pryce and Seifritz, 2011).
 The adverse consequences of chronic stress exposure have been explained by the 
concepts of allostasis and allostatic load. Allostasis, stability through change, is an essential 
component of maintaining homeostasis as it encompasses the adaptations that are 
induced in response to a (stressful) challenge. The costs of the adaptations associated 
with allostasis have been termed allostatic load. In circumstances where challenges are 
not adequately met (maladaptation), chronic stress exposure will increase this allostatic 
load, which ultimately can lead to exhaustion of adaptive mechanisms, and disease 
(Sterling and Eyer, 1988; McEwen, 1998). It has recently been proposed that, in certain 
cases, mitochondrial dysfunction could be a major predisposition to psychopathology 
that arises from maladaptation because of a lack of energy availability (Morava and Kozicz, 
2013).
2.1 Early life stress
Early life stress (ELS) in the form of childhood maltreatment has been associated with 
increased risk to develop depression, but also bipolar disorder, anxiety disorders, 
post-traumatic stress disorder (PTSD), substance abuse, personality disorders and 
psychoses (Mullen et al., 1996; McCauley et al., 1997; MacMillan et al., 2001; Scott et al., 2010; 
Teicher and Samson, 2013). Childhood maltreatment is characterized by sustained or 
Box 2   Assessment criteria for childhood maltreatment (adapted from Teicher  
and Samson, 2013); before the age of 18 years: sustained or repeated exposure 
to events involving a betrayal of trust by caretakers or other significant 
individuals in the child’s life
Active maltreatment
· Emotional abuse
 -  Verbal aggression (communications intended to inflict intense humiliation, 
denigration, or extreme fear)
 -  Emotional manipulation (placing the child in a situation intended to elicit shame, 
guilt or fear in order to serve the emotional needs of the perpetrator or to persuade 
the child to perform actions against his or her will or denigrating or destroying 
things of value to the child)
 -  Witnessing domestic violence (witnessing adults in the household intentionally 
humiliating, demeaning, or threatening to harm one another or other family 
members or actively engaged in physically harming family members)
· Physical abuse (hitting with objects, intentionally inflicting harm that results in bruises, 
welts, or need for medical attention, forcing child to remove clothing or otherwise 
humiliate him- or herself in front of others)
· Sexual abuse (adults or older children touching or fondling the child’s body in a 
sexual way or forcing the child to touch or fondle the perpetrator’s body in a sexual 
way, or forcing the child to engage in other activities with a sexual content or 
attempted or actual sexual intercourse)
Passive maltreatment
· Emotional neglect (failure to provide for the child’s basic emotional needs, being 
emotionally unresponsive to the child’s distress, not attending to the child’s distress, 
not attending to the child’s social and emotional development or expecting the 
child to routinely manage situations that are beyond his or her maturity level or are 
not safe) 
· Physical neglect (failure to provide for the child’s basic needs, such as for food, clothing, 
physical safety, adequate supervision, physical health)
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over time and thereby increase the individual’s vulnerability to stress-related disorders 
(Scharf and Schmidt, 2012). Recently, an alternative model, the match/mismatch hypothesis, 
was introduced (Champagne et al., 2009; Schmidt, 2011; Nederhof and Schmidt, 2012; 
Daskalakis et al., 2013). This model proposes that individuals can use the experience of past 
stressors to adaptively respond to future challenges (predictive adaptive response, 
Gluckman et al., 2007). Specifically, individuals with high programming sensitivity are 
predicted to be capable of phenotypic adaptation that is beneficial if the environmental 
challenges remain the same or similar (match). Therefore, individuals exposed to ELS could 
benefit from a match of the environment between different stages of life, but would be 
maladapted in a mismatched environment (Homberg and Van den Hove, 2012; Scharf 
and Schmidt, 2012). It should be noted that there is considerable empirical evidence for 
both the cumulative stress as well as match/mismatch hypotheses, and it is therefore 
conceivable that these models may co-apply in varying degrees, dependent on the 
individual programming sensitivity and the severity of stressful life events (Nederhof and 
Schmidt, 2012).
 Genetic variation inherently underlies individual differences in sensitivity to ELS 
exposure. Specifically, the depressogenic effects of ELS have been shown to be moderated 
by (single nucleotide) polymorphisms in several genes, of which a number of candidate 
genes have arguably received the most attention: BDNF (Gatt et al., 2009), CRF1R (Bradley 
et al., 2008), FKBP5 (Zimmermann et al., 2011) and SLC6A4 (Caspi et al., 2003). Not surprisingly, 
these polymorphisms have also been shown to display epistatic (GxG) interactions in their 
moderation of the effects of ELS exposure (GxGxE) (Kaufman et al., 2006; Wichers et al., 
2008; Ressler et al., 2009; Cicchetti et al., 2011). In this thesis, the focus is primarily on a 
polymorphic region of the serotonin transporter gene, SLC6A4.
3. 5-HTTLPR
Serotonin or 5-hydroxytryptamine (5-HT) is primarily present in blood platelets, the gas-
trointestinal tract and the CNS (Lucki, 1998). The neurotransmitter 5-HT is produced by 
neurons in the raphe nuclei of the brainstem, of which the dorsal and median raphe (DR, 
MR) are the main forebrain-projecting nuclei. The DR especially has been implicated in the 
behavioural and physiological stress response (Hale et al., 2012). When released from the 
nerve terminals of the presynaptic neuron into the extracellular space of the synaptic cleft, 
5-HT can exert its actions via a wide variety of receptors (Hoyer et al., 2002), which 
modulate signal transduction in the post-synaptic neuron, affecting its electrophysiology 
and/or gene expression (Sibille and Lewis, 2006). The serotonin/5-HT transporter (5-HTT) 
plays a critical role in the termination of 5-HT neurotransmission by the re-uptake of 5-HT 
into the presynaptic neuron (Amara and Kuhar, 1993), and is the target of the most widely 
prescribed class of antidepressants (SSRIs, Mandrioli et al., 2012).
It has been suggested that ELS confers increased vulnerability for later life stressors 
that trigger depressive episodes (Heim and Nemeroff, 2001). Furthermore, maltreated 
individuals that develop depression display an earlier age at onset, greater symptom 
severity, more comorbidity and poorer treatment response than non-maltreated depressed 
individuals (Bernet and Stein, 1999; Nemeroff et al., 2003; Nanni et al., 2012; Teicher and 
Samson, 2013). Therefore, the combination of ELS and depression may represent a 
depressive subtype with distinct pathophysiology. In addition to maltreatment, exposure 
to ELS can constitute the loss of a parent, or exposure to prenatal stress through adverse 
experiences of the mother (Heim and Nemeroff, 2001).
2.2 Resilience to stress
Thus far, it has only been discussed how stressors convey vulnerability for the development 
of psychiatric diseases. Yet, although the majority of the general population (50-60 %) 
experiences a severe trauma during their lifetime, the prevalence of PTSD has been 
estimated to be only 7.8% (Kessler et al., 1995). Also among children, despite a range of ELS 
events, resilience is the rule rather than the exception (Masten, 2001). Indeed, it has been 
suggested that overcoming stress-inducing situations can have a pro-resilience effect. 
Accordingly, low and high levels of stress exposure during development would impair 
coping, whereas moderate and temporally confined stress exposures would promote 
adaptive coping responses (Russo et al., 2012; Scharf and Schmidt, 2012). Notably, resilience 
is regarded as an active process, not just the absence of pathology (Bonanno and Mancini, 
2008; Feder et al., 2009).
 In squirrel monkeys, a potentially related phenomenon has been observed, which 
has been termed “stress inoculation” (SI). These socially housed monkeys were subjected 
to 10 weekly separations of 1 hour, or an unseparated (US) control treatment, starting at 17 
weeks of age (juvenile stage). With 8 weeks after the final separation, the monkeys were 
placed in a moderately stressful, novel environment for 30 minutes, for 5 consecutive days. 
Observations showed that the SI monkeys displayed reduced anxiety, expressed by 
decreased maternal clinging, enhanced exploratory behaviour, and increased food 
consumption compared with the US offspring. Interestingly, the behaviour of SI and US 
monkeys was initially observed to be similar, but differences emerged over repeated test 
sessions. Moreover, another 15 weeks later, the SI monkeys were still observed to show 
reduced anxiety-like behaviour (Parker et al., 2004; Lyons and Parker, 2007).
 In laboratory experiments, frequently only single exposures to a stressor are examined, 
but in real life this is the exception rather than the rule. Most individuals experience 
multiple significant stressful life events across different developmental time windows, 
as well as in adulthood (Scharf and Schmidt, 2012). A dominant view has been that the 
exposure to (early life) stress predisposes individuals to increased vulnerability to subsequent 
periods of stress (cumulative stress hypothesis), based on the earlier introduced notion of 
allostatic load. In this view, multiple stress exposures would increase the allostatic load 
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3.1 Moderation of stress-precipitated depression
In 2003, a longitudinal prospective study reported that 5-HTTLPR moderates the 
association of stressful life events (SLEs) with depression (Caspi et al., 2003). Compared to 
L/L homozygotes, S-allele carriers were found to have increased risk (2-3 times) to develop 
depression when they had endured 3 or more SLEs (life history calendar; events included 
employment, financial, housing, health and relationship stressors). Since then, numerous 
follow-up studies have been published, confirming the vulnerability of S-allele carriers or 
S/S homozygotes, or presenting null findings (e.g. Kaufman et al., 2004; Gillespie et al., 
 The human 5-HTT gene (SLC6A4) was cloned in the early 1990s and was mapped to 
chromosome 17q11.2-q12 (Lesch et al., 1993; Ramamoorthy et al., 1993). The protein product of 
the human 5-HTT gene is 630 amino acids in length and is 92% homologous to the rat 5-HTT 
gene (Lesch et al., 1994). The 5-HTT-linked polymorphic region (5-HTTLPR) is a variable repeat 
sequence in the promoter region of the gene, which constitutes two genetic variants: a short (S) 
allele comprising 14 copies of a 20-23 bp repetitive sequence, and a long (L) allele comprising 16 
copies. The deletion (S-allele) has an overall length of 44 bp and is located 1212-1255 bp upstream 
of the transcription start site (Figure 1) (Heils et al., 1995, 1996; Hariri and Holmes, 2006). The basal 
as well as stimulus-induced promoter activity of the 5-HTT gene was found to be significantly 
lower in vitro with the S-allele compared to the L-allele. In addition, in vitro 5-HT uptake and 
5-HTT binding were found to be significantly lower in cell lines and platelets carrying the 
S-allele compared to the L-allele. In all of these studies, the S/S and S/L genotypes were found 
to produce similar phenotypic measurements (e.g., both approximately two-fold lower 
 transcriptional efficiency compared to L/L homozygotes), suggesting that the polymorphism 
may have a dominant-recessive effect (Heils et al., 1996; Lesch et al., 1996; Greenberg et al., 1999). 
With regard to 5-HTT binding in the brain, results are not unambiguous, as some studies 
reported the S-allele to confer lower 5-HTT binding levels compared to the L-allele (Little et al., 
1998; Heinz et al., 2000; Praschak-Rieder et al., 2007; Reimold et al., 2007), while others found 
no significant differences (Willeit et al., 2001; Shioe et al., 2003; Parsey et al., 2006a; Murthy et al., 
2010). Interestingly, a recent study found that 5-HTTLPR interacted with the subjects being 
chronic smokers or not (Kobiella et al., 2011), indicating that beyond genetic impact, the 
expression of 5-HTT is influenced by various environmental factors (Cosgrove et al., 2009; 
Reimold et al., 2011), possibly explaining the discrepant studies.
 The 5-HTTLPR polymorphism is very common, as the allele frequency of the S-allele is 
around 40% and heterozygosity around 50% in Caucasian populations (Heils et al., 1996; 
Lesch et al., 1996). Notably, there are considerable ethnical differences (Gelernter et al., 1999), 
with S-allele frequencies being lower in African-Americans (20-25%, Lotrich et al., 2003; 
Odgerel et al., 2013) and higher in Asian populations (75-80%, Kunugi et al., 1997; Kim et al., 
2000; Lee and Ham, 2008). Furthermore, within 5-HTTLPR two single nucleotide 
polymorphisms (SNPs), rs25531 and rs25532, have been identified. The rs25531 polymorphism 
has a minor-allele frequency of 9-15% in Caucasians and 24% in African Americans. 
Importantly, rs25531 (as well as rs25532) is present only in the L-allele, with the LG variant and 
the S-allele showing nearly equivalent transcriptional efficiency, while the LA variant is 
associated with higher levels of 5-HTT gene expression (Hu et al., 2006; Wendland et al., 
2006). Accordingly, subsequent studies have incorporated the rs25531 polymorphism in 
their analyses. In this thesis, the S- and LG variant will be jointly referred to as the S-allele (low-
expressing 5-HTTLPR) and the LA variant will be denoted as the L-allele (high- expressing 
5-HTTLPR). Additional variants within the 5-HTT gene include a variable number of tandem 
repeats in intron 2 and several rare SNPs that modulate the structure and/or function of 
5-HTT (Lesch et al., 1994; Murphy and Lesch, 2008).
Figure 1  The human 5-HTT gene (SLC6A4) is located at chromosome 17q11.2-q12 (Lesch et al., 
1993; Ramamoorthy et al., 1993) and its promoter region contains the 5-HTT-linked polymorphic 
region (5-HTTLPR). This polymorphism is generated by a deletion (lowercase letters, bottom-left of 
the figure) of a 44 bp sequence located 1212-1255 bp upstream of the transcription start site, and 
thus results in a short (S) allele versus a long (L) allele (insertion). The S-allele has been associated 
with reduced transcriptional efficiency of the gene and in vivo 5-HTT binding levels (although the 
latter is not consistently reported). Therefore, the S-allele is thought to result from compromised 
5-HTT function across ontogeny, leading to prolonged 5-HT (5-hydroxytryptamine; serotonin) neu-
rotransmission, and functional and structural alterations in the brain, because of the important 
developmental role of 5-HT (Heils et al., 1996; Gaspar et al., 2003; Hariri and Holmes, 2006). MAO-A: 
monoamine oxidase A, enzyme that degrades 5-HT. This figure has been adapted and reprinted 
with permission from Macmillan Publishers Ltd: [Nature Neuroscience] (T. Canli and K-P Lesch), 
copyright (2007).
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S-allele carriers exhibit increased anxiety-like traits (Lesch et al., 1996; Sen et al., 2004; Stein 
et al., 2008), increased acquisition of conditioned fear responses (Garpenstrand et al., 2001; 
Lonsdorf et al., 2009; Klumpers et al., 2012) and an elevated attentional bias towards 
negative stimuli (Williams et al., 2009; Fox et al., 2011; Pergamin-Hight et al., 2012). But, 
S-allele carriers have also been shown to outperform L/L homozygotes on various 
cognitive tasks (Homberg and Lesch, 2011) and to exhibit increased attentional bias 
towards positive stimuli (Beevers et al., 2009; Fox et al., 2011).
3.3 The 5-HTT paradox; altered neurodevelopment
The finding that genetically-conferred low availability of 5-HTT increases the probability 
of developing depression has given rise to a conundrum that has been referred to as ‘the 
5-HTT paradox’ (Sibille and Lewis, 2006). Because, how can this finding be reconciled with 
the clinical observation that SSRIs improve depressive symptoms (by reducing 5-HTT 
function)? The most probable answer is that the altered availability of 5-HTT from 
conception onwards profoundly affects ontogeny. The importance of the 5-HT system in 
neurodevelopment has long been recognized, affecting developmental events as 
neurogenesis, neurite outgrowth and apoptosis (Gaspar et al., 2003). For instance, the 
development of the rodent somatosensory cortex is affected by knockout of the 5-HTT 
gene (Persico et al., 2001; Esaki et al., 2005; Miceli et al., 2013). In rats, 5-HTT levels have been 
found to peak early in the postnatal period (postnatal day 0-21), followed by lower levels 
in the adult brain (Galineau et al., 2004), and early life (postnatal day 4-21) blockade of 
5-HTT has been shown to recapture the adult anxiety-like phenotype of knockout of the 
5-HTT gene in mice (Ansorge et al., 2004). Therefore, alterations in 5-HTT levels early in 
development likely affect the formation of neural networks into adulthood. The neural 
consequences of 5-HTTLPR indeed extend beyond alterations in the functioning of the 
5-HT system (Hariri and Holmes, 2006). Furthermore, the discrepant 5-HTTLPR studies on 
in vivo 5-HTT binding, and the finding that the cognitive impact of 5-HTTLPR is associated 
with differential brain morphology rather than changes in the 5-HT system (Jedema et al., 
2010), has led some researchers to suggest that the increased stress sensitivity of 5-HTTLPR 
S-allele carriers may be due to an altered development of stress-related neurocircuitry 
rather than an altered adult functioning of the 5-HT system (Hariri and Holmes, 2006).
 Functional magnetic resonance imaging (fMRI) studies have provided some initial 
insight into the influence of 5-HTTLPR on stress-related neurocircuitry. Firstly, it was shown 
that S-allele carriers exhibit greater activity of the amygdala in response to fearful stimuli 
(Hariri et al., 2002; Munafò et al., 2008; Murphy et al., 2013), which could in part be mediated 
by alterations in amygdala volume (Kobiella et al., 2011). Furthermore, a model was 
proposed in which the stress x 5-HTTLPR interaction increases the resting state activity of 
the amygdala and hippocampus, leading to a heightened state of vigilance, and as such 
an increased sensitivity to the environment (Canli et al., 2005, 2006). Additional studies 
have indicated that the medial prefrontal cortex (mPFC) and the anterior cingulate cortex 
2005; Kendler et al., 2005; Sjöberg et al., 2006; Surtees et al., 2006; Taylor et al., 2006; Aguilera 
et al., 2009). Importantly, 5-HTTLPR was also found to interact with ELS to affect the risk to 
develop depression (e.g. Caspi et al., 2003; Kaufman et al., 2004; Taylor et al., 2006; Aguilera 
et al., 2009). 
 Some controversy arose in 2009 when two meta-analyses reported that the statistical 
significance of the 5-HTTLPR x SLE interaction regarding depression could not be 
supported (Munafò et al., 2009; Risch et al., 2009). In the discussion in the literature that 
followed these meta-analyses were criticized not to adhere to ‘best practice’ (Caspi et al., 
2010). Specifically, the meta-analyses disregarded exposure to multiple SLEs, included only 
a subset of available studies, and these selections were found to be biased towards the 
inclusion of negative studies (Kaufman et al., 2010; Uher and McGuffin, 2010). Moreover, 
the 2009 meta-analyses focused on studies that explored an interaction of 5-HTTLPR with 
SLEs, excluding the studies that have assessed 5-HTTLPR x ELS interaction.
 In 2011, a comprehensive meta-analysis was published that may have ended the 
debate on “arguably the most and least loved gene of psychiatric genetics” (Blakely and 
Veenstra-VanderWeele, 2011; Karg et al., 2011). In this study, Karg and colleagues reported 
a highly significant moderation by 5-HTTLPR of the relationship between stress and 
depression. When the studies were stratified by stressor, 5-HTTLPR was found to have a 
particularly strong association with stress sensitivity to childhood maltreatment, compared 
to its moderation of the relationship between SLEs and depression (Karg et al., 2011). 
Recently, a new meta-analysis was published comprising another 27 studies that were 
published until June 2013. This study has confirmed the significance of 5-HTTLPR in 
moderating the relation between stress and depression (Sharpley et al., 2014).
3.2 Differential susceptibility
Importantly, the increased environmental sensitivity of S-allele carriers is not restricted to 
adverse events, as S-allele carriers also show increased benefit from positive, supportive 
environments (Kaufman et al., 2004; Taylor et al., 2006; Pluess et al., 2010; Van IJzendoorn et 
al., 2012). For example, social support was shown to ameliorate the depressogenic effects 
of ELS (childhood maltreatment, stressful family environment) to a larger extent in S-allele 
carriers compared to L/L homozygotes (Kaufman et al., 2004; Taylor et al., 2006). Thereby, 
the 5-HTTLPR polymorphism seems to be consistent with the differential susceptibility 
model. Whereas the diathesis-stress hypothesis focusses solely on the adverse consequences 
of genetic predispositions, the differential susceptibility hypothesis provides a theoretical 
framework to explain the evolutional survival of ‘risk’ genes by emphasizing them as 
‘plasticity’ genes, with greater sensitivity to adverse as well as positive environmental events; 
‘for better and for worse’ (Belsky et al., 2007; Bakermans-Kranenburg and Van IJzendoorn, 
2011; Ellis et al., 2011; Homberg and Lesch, 2011).
 The ‘for better and for worse’ characteristic of 5-HTTLPR has also been identified at 
the endophenotype level in healthy controls. For instance, compared to L/L homozygotes, 
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Experiments are necessary to move towards causal relationships, and for such experiments, 
animal models are needed. In rhesus monkeys, an orthologue of 5-HTTLPR has been 
identified (rh5-HTTLPR), of which the S-allele is also associated with decreased transcrip-
tional efficiency (Lesch et al., 1997; Bennett et al., 2002). Similar to the human situation 
however, the rh5-HTTLPR is not unequivocally associated with altered in vivo 5-HTT 
binding levels (Christian et al., 2009, 2013; Jedema et al., 2010; Embree et al., 2013). The 
influence of rh5-HTTLPR on the sensitivity to ELS exposure has been studied by separating 
infant rhesus monkeys from their mothers and rearing them with other infants 
(peer-rearing; PR). The interaction of ELS and rh5-HTTLPR has been shown to affect 
behavioural responses to social separation; of the monkeys that experienced PR, S-allele 
carriers were found to display increased agitation and stereotypic behaviour, while L/L 
homozygotes showed increased self-directed behaviour and withdrawal (Spinelli et al., 
2007). Furthermore, S-allele carriers subjected to PR were found to exhibit increased 
ethanol preference (Barr et al., 2004a), increased neuroendocrine activity in response to 
social isolation (Barr et al., 2004b, 2004c), and lower 5-HT metabolite levels in the 
cerebrospinal fluid, indicative of increased 5-HT neurotransmission (Bennett et al., 2002).
 Research using rodents allows the control over genetic background and the 
environment to a degree that is practically nor ethically feasible in human or even 
nonhuman primate studies (Caspi et al., 2010). Furthermore, the use of rodents in 
biomedical research allows for invasive experiments and detailed molecular/physiological 
analyses, while additional advantages are the short life cycle and relatively low costs for 
housing and caretaking. In the case of complex psychiatric diseases as depression, an 
important question is however whether or not its etiology and pathophysiology can 
actually be reliably modeled in rats or mice. This is a critical issue as some of the symptoms 
of depression, as e.g. low self-esteem, feelings of guilt and suicidality do not seem to have 
a rodent equivalent. Yet, metabolic and sleep disturbances, and alterations in hedonic, 
psychomotor and cognitive behaviour can be inferred from rodent models (Nestler and 
Hyman, 2010; Schmidt et al., 2011).
 To assess whether an animal model appropriately models disease symptoms, three 
types of validators are classically used: construct, face and predictive validity (Willner, 
1984). Construct validity refers to the relevance of the methods by which the model is set 
up, and is generally considered the most compelling and useful approach. Ideally, 
construct validity would be achieved by recreating the entire etiological process that 
causes depression in humans. Therefore, by incorporating known genetic and 
environmental risk factors of depression a rodent model would be regarded to possess 
construct validity (Nestler and Hyman, 2010; Schmidt et al., 2011; Homberg, 2013). Face 
validity indicates that a model recapitulates important anatomical, biochemical, 
physiological or behavioural features of a human disease. In the case of depression, face 
validity of animal models is largely limited to behavioural features because of the limited 
knowledge on the pathophysiology of depression. Unfortunately, at the level of behaviour, 
(ACC) regulate amygdala activity during the processing of fearful stimuli. Specifically, the 
amygdala of S-allele carriers was found to show increased and decreased functional 
connectivity with respectively the ventral mPFC and ACC (Heinz et al., 2005; Pezawas et al., 
2005). It has been proposed that decreased amygdala-ACC coupling leads to amygdala 
hyperreactivity and increased anxiety-related traits, which would induce compensatory 
overactivity of the ventral mPFC (Pezawas et al., 2005). In addition, S-allele carriers have 
been found to display decreased structural integrity of the uncinate fasciculus, the white 
matter tract that connects the amygdala with the mPFC (Pacheco et al., 2009). Furthermore, 
dynamic causal modeling of fMRI data suggested that the increased amygdala activity 
displayed by S-allele carriers during the processing of fearful stimuli is the result of reduced 
prefrontal inhibitory regulation (Volman et al., 2013).
 With regard to the hypothesis that altered neurcircuitry underlies ELS x 5-HTTLPR 
interaction, the epistasis with the BDNFVal66Met polymorphism could be highly relevant 
(Kaufman et al., 2006; Wicher et al., 2008). Brain-derived neurotrophic factor (BDNF) is the 
most abundant and widely distributed neurotrophin in the CNS. While it was initially 
recognized as an important mediator of cell survival and growth during ontogeny, the 
main function of BDNF in the adult brain is considered to be the regulation of synaptic 
plasticity. As such, BDNF has been implicated in behaviour, and cognitive functions as 
memory acquisition and consolidation (Martinowich and Lu, 2008). The Val66Met 
polymorphism (substitution of the valine for a methionine residue at amino acid position 
66 of the prodomain of BDNF) impairs the dendritic trafficking, synaptic localization and 
secretion of BDNF (Egan et al., 2003). The transcriptional regulation and cellular localization 
of BDNF is furthermore complicated by differential exon usage and polyadenylation of the 
3’-untranslated region (3’-UTR) (Pattabiraman et al., 2005; An et al., 2008).
 The epistatic interaction between 5-HTTLPR and BDNFVal66Met
 is not surprising, given 
the interactions of BDNF and the 5-HT system at the molecular and cellular level. For 
instance, BDNF is known to promote the survival and morphological differentiation of 
5-HT neurons. Moreover, the therapeutic effect of SSRIs is thought to be mediated in part 
by the upregulation of BDNF expression, and the subsequent induction of neurogenesis 
and altered synaptic plasticity (Duman et al., 1997; Castren, 2004; Martinowich and Lu, 
2008; Homberg et al., 2014). In this regard, BDNF is also thought to play a major role in the 
neural and behavioural alterations that underlie the increased sensitivity of 5-HTTLPR 
S-allele carriers to stress (Homberg et al., 2014).
4. Translational psychiatry
Most studies with human subjects are limited because they can only look for correlations 
between behavioural phenotypes and genotypes (or GxE interactions), while meta- 
analyses are hampered by the heterogeneity of studies with human populations. 
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mo-pituitary-adrenal (HPA) axis, the main stress-responsive neuroendocrine system of the 
body, which is considered to mediate the influence of ELS on the risk for later life depression 
(Lupien et al., 2009). Therefore, we first introduce the HPA-axis, before going into the 
selected rodent models of ELS exposure and 5-HTT genotype.
5. Hypothalamo-pituitary-adrenal (HPA) axis
The HPA-axis ultimately functions to regulate the cortex of the adrenal glands with regard 
to the synthesis and release of glucocorticoids in the bloodstream. In response to stress, 
glucocorticoids, mainly cortisol in primates and corticosterone in rodents (collectively 
referred to as CORT), mobilize energy resources together with catecholamines (released 
by the adrenal medulla and sympathetic nerve terminals) by elevating circulating glucose 
levels, increasing heart rate and blood pressure, and decreasing the activity of the immune 
and digestive systems. Furthermore, in addition to peripheral tissues, CORT acts on the 
brain to affect neural plasticity, cognition and behaviour (Roozendaal, 2000; de Kloet et al., 
2005; Joëls et al., 2011, 2012; Hermans et al., 2014).
 A stress response of the HPA-axis is initiated when, from other parts of the CNS, signals 
encoding physical or psychological stressors stimulate the activity of parvocellular 
neurons in the paraventricular nucleus (PVN) of the hypothalamus. These neurons secrete 
corticotropin-releasing factor/hormone (CRF/CRH) and arginine vasopressin in the 
external zone of the median eminence, at the base of the third ventricle. From here, these 
peptides enter the hypophysial portal system and stimulate the anterior pituitary to 
synthesize and release adrenocorticotropic hormone (ACTH), which itself stimulates the 
synthesis and release of CORT from the adrenal cortex (Figure 2) (De Kloet et al., 1998; Ladd 
et al., 2000; Joëls et al., 2012). In response to a stressor, circulating CORT levels usually reach 
peak levels after 15-30 minutes and return to baseline 60-90 min later. Under basal 
conditions, CORT levels furthermore show an ultradian rhythm by hourly secretory pulses 
from the adrenal cortex. The amplitude of these ultradian pulses actually determine the 
circadian peak and through of CORT levels, with the largest pulses underlying the 
awakening response and onset of circadian activity (night-time in nocturnal animals such 
as rodents) (Young et al., 2004; Lightman and Conway-Campbell, 2010). Interestingly, it was 
recently shown that pulsatility of CORT levels is needed for adequate HPA responses to 
stress, and that stressors applied during the falling phase of a CORT pulse result in lower 
ACTH responses than those applied during the rising phase (Sarabdjitsingh et al., 2010a, 
2010b).
 The activity of the HPA-axis is regulated through direct feedback action of CORT at 
the level of the pituitary and the PVN, but also via extra-hypothalamic brain areas such as 
the medial prefrontal cortex, hippocampus and extended amygdala (Ulrich-Lai and 
Herman, 2009). This feedback action is mediated via the mineralocorticoid and 
the translational gap between rodent and human subjects is probably the largest (Nestler 
and Hyman, 2010). To improve the face validity of rodent behavioural readouts, an 
important improvement could therefore be the implementation of human task parameters 
in rodent tests (Homberg, 2013). Predictive validity is concerned with the extent to which 
an animal model displays responses to treatments that are predictive for therapeutic 
effects in humans. The lack of knowledge of the mechanisms by which psychiatric drugs 
exert their therapeutic effect was the reason for pharmacologists to develop rodent 
behavioural tests which are sensitive to drugs known to be effective in humans (Hyman, 
2014), such as the forced swim test (FST) for SSRIs (Porsolt et al., 1977; Lucki et al., 2001) and 
the elevated plus maze for the anxiolytic benzodiazepines (Steru et al., 1985). A concern 
has been though that these assays only detect drugs with the same underlying mechanism 
and thus not detect potentially effective drugs that act by different mechanisms (Hyman, 
2014). Moreover, whereas SSRIs acutely increase active coping behaviour in the FST, 
depressed patients only show clinical improvement after several weeks of treatment, 
suggestive of significantly different underlying mechanisms. Whereas the FST was initially 
used only as a screening test for novel antidepressants, it has later increasingly been used 
as a readout of depressive-like behaviour, as the immobility that develops across time in 
the FST has been interpreted as a measure of behavioural despair. The problem however 
is that immobility in the FST, but also other tests, may in fact be an adaptive coping 
strategy (to save energy) under inescapable stress conditions (Krishnan and Nestler, 2010; 
Homberg, 2013; Pryce and Klaus, 2013).
 In the translation of rodent behavioural studies to human clinical phenotypes there is 
the inherent risk for anthropomorphic interpretation, and the difficulty in judging what is 
adaptive or maladaptive behaviour in a given context. In the learned helplessness (LH) 
paradigm however, the testing phase actually confers an unambiguous advantage 
towards active, goal-directed compared to passive, enduring behaviour. In this paradigm, 
rodents are exposed to a series of unpredictable and inescapable electrical (usually foot) 
shocks, after which the animals are tested for their coping behaviour in a shuttle-box 
where the shocks are escapable. After the exposure to inescapable shocks, a subset of the 
animals will however display maladaptive behaviour as they fail to escape from the shocks 
in a majority of the trials, despite the presence of a clear escape route (Vollmayr and Henn, 
2001). It has been shown that the lack of (perceived) control - not the exposure to shocks 
by itself - is central to the development of this passive coping behaviour, which has been 
termed “learned helplessness” (Maier and Seligman, 1976; Amat et al., 2005).
 For this thesis, we have used the LH paradigm as a behavioural readout for stress 
coping behaviour and adult stress vulnerability. We have applied it to experiments in 
which we combined a model of ELS exposure with a model of low vs high availability of 
5-HTT, in order to produce a rat model of ELS x 5-HTT genotype interaction. In addition to 
stress coping behaviour, we have addressed the physiological changes that underlie ELS 
x 5-HTTLPR interaction. We have focused a large part of our studies on the hypothala-
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glucocorticoid receptors (MR, GR), with MR being mainly involved in the maintenance of 
basal HPA activity and GR with the recovery from stress-induced activity (De Kloet et al., 
1998, 2005). The balance between GR and MR functioning has been proposed to be 
central to stress-related psychopathology, as GR and MR serve such complementary CORT 
functions during the stress response (De Kloet et al., 1998; De Kloet, 2014). Of note, GR and 
MR are classically known to be nuclear receptors and therefore to exert their effects via 
the modulation of gene expression. However, whereas the genomic effects of CORT are 
slow in onset, many rapid – putatively non-genomic – effects of CORT have been reported 
in the literature (Hermans et al., 2014). Indeed, a number of studies have recently indicated 
the existence of membrane-associated forms of GR and MR (Karst et al., 2005, 2010; 
Groeneweg et al., 2011, 2012).
 Besides the PVN, major sources of CRF include the amygdala and the bed nucleus of 
the stria terminalis (BNST), which are thought to contribute to the regulation of HPA-axis 
activity (Korosi and Baram, 2008). The central amygdaloid nucleus (CeA) and the oval 
subdivision of the BNST (BNSTov) contain the major populations of CRF neurons in the rat 
amygdala and BNST, respectively (Merchenthaler et al., 1982; Morin et al., 1999; Sterrenburg 
et al., 2012). These CRF populations are responsive to acute and chronic exposure to stress 
(Rouwette et al., 2011; Sterrenburg et al., 2011), and their modulation has been shown to 
affect the HPA-axis as well as stress-related behaviour (Keen-Rhinehart et al., 2009; Regev 
et al., 2011; Flandreau et al., 2012; Regev et al., 2012; Callahan et al., 2013; Sink et al., 2013). 
In addition, evidence has accumulated suggesting that other members of the CRF family 
of neuropeptides, certainly urocortin 1 (Ucn1), but also urocortin 2 and urocortin 3, 
complement the actions of CRF in the regulation of the stress response (Kuperman and 
Chen, 2008; Kozicz et al., 2011a; Ryabinin et al., 2012). The actions of CRF and the urocortins 
are mediated by two G-protein coupled receptors, corticotropin-releasing factor receptor 
1 and 2 (CRF1R, CRF2R). Ucn1 binds both receptors with high affinity, while CRF has low 
affinity for CRF2R, and Ucn2 and Ucn3 selectively bind to CRF2R (Vaughan et al., 1995; Hsu 
and Hsueh, 2001; Lewis et al., 2001; Reyes et al., 2001). In the mammalian brain, Ucn1 is most 
abundantly expressed by neurons of the centrally projecting Edinger-Westphal nucleus 
(EWcp) in the midbrain (Vaughan et al., 1995; Kozicz et al., 1998, 2011b; Bittencourt et al., 
1999; Iino et al., 1999). In contrast to the HPA-axis, EWcp-Ucn1 neurons do not show 
habituation upon chronic stress exposure (Viau and Sawchenko, 2002; Korosi et al., 2005; 
Xu et al., 2010). It has therefore been proposed that Ucn1 is involved in the termination of 
the central stress response (Kozicz et al., 2011a; Ryabinin et al., 2012).
5.1 The HPA-axis; depression and 5-HTTLPR
In depression, about 50% of patients display basal hypercortisolemia and resistance to 
GR-mediated negative feedback (Checkley, 1996; Pariante and Miller, 2001), possibly 
representing the melancholic clinical subtype of depression (Gold and Chrousos, 2002; 
Lamers et al., 2013). In contrast, HPA hypoactivity has been observed for atypical depression 
Figure 2  The hypothalamo-pituitary-adrenal (HPA) axis is a key system for the coordinated 
physiological and behavioural response to stress, as it interacts with other physiological systems 
and information processing in the brain. A stress response of the HPA-axis is initiated when, from 
other parts of the central nervous system, signals encoding physical or psychological stressors 
stimulate the activity of parvocellular neurons in the paraventricular nucleus (PVN) of the 
hypothalamus. These neurons secrete corticotropin- releasing factor/hormone (CRF/CRH) and 
arginine vasopressin (AVP) in the external zone of the median eminence at the base of the third 
ventricle. From here, these peptides enter the hypophysial portal system and stimulate the anterior 
pituitary to synthesize and release adrenocorticotropic hormone (ACTH), which itself stimulates the 
synthesis and release of glucocorticoids from the adrenal cortex. The activity of the HPA-axis is 
regulated by negative feedback of glucocorticoids through binding of the glucocorticoid receptor 
(GR) at the level of the pituitary and the PVN, but also through brain areas as the frontal cortex, 
hippocampus and amygdala, in which the mineralocorticoid receptor (MR) is also involved (De Kloet 
et al., 2005; Joëls and Baram, 2009; Lupien et al., 2009; Roozendaal et al., 2009; Ulrich-Lai and Herman, 
2009). This figure has been reprinted with permission from MacMillan Publishers Ltd: [Nature 
Reviews. Neuroscience] (S.J. Lupien, B.S. McEwen, M.R. Gunnar and C. Heim), copyright (2009).
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6. 5-HTT knockout
In addition to the mouse, a 5-HTT-/- rat line has been obtained by ENU (N-ethyl-N-nitro-
sourea)-driven, target-selected mutagenesis. In short, high-throughput screening of 
genomic targets in offspring of mutagenized Wistar rats revealed an ENU-induced 
mutation that resulted in a premature stop codon in exon 3 of the 5-HTT gene (Slc6a4) 
(Smits et al., 2006; Homberg et al., 2007). Both 5-HTT-/- mice and 5-HTT-/- rats have been 
shown to display reduced 5-HT uptake (synaptosomes, primary neurons), increased 
extracellular and decreased tissue 5-HT levels across the brain, decreased spontaneous 
firing of raphe neurons, and decreased expression and sensitivity of 5-HT1A inhibitory 
autoreceptors (Bengel et al., 1998; Li et al., 1999; Fabre et al., 2000; Gobbi et al., 2001; Pan et 
al., 2001; Mathews et al., 2004; Homberg et al., 2007, 2008a). No gross health abnormalities 
are observed for 5-HTT-/- rodents, as they are similar to their wild-type (5-HTT+/+) 
counterparts on measures as locomotor activity, coat and whisker condition, neurological 
reflexes and piloerection (Holmes et al., 2002; Carroll et al., 2007; Homberg et al., 2007).
 With regard to stress coping behaviour, both 5-HTT-/- mice and rats show increased 
immobility in the FST (Holmes et al., 2002; Lira et al., 2003; Carroll et al., 2007; Olivier et al., 
2008a; Popa et al., 2008; Schipper et al., 2011a, 2011b), increased anxiety-like behaviour in 
the elevated plus maze (EPM), light-dark exploration (LDE), open field (OF), marble burying 
and novelty-suppressed feeding (NSF) tests (Holmes et al., 2003a, 2003b; Ansorge et al., 
2004; Zhao et al., 2006; Carroll et al., 2007; Olivier et al., 2008a; Popa et al., 2008; Jansen et 
al., 2010; Schipper et al., 2011a, 2011b), and impaired extinction recall of fear memory 
(Wellman et al., 2007; Narayanan et al., 2011; Schipper et al., 2011a; Nonkes et al., 2012a). 
There is no difference in sensitivity to electric shocks (measured by startle amplitude) or 
mechanical allodynia between 5-HTT-/- and 5-HTT+/+ mice (Lira et al., 2003; Vogel et al., 
2003), but it has been noted that 5-HTT-/- mice display diminished thermal hyperalgesia 
upon nerve injury or hind paw inflammation (Vogel et al., 2003; Palm et al., 2008). 
 With regard to cognitive functioning, both 5-HTT-/- mice and rats show improved 
reversal learning (Brigman et al., 2010; Schipper et al., 2011b; Nonkes et al., 2013). In addition, 
5-HTT-/- rats have been shown to perform better than their 5-HTT+/+ counterparts on 
strategy set-shifting (Nonkes et al., 2012b) and a rodent version of the Iowa Gambling task 
(Homberg et al., 2008b), but perform worse on the object recognition task (Olivier et al., 
2009). No sex differences have been noted with regard to the behavioural phenotype of 
5-HTT-/- rodents (Holmes et al., 2003b; Alexandre et al., 2006), although admittedly, many 
of the above studies did not directly compare male to female subjects. It does seem that 
the genetic background has a strong influence on the behavioural consequences of 
5-HTT knockout (Homberg et al., 2010a), as also evidenced by direct comparison of 
anxiety-like behaviour displayed by inbred mouse 5-HTT-/- strains (C57BL/6J, 129S6) 
(Holmes et al., 2003a).
and PTSD (Gold and Chrousos, 2002; Yehuda, 2009). The observation that remission of 
depression coincides with normalization of the HPA-axis underscores its pathophysiological 
role (Heuser et al., 1996; Binder et al., 2009). In addition, postmortem studies have found an 
increased number of CRF neurons and CRF mRNA content in the PVN of depressed 
subjects (Raadsheer et al., 1994; Raadsheer et al., 1998; Wang et al., 2008), and these 
patients display increased levels of CRF in their cerebrospinal fluid, which can be reduced 
by treatment with antidepressants or electroconvulsive shocks (Nemeroff et al., 1984; 
Nemeroff et al., 1991; Heuser et al., 1998). Furthermore, single nucleotide poly morphisms 
and altered expression levels of the genes encoding GR (NR3C1) and MR (NR3C2) have 
been associated with depression (Webster et al., 2002; Van Rossum et al., 2006; Klok et al., 
2011a, 2011b; Medina et al., 2013; Qi et al., 2013)which might be caused by impaired 
glucocorticoid signaling. Glucocorticoids act through the glucocorticoid receptor (GR. 
In addition, FK506-binding protein 51 (FKBP5) has recently warranted attention, as genetic 
variation of FKBP5 was found to interact with ELS to modulate the risk of depression and 
PTSD, mediated by epigenetic regulation of GR expression (Binder, 2009; Zimmermann et 
al., 2011; Klengel et al., 2013).
 The 5-HTTLPR S-allele has been associated with increased basal CORT levels (O’Hara 
et al., 2007; Chen et al., 2009; Goodyer et al., 2009; Wüst et al., 2009, Wankerl et al., 2010), and 
S/S homozygotes show increased CORT stress reactivity compared with individuals 
carrying a long (L) allele of the 5-HTTLPR (Gotlib et al., 2008; Way and Taylor, 2010; Miller et 
al., 2013). In the case of ELS × 5-HTTLPR genotype interaction, only a history of severe 
stress has been shown to trigger increased CORT responses in human S-allele carriers 
(Alexander et al., 2009; Mueller et al., 2011). In contrast, in macaques the combination of 
the S-allele with adverse rearing conditions results in increased ACTH but unaffected 
CORT responses to social separation (Barr et al., 2004a, 2004b). There have been reports of 
functional variation in the mouse 5-HTT gene (Carneiro et al., 2009), but there is no rodent 
orthologue of (rh)5-HTTLPR. Therefore, several mouse 5-HTT knockout (5-HTT-/-) lines 
(C57BL/6J, 129S6 and CD-1 backgrounds) have been generated by the genetic engineering 
of embryonic stem cells (Bengel et al., 1998; Holmes et al., 2003a; Lira et al., 2003; Zhao et 
al., 2006). The 5-HTT-/- mice show increased adrenomedullary but not CORT responses to 
stress, and basal plasma CORT levels have been reported to be unaltered or lower in 
5-HTT−/− mice (Li et al., 1999; Lanfumey et al., 2000; Tjurmina et al., 2002, 2004; Bartolomucci 
et al., 2010; Jansen et al., 2010; Van den Hove et al., 2011; Hohoff et al., 2013; Spinelli et al., 
2013). Furthermore, 5-HTT-/- mice have been reported to exhibit decreased CRF and GR 
mRNA levels in the PVN, and decreased GR mRNA in the pituitary gland (Jiang et al., 2009). 
Extrahypothalamic CRF, GR, MR and FKBP5 mRNA have not been assessed in 5-HTT-/- mice, 
but they have been found to display decreased expression of Ucn1 in the EWcp (Fabre et 
al., 2011). 
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mammals (Clancy et al., 2007). As such, it has been estimated that the maturity of the 
cerebral cortex of humans at birth corresponds approximately with PND12-13 in rodents 
(Romijn et al., 1991; Homberg et al., 2010b). In addition, compared to primates and other 
mammals, the HPA-axis of rodents is relatively immature at birth (Owen et al., 2005). With 
regard to developmental timing, the MS model may therefore be more suitable for 
prenatal compared to postnatal/childhood ELS experiences.
 The first demonstration that early postnatal manipulation of rodents can have 
significant influence on adult stress responsiveness came from studies by the late Seymour 
Levine and others, who demonstrated that daily handling of the pups attenuated the 
effects of adulthood stressors, compared to rats in undisturbed laboratory conditions, i.e., 
non-handled (NH) rats (Levine et al., 1956; Levine, 1957; Denenberg, 1964). This treatment 
is often called early handling (EH), but it actually also comprises the isolation in a novel 
environment and therefore separation from the dam for up to 15 minutes (MS15). Adult 
rats subjected to MS15, compared to NH, were shown to exhibit decreased anxiety-like 
behaviour and HPA responses to stress (Levine and Lewis, 1959; Viau et al., 1993; Meerlo et 
al., 1999; Caldji et al., 2000). Although the MS15 procedure was considered as a stressful 
experience, the associated phenotype could plausibly be interpreted as beneficial. 
Therefore, the findings with the MS15 experiments indicated that exposure to moderate 
stress could provide resilience to later life stressors, just as was later suggested by the 
‘stress inoculation’ procedure of squirrel monkeys (Claessens et al., 2011).
 In the laboratory setting, maternal care is observed to occur in bouts of retrieving, 
nursing and L/G of the pups, and otherwise the dam is usually off the nest for periods of 
typically 20-25 min (Jans and Woodside, 1990). Therefore, the MS15 procedure does not 
result in an abnormal period of separation. In seminaturalistic conditions, subordinate 
dams are often forced to build their nests far from nutritional sources, and this 
environmental challenge results in periods of separation for 2-3 h (Calhoun, 1962; Meaney, 
2001). Therefore, to obtain an ethologically relevant model of ELS exposure, the MS15 
procedure has been adjusted by prolonging the repeated MS to typically 180 min (MS180), 
although in the literature repeated separations of up to 8 h, or a single separation of 24 h 
(maternal deprivation) are used as well. Further, several studies on the effect of MS180 and 
MS15 have also incorporated an additional reference group (next to NH); that of ‘standard’ 
animal facility rearing (AFR), which constitutes handling once or twice a week due to the 
cleaning of cages and changing of bedding material.
 Overall, rats that underwent MS180 show a phenotype reminiscent of increased stress 
sensitivity (HPA responses, anxiety-like behaviour), while NH rats show an intermediate 
phenotype, in comparison to rats with an early life history of MS15 or AFR (Plotsky and 
Meaney, 1993; Caldji et al., 2000; Liu et al., 2000; Huot et al., 2001, 2004; Ladd et al., 2000, 
2004; Plotsky et al., 2005; Lee et al., 2007; Lippmann et al., 2007; Toda et al., 2014). Therefore, 
although it should be noted that findings have not always been consistent, the MS180 
treatment is generally regarded as a robust model for ELS exposure (Ladd et al., 2000; 
The 5-HTT-/- mice and rats have a complete absence of 5-HTT expression, although in rats 
some residual synaptosomal 5-HT uptake has been noted, probably by the noradrenaline 
transporter (Bengel et al., 1998; Homberg et al., 2007). A complete knockout of 5-HTT does 
not exist in humans, and the reduction in 5-HTT expression conferred by the 5-HTTLPR 
S-allele appears to be approximately 50% (Lesch et al., 1996; Heinz et al., 2000). Yet, because 
of the behavioural similarities between 5-HTT-/- rodents and S-allele carriers in terms of 
negative emotionality and cognitive functioning, it is argued that 5-HTT-/- rodents are a 
robust phenotypic model for the 5-HTTLPR (Kalueff et al., 2010). From the perspective of 
genotype, heterozygous 5-HTT knockout (5-HTT+/-) rodents would represent an improved 
S-allele model, as they also show an approximate 50% reduction in 5-HTT expression 
(Bengel et al., 1998; Homberg et al., 2007) and an intermediate phenotype on other 
measures of 5-HT homeostasis (Gobbi et al., 2001; Mathews et al., 2004; Homberg et al., 
2007; Murphy and Lesch, 2008). In terms of behaviour, 5-HTT+/- rodents are often found to 
show a phenotype similar to 5-HTT+/+ rodents, or an intermediate phenotype. For instance, 
5-HTT+/- mice have been reported to show intermediate (significantly different from 
5-HTT+/+ mice) anxiety-like behaviour in the LDE (Holmes et al., 2003a), but not in the EPM 
or NSF tests (Holmes et al., 2003b; Ansorge et al., 2004). Considering the increased stress 
sensitivity of 5-HTTLPR S-allele carriers, behavioural abnormalities (as observed in 5-HTT-/- 
rodents) may only become apparent in 5-HTT+/- rodents after exposure to stress. A number 
of studies have conducted such experiments in which the consequences of stressor 
exposure were compared between 5-HTT+/- and 5-HTT+/+ mice (Carola et al., 2008; Heiming 
et al., 2009; Bartolomucci et al., 2010; Narayanan et al., 2011; Van den Hove et al., 2011; 
Kloke et al., 2013; Spinelli et al., 2013). These studies showed that 5-HTT+/- mice are indeed 
more sensitive to stressors than 5-HTT+/+ mice, across different phases of life. Furthermore, 
they have provided some starting points for the elucidation of the neurobiology (BDNF, 
amygdala-prefrontal connectivity) that underlies ELS x 5-HTTLPR interaction. All by all 
however, knowledge has still been very limited, and therefore, the goal of this thesis was 
to further explore how (neuro)physiology and stress coping behaviour are affected in 
rodents, when exposure to ELS and 5-HTT deficiency come together. For this purpose, 
we have exposed 5-HTT-/-, 5-HTT+/- and 5-HTT+/+ rats to a frequently used model of ELS 
exposure; repeated maternal separation.
7. Maternal separation
The maternal separation (MS) paradigm entails the repeated separation of the pups from 
their mother, during the early postnatal period. As in this period the developing brain is 
undergoing many changes and shows a high degree of plasticity, it is considered as one 
of the ‘vulnerable’ developmental time windows (Levine, 2005). The timing and sequence 
of early events in brain development have been found to be remarkably conserved across 
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interaction. Furthermore, it has thus far been unclear at what level of the HPA-axis and 
through what mechanisms the activity of the HPA-axis is programmed by ELS x 5-HTTLPR 
interactions. This programming could be mainly present within the HPA-axis itself, but 
also likely involves altered gene expression of CRF, Ucn1, GR, MR and FKBP5 in extra-hypo-
thalamic brain areas. Therefore, we have subjected 5-HTT+/+, 5-HTT+/- and 5-HTT-/- rats to 
daily 3 h maternal separations (MS180) or a comparison/control treatment (MS0) during 
PND2-14 and examined their adult levels of stress coping behaviour, HPA-axis activity, and 
gene expression in the mPFC, hippocampus, central amygdala, BNSTov, and the HPA-axis 
itself.
 In chapter 2, we have assessed adult stress coping behaviour in the LH paradigm. 
Specifically, escape latencies and escape failures were recorded in a shuttle-box escape 
test after exposure to inescapable, unpredictable foot shocks. In chapter 3, we examined 
if, and at what level, the HPA-axis is affected in our animal model of ELS x 5-HTTLPR 
interaction, by measuring plasma levels of ACTH, CORT and adrenalin and assessing gene 
expression of main mediators at the level of the hypothalamus, pituitary and adrenal 
glands. In chapter 4, we examined if the alterations of the HPA-axis that we identified are 
paralleled by adaptations of the mRNA levels of GR, MR and FKBP5 in the mPFC, 
hippocampus, central amygdala and BNSTov. In chapter 5, we have examined the 
expression of CRF at the mRNA and protein level in the PVN, central amygdala and BNSTov 
of the rats that underwent the LH paradigm and rats that were naïve in terms of adult 
stress exposure. Furthermore, we assessed the role of DNA methylation of the promoter 
region of the CRF gene. In chapter 6, we have examined the immunocytochemical 
expression of 5-HT in the DR, together with the measurement of mRNA levels of 5-HT1A, 
GR, CRF1R and CRF2R in the DR and EWcp. Furthermore, DNA methylation of the promoter 
region of the Ucn1 gene and its expression at the mRNA and protein level in the EWcp was 
included. In chapter 7, different functional transcripts (short/long 3’-UTR, exon IV, VI) of 
the BDNF gene were measured in the mPFC and hippocampus of our rat model of ELS x 
5-HTTLPR interaction. Finally, chapters 8 and 9 are dedicated to a summary and a general 
discussion of the findings that are presented in chapter 2-7. 
Levine, 2005; Pryce et al., 2005; Schmidt, 2010), while it has been proposed that the 
intermediate NH phenotype is related to understimulation of the pups (for an extended 
discussion see Pryce et al., 2005).
 The differential findings in the literature with regard to MS are likely related to different 
experimental procedures across different laboratories; duration, frequency, and age of 
onset of the separation. Furthermore, the genetic background of the rodent is highly 
relevant as well, given the differential effects of MS in different rat and mouse strains 
(Anisman et al., 1998; Ellenbroek and Cools, 2000; Kember et al., 2012). For this thesis, we 
have adopted the protocol of Plotsky, Meaney and co-workers who have contributed 
many key studies in the field of prolonged-MS experimentation. This procedure is 
performed for PND2-14 and consists of daily 3 h separations of the pups from the dam, 
during which the complete litter is transferred to an adjacent room and placed in a novel 
cage with clean bedding, that is heated to maintain the body temperature of the pups 
(Plotsky and Meaney, 1993; Francis et al., 2002; Huot et al., 2004; Ladd et al., 2004; Plotsky et 
al., 2005). The exposure to novelty presumable enhances the long-term impact of 
prolonged-MS (Tang, 2001; Tang et al., 2006; Enthoven et al., 2008). The comparison 
treatments that are typically used are AFR, MS15 or a treatment which consists of the exact 
same handling as MS15/MS180 but in which the pups and dam are immediately reunited 
(MS0). Although the MS0 treatment has been used less frequently, the advantage over 
MS15 is that it closer resembles a naïve comparison group, as the pups do not experience 
separation nor exposure to novelty. We have furthermore chosen to use the MS0 treatment 
over the use of an AFR group. The rationale for this was two-fold; 1) in comparison to 
MS180, the MS0 represents a ‘cleaner’ comparison group as the AFR pups would not 
receive the same degree of handling, and 2) although the term would imply otherwise, 
AFR procedures (cage cleaning, bedding changes, way of handling the animals, number 
of care takers, frequency of entering the room for daily controls) are far from consistent 
across laboratories (Crabbe et al., 1999), and hence the choice of the MS0 treatment (with 
no involvement of animal care takers other than the experimentator) actually offers 
increased standardization and chances of replication by other laboratories.
8. Aims and outline of the thesis
The aim of this thesis has been to come to a further understanding of the interaction 
between ELS and 5-HTTLPR, and its relation with adult stress-related behaviour and the 
pathophysiology of depression. Alterations in the regulation of HPA-axis activity and of 
hippocampal BDNF expression have been related to the increased stress sensitivity 
displayed by 5-HTTLPR S-allele carriers (e.g. Kaufman et al., 2006; Carola et al., 2008; Mueller 
et al., 2011; Alexander et al., 2012). It has been unknown however which functional 
transcripts (3’-UTR, differential exon usage) of BDNF are affected by ELS x 5-HTT genotype 
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Early life adversity in the form of childhood abuse has been associated with increased risk 
for the development of psychiatric disorders such as major depression (Mullen et al., 1996; 
McCauley et al., 1997). Recent reviews, however, have postulated the match/mismatch 
hypothesis of disease, which states that early life stress (ELS) is not necessarily pathological 
but can be of adaptive value (Schmidt, 2011; Homberg, 2012). Central to this hypothesis is 
the concept of the predictive adaptive response (PAR) (Gluckman et al., 2007), which 
entails that an individual uses the experience of past stressors to adaptively respond to 
future stressors. PAR is expected to be most pronounced in stress-sensitive individuals, 
similar to humans carrying the low activity short (S) allelic variant of the serotonin 
transporter (5-HTT) promoter polymorphism (5-HTTLPR) and 5-HTT knockout rodents 
modeling this polymorphism (Homberg and Van den Hove, 2012). In this study, we used 
the maternal separation paradigm to test the hypothesis that ELS can improve adult stress 
coping behaviour as a function of serotonin transporter gene variation.
 The methods are fully available in the Supplementary Materials. Briefly, from postnatal 
day 2 to 14 litters were either exposed to a daily 180 min maternal separation (MS180) or a 
control treatment, which involved the exact same handling, but immediate reunion of 
dam and pups (MS0). Adult male offspring was subjected to inescapable (IS) shock stress 
in a shuttle-box (model ENV-010MD, Med Associates, St Albans, VT, USA). For 2 consecutive 
days, rats received 50 IS, unpredictable 0.6 mA foot shocks. Exactly 24 h after the start of 
the second exposure to IS, the rats were tested for 30 consecutive trials in which they 
could escape shocks by moving to the opposite end of the shuttle-box. The latency to 
escape the shocks was automatically recorded and the maximum of 15 s was registered in 
case of escape failure.
 The escape latencies were found to be affected by both genotype (F2,105 = 4.013, p < 0.05, 
Figure 1) and early life treatment (ELT; F1,105 = 5.160, p < 0.05, Figure 1). The genotype effect 
was attributed to the 5-HTT homozygous knockout (5-HTT-/-) rats, which displayed lower 
escape latencies irrespective of their ELT (p < 0.05 for pairwise comparison with the other 
two genotypes). On the other hand, the effect of ELT was only significant for the 5-HTT 
heterozygous knockout (5-HTT+/-) rats (p < 0.05, Figure 1).
 This study supports the PAR concept by showing that ELS can lead to improved 
stress-coping behaviour in later life. Interestingly, this adaptive effect of ELS was only 
significant for 5-HTT+/- rats, which fits our previous prediction that behaviour of 5-HTT+/- 
rats is strongly modified by environmental conditions (Kalueff et al., 2010; Homberg and 
Van den Hove, 2012). Furthermore, 5-HTT-/- rats showed lower escape latencies regardless 
of ELT, supporting the notion that 5-HTT-/- rats display increased attentional vigilance 
under stressful conditions (Pergamin-Hight et al., 2012). Notably, earlier studies revealed 
increased escape latencies in 5-HTT-/- mice compared with wild-type controls (Muller et al., 
2010). However, these mice underwent several behavioural tests before the final escape 
test, which may have influenced the behavioural response.
36 37
CHAPTER 2 ESCAPE AFTER EARLY LIFE STRESS
2
Supplementary material: methods
Animals
Serotonin transporter knockout rats (Slc6a41Hubr) were generated by ENU-induced 
mutagenesis (Smits et al., 2006). Experimental animals were derived from crossing 3 
month old heterozygous 5-HTT knockout (5-HTT+/-) rats that were outcrossed for at least 
eight generations with commercial (Harlan, Ter Horst, The Netherlands) wild-type Wistar 
rats. The pregnant dams were housed in standard polypropylene cages (40 x 20 x 18 cm) 
with sawdust bedding and ad libitum access to water and rodent chow (Ssniff Spezialdiäten, 
Soest, Germany) in a temperature (21 ± 1 °C) and humidity-controlled room (45-60% 
relative humidity), with a 12 : 12 h light : dark cycle (lights on at 07.00 a.m.). The dams were 
inspected daily for delivery at 5.00 p.m. and day of birth was designated as postnatal day 
(PND) 0. At PND1, two paper towels (22,5 x 24,5 cm) were supplied to the dam for nest 
construction. Further, the litters were culled to a maximum of 10 pups, with gender ratios 
in favor of a male majority to maximally 7 : 3, and litters were randomly allocated to one of 
the following rearing conditions (from PND 2 to 14): maternal separation for 180 min 
(MS180) or a control treatment with immediate reunion of dam and pups (MS0). MS180 
was started daily between 08.30 and 09.00 a.m., and consisted of the following procedure: 
The dam was removed from the home cage and placed into an identical cage until the 
end of the separation period. Pups were then removed from the nest as complete litters 
and placed into a cage (24 x 15 x 14 cm) with only sawdust bedding, and then transferred 
to an adjacent room. There, the cages were placed on heat pads, which were set to 
maintain a bedding temperature of 31-33 °C for PND 2-7 and at 29-31 °C at PND8-14. At the 
end of the separation period, litters were returned to their home cage by first rolling them 
in the home cage bedding material and then placing them in the nests. This was followed 
by reunion with the dams. During PND 0-22, half of the bedding material of the home 
cages was refreshed every week. At PND 22, the pups were weaned and housed in groups 
of 2-3 littermates of the same sex, under the same conditions as mentioned above. Only 
the male offspring were used for subsequent experimental testing. All experiments were 
approved by the Committee for Animal Experiments of the Radboud University Nijmegen, 
The Netherlands, and all efforts were made to minimize animal suffering and to reduce 
the number of animals used.
Inescapable shock stress
When the male rats reached adulthood, they were subject to inescapable shock stress in 
a shuttle box (model ENV-010MD, Med Associates, St. Albans, VT, USA) located within a 
sound-attenuating cubicle. The box was equipped with eight infrared beams to detect 
the position of the animal, and separated into two identical chambers by an automated 
door that opened vertically. The grid floor of the apparatus was connected to a scrambled 
shock generator (model ENV-412, Med Associates), which enabled the variation of potential 
In conclusion, our results nuance the prevailing theory that 5-HTTLPR s-allele carriers have 
an increased risk to develop depression when exposed to ELS (Caspi et al., 2003), and 
suggest that carrying the S-allele does not inevitably have negative consequences. Rather, 
the increased sensitivity of S-allele carriers to a respective match or mismatch between 
the early and adult life environment may govern their adaptive or maladaptive responses 
to stress.
Figure 1  The average escape latencies of the shock escape test. Serotonin transporter homozygous 
(5-HTT-/-) and heterozygous (5-HTT+/-) knockout rats and their wild-type littermates (5-HTT+/+) 
(n = 14-23) with an early life history of maternal separation (MS180) or control treatment (MS0) 
were exposed to two sessions of inescapable (IS) foot shocks. This was followed by a third session 
in which the foot shocks were escapable. Data show mean ± SEM escape latencies (s). G, genotype 
effect, p < 0.05; E, early life treatment effect, p < 0.05; *MS180 5-HTT+/- rats different from MS0 5-HTT+/- 
rats, p < 0.05.
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differences between the bars of the grid floor in order to prevent animals from avoiding 
the foot shocks. For two consecutive days, between 08.30 and 12.00 a.m., rats received 50 
inescapable, unpredictable 0.6 mA foot shocks. After a 5 min (day 1) or 2.5 min (day 2) 
habituation period, the IS session started with varying interval durations (10-18 s) and 
shock durations (6-14 s), amounting to a total session duration of 25 or 22.5 min, 
respectively. During the intervals, the door separating the chambers was raised, allowing 
the rats to move freely across the shuttle box.
Escape testing
Exactly 24 h after the start of the second exposure to IS, the rats were assessed for their 
ability to escape shocks in the same apparatus. The difference with the IS sessions was 
that the door was now raised 1 s after the onset of the shock exposure and that rats could 
escape the shock by moving to the opposite end of the shuttle box. The rats were tested 
for 30 consecutive trials with a fixed interval duration (25 s) and a maximum shock duration 
of 15 s. The latency of the rats to escape the shocks was automatically determined by use 
of the infrared beams. If the rat failed to escape, the maximum 15 s was registered as the 
escape latency score. 
Statistical analysis
The results are presented as the mean and the standard error of the mean (SEM) for all 
experimental groups. Mean escape latencies were analyzed with factorial analysis of 
variance (ANOVA), and if a significant main effect (“genotype”, “treatment”) or interaction 
(“genotype x treatment”) was found, appropriate a posteriori tests were performed 
(one-way ANOVA and independent samples t-test). If doubt about the normality of the 
sample distributions existed, bootstrapping was applied to test the robustness of the 
parametric tests. Statistical significance was set at p < 0.05. All statistical tests were carried 
out using SPSS (version 20, IBM corporation, Armonk, NY, USA)).
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Introduction
The risk to develop depression is largely determined by both genetic and environmental 
factors, and understanding the precise mechanisms is essential to design personalized 
treatments. Although severe adverse events such as childhood abuse and neglect have 
been convincingly associated with depression (Heim and Nemeroff, 2001), a discrepancy 
exists between the high heritability estimates of depression and the replicability of 
genetic association studies (Nestler et al., 2002; Bogdan et al., 2013). It has become apparent 
that the effects of genetic and environmental factors should not merely be regarded as 
independent, but should be considered to have an interactive nature. For instance, the 
effects of stressful life events on the individual risk to develop depression have been 
shown to be dependent on serotonin transporter (5-HTT) promoter-linked polymorphic 
region (5-HTTLPR) genotype (Caspi et al., 2003). Although some meta-analyses could not 
confirm this gene × environment (GxE) interaction (Munafò et al., 2009; Risch et al., 2009), 
others have shown that it is especially significant after a history of early life stress (ELS) 
(Karg et al., 2011). Specifically, individuals with the short (S) allele of the 5-HTTLPR 
polymorphism were found to be more sensitive to the depressogenic effects of stress 
(Clarke et al., 2010; Kiyohara and Yoshimasu, 2010; Karg et al., 2011).
 One biological system through which the 5-HTTLPR may interact with stress is the 
stressor-responsive hypothalamo-pituitary-adrenal (HPA) axis (Caspi et al., 2010). A stress 
response of the HPA-axis is initiated by parvocellular neurons in the paraventricular 
nucleus (PVN) of the hypothalamus, by secreting corticotropin-releasing factor (CRF) at 
the median eminence to stimulate the synthesis and release of adrenocorticotropic 
hormone (ACTH), which itself stimulates the synthesis and release of glucocorticoids from 
the adrenal cortex (De Kloet et al., 2005). The major glucocorticoid in humans is cortisol, 
whereas in rodents it is corticosterone (both referred to as CORT).
 For 5-HTTLPR as an independent factor, it has been reported that S-allele carriers 
display increased basal activity of the HPA-axis (O’Hara et al., 2007; Chen et al., 2009; 
Goodyer et al., 2009; Wüst et al., 2009, Wankerl et al., 2010), and that S/S homozygotes 
show increased CORT stress reactivity compared with individuals carrying a long (L) allele 
of the 5-HTTLPR (Gotlib et al., 2008; Way and Taylor, 2010; Miller et al., 2013). In macaques, 
however, 5-HTTLPR genotype has not been shown to affect basal and stress-induced 
CORT levels (Barr et al., 2004b, 2004c). In mice, 5-HTT knockout (5-HTT−/−) leads to increased 
adrenomedullary but not CORT responses to stress, and basal plasma CORT levels have 
been reported to be unaltered or lower in 5-HTT−/− mice (Li et al., 1999; Lanfumey et al., 
2000; Tjurmina et al., 2002, 2004; Bartolomucci et al., 2010; Jansen et al., 2010; Van den Hove 
et al., 2011; Hohoff et al., 2013; Spinelli et al., 2013). In the case of ELS × 5-HTTLPR genotype 
interaction, only a history of severe stress has been shown to trigger increased CORT 
responses in human S-allele carriers (Alexander et al., 2009; Mueller et al., 2011). In contrast, 
in macaques the combination of the S-allele with adverse rearing conditions results in 
Abstract
The short allelic variant of the serotonin transporter (5-HTT) promoter-linked polymorphic 
region (5-HTTLPR) has been associated with the etiology of major depression by 
interaction with early life stress (ELS). Furthermore, 5-HTTLPR has been associated with 
abnormal functioning of the stress-responsive hypothalamo-pituitary-adrenal (HPA) axis. 
Here, we examined if, and at what level, the HPA-axis is affected in an animal model for ELS 
x 5-HTTLPR interactions. Heterozygous and homozygous 5-HTT knockout rats and their 
wild-type littermates were exposed daily at postnatal days 2–14 to 3 h of maternal 
separation. When grown to adulthood, plasma levels of adrenocorticotropic hormone 
(ACTH), and the major rat glucocorticoid, corticosterone (CORT), were measured. 
Furthermore, the gene expression of key HPA-axis players at the level of the hypothalamus, 
pituitary and adrenal glands was assessed. No 5-HTT genotype x ELS interaction effects 
on gene expression were observed at the level of the hypothalamus or pituitary. However, 
we found significant 5-HTT genotype x ELS interaction effects for plasma CORT levels and 
adrenal mRNA levels of the ACTH receptor, such that 5-HTT deficiency was associated 
under control conditions with increased, but after ELS with decreased basal HPA-axis 
activity. With the use of an in vitro adrenal assay, naïve 5-HTT knockout rats were 
furthermore shown to display increased adrenal ACTH sensitivity. Therefore, we conclude 
that basal HPA-axis activity is affected by the interaction of 5-HTT genotype and ELS, and 
is programmed, within the axis itself, predominantly at the level of the adrenal gland. This 
study therefore emphasizes the importance of the adrenal gland for HPA-related 
psychiatric disorders.
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the procedure can be found in the Supplementary Material. From PND 2 to 8, the mothers 
were observed to score their maternal care behaviour outside the maternal separation 
period. The scoring of maternal care was performed daily at 0700, 1300, 1700 and 2000 
hours. The distribution of the observation periods was based on the finding that nursing 
in rats occurs more frequently during the light period (Champagne et al., 2003). The 
observation periods lasted 1 h, with 20 single, focal observations spaced by 3 min. The 
observations were scored within 5–10 s by a trained observer in front of the cages. The 
following behaviours were scored (not mutually exclusive): (1) mother away from the pups, 
(2) mother in any type of contact with the pups, (3) mother licking/grooming any pup, (4) 
arched-back nursing (ABN), (5) blanket-posture nursing and (6) passive-posture nursing. 
The scoring of the nursing postures was based on the descriptions by Myers et al (Myers 
et al., 1989). The frequency of the (combinations of) behaviours across each observation 
period was calculated by dividing the number of times the specific behaviour was 
observed (0–20) by the total number of observations in that period (20). At PND 14, ear 
punches were taken of the pups for identification and genotyping, which was performed 
by Kbiosciences (Hoddesdon, UK). The procedure of genotyping has been described 
previously (Homberg et al., 2007). At PND 22, the pups were weaned, weighed and housed 
in groups of 2–3 littermates of the same sex, under the same conditions as mentioned 
above. From weaning until adulthood, the rats were regularly weighed (PND 30, 38, 46, 58, 
65, 72, 79).
Tissue collection
For the collection of tissues only adult (PND85–95) male rats were used. Of every litter, 
where possible, a single rat was selected of all three genotypes. The rats were sacrificed 
between 0900 and 1400 hours by either acute decapitation or by transcardial perfusion. 
Across this time period, the rats were randomized for their genotype and early life 
treatment.
 For decapitations, the rats were taken from their home cage into a separate room and 
decapitated within 10 s. Immediately, the trunk blood was collected in EDTA-coated vials 
and the brain and pituitary were dissected. The blood samples were put on ice and 
subsequently centrifuged (3400 r.p.m., 15 min) to obtain plasma samples, which were then 
stored at −80 °C until measurements. The brains and pituitaries were frozen in aluminum 
foil on dry ice and also stored at −80 °C.
 Before transcardial perfusion, rats received an intraperitoneal injection of sodium 
pentobarbital (50 mg kg−1 body weight). With anesthetization commencing within 3–5 
min, the transcardial perfusion was performed with a clamp on the abdominal aorta to 
limit the perfusion to the upper body parts. The perfusion was performed with phos-
phate-buffered saline and followed by fixation with 4% paraformaldehyde in phos-
phate-buffered saline. Directly after the start of the perfusion (5 min), the adrenal glands 
were dissected, weighed and stored at −80 °C.
increased ACTH but unaffected CORT responses to social separation (Barr et al., 2004b, 
2004c).
 Despite the relatively large body of literature it is yet unclear at what level of the 
HPA-axis and through what mechanisms the activity of the HPA-axis is programmed by 
5-HTTLPR x ELS interactions. Therefore, we assessed the HPA-axis at both central and 
peripheral levels in 5-HTT knockout rats, which model the 5-HTTLPR S-allele and display 
depression-related behaviour (Olivier et al., 2008a). Specifically, we tested the effect of ELS 
– that is, maternal separation – on plasma stress hormone, PVN, pituitary and adrenal gene 
expression levels, and we measured ACTH sensitivity of the adrenal gland as a function of 
5-HTT genotype. The outcome of this study is potentially important, because whether to 
target central or peripheral components of the HPA-axis is essential for future drug design, 
due to the constraints of the blood–brain barrier. 
Materials and Methods
Animals
All experiments were approved by the Committee for Animal Experiments of the Radboud 
University Nijmegen, The Netherlands, and all efforts were made to minimize animal 
suffering and to reduce the number of animals used. Serotonin transporter knockout rats 
(Slc6a41Hubr) were generated by N-ethyl-N-nitrosourea-induced mutagenesis (Smits et 
al., 2006). Experimental animals (5-HTT homozygous knockout (5-HTT−/−), 5-HTT 
heterozygous knockout (5-HTT+/−) and wild-type (5-HTT+/+)) were derived from crossing 
3-month-old 5-HTT+/− rats that were outcrossed for at least 12 generations with commercial 
(Harlan, Ter Horst, The Netherlands) wild-type Wistar rats. The pregnant dams were housed 
in standard polypropylene cages (40 × 20 × 18 cm) with sawdust bedding and ad libitum 
access to water and rodent chow (Sniff Spezialdiäten, Soest, Germany) in a temperature 
(21 ± 1 °C) and humidity-controlled room (45–60% relative humidity), with a 12:12 h 
light:dark cycle (lights on at 0700 hours). The dams were inspected daily for delivery at 
1700 hours and day of birth was designated as postnatal day (PND) 0. At PND1, two paper 
towels (22.5 x 24.5 cm) were supplied to the mother for nest construction. Further, the 
litters were culled to a maximum of 10 pups, with gender ratios in favor of a male majority 
to maximally 7:3.
Early life stress
We used repeated and prolonged maternal separation as a model for ELS, as this paradigm 
has previously been shown to affect adult HPA-axis functioning (Smotherman et al., 1977; 
Plotsky and Meaney, 1993). Litters were randomly allocated to one of two rearing 
conditions (from PND 2 to 14): maternal separation for 180 min (MS180) or a control 
treatment with immediate reunion of mother and pups (MS0). A detailed description of 
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Relative expression of the genes of interest was calculated by the 2−ΔCt method (Schmittgen 
and Livak, 2008). The procedure was concluded with a melting curve protocol, from 65 °C 
to 95 °C, measuring fluorescence every 0.5 °C, to control for product specificity. All qRT–
PCR analyses were carried out in triplicate, with newly synthesized cDNA.
Adrenal in vitro assay
Adult male 5-HTT+/+, 5-HTT+/− and 5-HTT−/− rats without any ELS were acutely decapitated, 
and trunk blood and adrenal glands were collected. After dissection, the adrenals were 
immediately placed in 1 ml of chilled (4 °C) Dulbecco’s modified Eagle’s medium (DMEM, 
Sigma-Aldrich, St.Louis, MO, USA) containing 3.7 g l−1 NaHCO3 and 2.5% BSA (one gland per 
tube). The adrenals were then processed into four pieces of equivalent size by two 
perpendicular cuts right through the medial axes of the adrenals, with the use of forceps, 
a sterile razor blade and a cutting mat. Then, the adrenal pieces were incubated at 37 °C in 
a 95% O2-5% CO2 atmosphere in 1 ml DMEM. After 2 × 60 min pre-incubation and 
refreshment of medium, 15-min samples were collected six times with ACTH-containing 
medium in the second fraction. The selected concentration of ACTH (10-12 M) was based 
upon experience with previous experiments (Zelena et al., 2008, 2011). After every 15-min 
incubation, medium was aspired, centrifuged and the supernatant was used for 
measurement of CORT concentrations by the use of a radioimmunoassay, as described 
elsewhere (Zelena et al., 2011).
Statistical analysis
All statistical tests have been carried out using SPSS (version 20, IBM corporation, Armonk, 
NY, USA)). The results are presented as the mean with the standard error of the mean (SEM). 
For the qRT–PCR results, the 2−ΔCt data have been expressed as a ratio compared with the 
average of the MS0 wild-type group. For the adrenal assay, CORT levels were expressed as 
percentage of the basal secretion measured in the first two 15-min samples. For the 
maternal care scores, body weight data and the adrenal assay, analysis of variance (ANOVA) 
with repeated measures was performed. In case of violation of the assumption of 
sphericity, Greenhouse–Geisser correction was applied to determine the F-ratio. Factorial 
ANOVA was applied for data from the plasma hormone, adrenal weight and qRT–PCR 
measurements, and if a significant main effect (‘genotype’, ‘early life stress’) or interaction 
(‘genotype x early life stress’) was found, appropriate a posteriori tests were performed 
(one-way ANOVA and independent samples t-test). For the adrenal assay, we examined 
the a priori hypothesis of greater CORT response in 5-HTT−/− versus 5-HTT+/+ rats with 
one-sided t-tests. If doubt about the normality of the sample distributions existed, 
logarithmic transformation and bootstrapping were applied to test the robustness of the 
parametric tests (see also Supplementary Material). Log-transformation was applied in the 
statistical analysis of plasma adrenalin, pituitary CRF1R, PVN MR and adrenal ACTH-R, 
CYP11B1/3 and StAR mRNA levels. Statistical significance was set at p < 0.05.
Plasma measurements
All plasma measurements were performed on samples derived from acutely decapitated 
rats. Plasma CORT was measured in duplicates using a colorimetric enzyme-linked 
immunosorbent assay kit (Demeditec Diagnostics GmbH, Kiel, Germany), ACTH with a 
luminescent enzyme-linked immunosorbent assay kit (Calbiotech, Spring Valley, CA, USA) 
and plasma adrenalin by analyzing 2,3-diphenyl quinoxalin derivatives using isocratic 
high-pressure liquid chromatography with fluorimetric detection after extraction from 
the plasma as described elsewhere (Willemsen et al., 1995).
RNA isolation & cDNA synthesis
Frozen brains were cut in 420 μm-thick coronal slices in a cryostat (−15 °C). From two of these 
slices (cut at Bregma −1.30 and −1.72 mm) the PVN was bilaterally punched out with a Miltex 
1.0 mm biopsy puncher (Integra Miltex, York, PA, USA). The punched samples were collected 
in sterile vials, immediately placed on dry ice and stored at −80 °C. After punching was 
completed for all samples, PVN RNA was isolated with the NucleoSpin RNA II kit (Macherey-
Nagel GmbH, Düren, Germany). For RNA isolation from the pituitary and adrenal glands, 800 
μl of ice-cold TRIzol (Life Technologies, Carlsbad, CA, USA) was added to the samples, which 
were thereafter homogenized by sonication. After chloroform extraction and isopropyl 
alcohol precipitation, RNA was dissolved in 30 μl of DEPC-treated, Rnase-free water. All RNA 
samples were stored at −80 °C. RNA concentrations were measured and RNA purity checked 
(A260/280 ratio between 1.8 and 2.0) with a NanoDrop 1000 spectrophotometer (Thermo 
Fisher Scientific, Waltham, MA, USA). First strand cDNA synthesis was performed using 40 ng 
of PVN RNA and 100 ng of pituitary and adrenal gland RNA. The RNA was dissolved in 12 μl 
of Rnase-free DEPC containing 0.25 mU random hexamer primers (Roche Applied Science, 
Penzberg, Germany) and then incubated at 70 °C for 10 min, followed by double-strand 
synthesis in first strand buffer with 10 mM DTT, 100 U Superscript II (Life Technologies), 
0.5 mM dNTPs (Roche Applied Science) and 20 U of rRNasin (Promega, Fitchburg, WI, USA) 
at 37 °C for 75 min. The cDNA samples were stored at −20 °C.
Quantitative real-time PCR
Quantitative real-time PCR (qRT–PCR) was performed with the CFX96 Touch Real-Time 
PCR Detection System (Bio-Rad, Hercules, CA, USA). For the reactions a total volume of 25 
μl buffer solution was used containing 5 μl template cDNA, 12.5 μl Power SYBR Green 
Master mix (Applied Biosystems, Foster City, CA, USA), 1.5 μl Rnase-free DEPC and 0.6 μM 
of each primer. The sequences of the primers are available in Supplementary Table 1. 
Before analysis of the relative expression of the genes of interest, for each tissue it was 
evaluated whether Rn18S, Gapdh or Hprt1 would be the best internal control gene. The 
cycling protocol started with 10 min at 95 °C, followed by 39 reaction cycles with 15 s at 95 
°C and 1 min at 60 °C. For each reaction, the Ct (cycle threshold) was determined, that is, 
the number of cycles needed to detect fluorescence above the arbitrary threshold. 
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Plasma measurements
Plasma ACTH levels of the adult offspring (PND85-95) were not significantly affected in our 
experimental design, which was also the case for plasma adrenalin (Figures 2A and C), the 
major output of sympathetic-adrenal medulla activation. It should be noted that it is 
difficult to reliably obtain basal plasma adrenalin levels from non-catheterized animals, as 
adrenalin levels rise within seconds when handling animals.
 In contrast, plasma CORT levels were significantly affected by an interaction of ELS 
with genotype (F2,34 = 3.51, p < 0.05), and not by either factor independently. Specifically, 
the GxE interaction comprised an opposite effect of 5-HTT genotype depending on ELS; 
5-HTT−/− rats displayed the highest plasma CORT levels in the control group (MS0), which 
was absent after MS180 exposure. In contrast, the 5-HTT+/+ rats showed an up-regulation 
Results
Maternal Care and Body Weight
Significant effects for both ELS (F1,20 = 23.49, p < 0.001) and time (F11.14,222.85 = 8.51, 
p < 0.001) on the percentage of time that the pups received ABN were found (MS0: 31.3 
± 2.0% versus MS180: 41.5 ± 0.9%). The main effect of ELS on ABN was found to be 
significant from PND 3–7 (p < 0.05, Figure 1). No interaction effects were found, nor main 
effects of ELS, on the other measures of maternal care including the licking/grooming 
of pups and its combination with ABN.
 For the post-weaning body weight development, significant main effects of time 
(F1.73,153.65 = 14380.56, p < 0.001), ELS (F1,89 = 14.76, p < 0.001) and genotype (F2,89 = 17.57, p 
< 0.001) were obtained. Further, significant interactions were present for time x ELS 
(F1.73,153.65 = 9.56, p < 0.001) and time x genotype (F3.45,153.65 = 12.07, p < 0.001), but not for 
ELS x genotype or time x ELS x genotype. The MS180 male offspring developed a 
significantly lower body weight than MS0 animals from PND30 onwards, whereas 5-HTT−/− 
rats had a significantly lower body weight compared with 5-HTT+/− and 5-HTT+/+ rats across 
all measurements (p < 0.05, Supplementary Figure 1).
Figure 1  The frequency of arched-back nursing (ABN) of the pups as displayed by the mother 
rats across postnatal days (PND) 2-8. The frequency of ABN by the mother was observed daily 
during four observation periods (7.00 a.m. and 1.00, 5.00 and 8.00 p.m.) in litters subjected daily to 
3 h maternal separation (MS180, n = 13) or a control treatment (MS0, n = 12). Data show mean ± SEM 
percentage of time. *: p < 0.05 for MS180 vs MS0.
Figure 2  Plasma levels (± SEM) of adrenocorticotropic hormone (A, ACTH), corticosterone (B, CORT) 
and adrenalin (C) of serotonin transporter (5-HTT) homozygous knockout (5-HTT-/-), heterozygous 
knockout (5-HTT+/-) and wild-type (5-HTT+/+) rats (n = 5-8) exposed to daily 3 h separations (MS180) 
or a control treatment (MS0). The plasma CORT concentrations were found to be significantly 
affected by the interaction of 5-HTT genotype and early life treatment (G x E, p < 0.05).
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 Pituitary mRNA levels
In the pituitary gland no significant effects on the expression of pro-opiomelanocortin 
(precursor protein of ACTH), GR and MR mRNA were found (Supplementary Figure 4). For 
the mRNA levels of CRF receptor 1 (CRF1R) there was a trend towards a 5-HTT genotype 
effect (Supplementary Figure 5A) (F2,34 = 2.63, p = 0.087), while pituitary FKBP5 mRNA 
levels were affected by a main effect of ELS (F1,34 = 6.42, p < 0.05). The exposure of ELS led 
to a decrease of FKPB5 expression in the pituitary of both 5-HTT+/+ and 5-HTT−/− rats 
(Supplementary Figure 5B).
Adrenal mRNA levels
Interestingly, the qRT–PCR analysis of adrenal mRNA levels revealed gene expression 
patterns that resemble the plasma CORT levels as a function of ELS x 5-HTT interaction. 
Although we did not find independent effects of either factor on adrenal mRNA levels, the 
GxE interaction significantly affected the expression of the ACTH-receptor (F2,36 = 7.91, p < 
0.01) and the mitochondrial enzyme 11β-hydroxylase (F2,36 = 15.38, p < 0.001) (Figures 3A 
and B), which is responsible for the last step in glucocorticoid biosynthesis (Zhou et al., 
1995). Furthermore, ELS x 5-HTT genotype interaction significantly affected the mRNA 
levels of steroidogenic acute regulatory protein (StAR, F2,36 = 3.61, p < 0.05) and 3β-hydrox-
ysteroid dehydrogenase (3βHSD1, F2,36 = 12.17, p < 0.001) (Supplementary Figure 6). 
Steroidogenic acute regulatory protein transports the steroid precursor cholesterol into 
the mitochondria, a process regarded as the rate-limiting step in corticosteroid synthesis 
of plasma CORT levels due to MS180, such that the 5-HTT+/+ rats showed the highest 
plasma CORT levels after MS180 treatment (Figure 2B).
PVN mRNA levels
In the PVN we measured the mRNA levels of CRF, glucocorticoid receptor (GR), mineralo-
corticoid receptor and the GR chaperone FK506-binding protein 51 (FKBP5). Factorial 
ANOVA revealed a significant effect of 5-HTT genotype on GR mRNA levels (F2,36 = 3.51, p 
< 0.05). It followed that 5-HTT−/− rats exhibited a significantly lower GR mRNA expression 
than 5-HTT+/+ rats, independent of ELS (p < 0.05, Supplementary Figure 2). The PVN CRF, 
MR and FKBP5 mRNA levels were not affected (Supplementary Figure 3).
Figure 3  Adrenocorticotropic hormone receptor (A, ACTH-R), 11β-hydroxylase (B, cytochrome 
P450 11B1/3, CYP11B1/3) and tyrosine hydroxylase (C) mRNA levels in the adrenal glands of serotonin 
transporter (5-HTT) homozygous knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and 
wild-type (5-HTT+/+) rats (n = 7) exposed to daily 3 h separations (MS180) or a control treatment 
(MS0). The mRNA levels of both ACTH-R and CYP11B1/3 were found to be significantly affected by 
the interaction of 5-HTT genotype and early life treatment (p < 0.01, p < 0.001 respectively). Data 
were normalized to the average of the MS0-5-HTT+/+ group. *: p < 0.05, **: p < 0.01, ***: p < 0.001.
Figure 4  Corticosterone (CORT) response to 10-12 M adrenocorticotropic hormone (ACTH), of 
adrenal tissue derived from serotonin transporter (5-HTT) homozygous knockout (5-HTT-/-), 
heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) rats (n = 6) which were reared in standard 
animal facility conditions. The CORT response was measured in vitro, in a static incubation system 
from which samples were collected every 15 min. *: 5-HTT-/- significantly different from 5-HTT+/+ 
(p < 0.05, one-sided t-test).
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in the PVN and pituitary gland were not affected by ELS x 5-HTT genotype interaction. It 
therefore seems that the ELS x 5-HTT genotype programming of basal HPA-axis activity is, 
within the axis itself, predominantly effectuated at the level of the adrenal gland. It 
remains, however, to be investigated how the interaction of ELS and 5-HTT genotype can 
actually program adrenal ACTH sensitivity. Interestingly, there are numerous intra-adrenal, 
paracrine pathways that are involved in the regulation of adrenocortical steroidogenesis, 
including the intra-adrenal CRF–ACTH and renin–angiotensin systems (Nussdorfer, 1996; 
Ehrhart-Bornstein et al., 1998). Moreover, the chromaffin cells of the rat adrenal medulla are 
known to contain 5-HT, which potently stimulates CORT release by the adrenal cortex 
(Verhofstand and Jonsson, 1983; Lefebvre et al., 1992; Contesse et al., 1998). In humans and 
frogs, this stimulation is mediated by activation of 5-HT4 receptors, but for the rat the 
responsible 5-HT receptor subtype remains elusive (Contesse et al., 1998). In this study, we 
found no effect of ELS x 5-HTT genotype on the expression of the 5-HT4 receptor in the 
adrenals (data not shown), but so far we have not further explored the possibility of ELS x 
5-HTT genotype programming of the intra-adrenal 5-HT system.
 In human 5-HTTLPR S-allele carriers basal CORT levels are increased (O’Hara et al., 
2007; Chen et al., 2009; Goodyer et al., 2009; Wüst et al., 2009, Wankerl et al., 2010), just as 
we found for 5-HTT−/− rats in control conditions. We expand this finding by showing that 
after exposure to ELS, the effect of 5-HTT deficiency is abolished, whereas 5-HTT+/+ rats 
show an up-regulation of their basal HPA-axis activity. Therefore, without a history of ELS, 
5-HTT−/− rats show the highest CORT levels, but after ELS 5-HTT−/− rats display decreased 
and 5-HTT+/+ rats show increased levels of basal CORT. These results resonate with the 
finding that 5-HTTLPR S/S individuals displayed the highest basal CORT levels within a 
low-risk for depression group, whereas in the high-risk group the S/S subjects showed the 
lowest and the L/L subjects the highest baseline CORT levels (Jabbi et al., 2007). 
Accordingly, CORT levels could mediate the combined effects of (early life) stress and 
5-HTTLPR on later life risk for psychopathology (Vinberg et al., 2014). However, although 
CORT is expected to have a significant role in the onset and course of depression, it is not 
exactly clear what this role is (Herbert, 2013). For instance, some studies have, whereas 
others have not, found a relation between basal CORT levels and the recurrence of 
depression in remitted patients (Goodyer et al., 2009; Bockting et al., 2012; Lok et al., 2012). 
Nevertheless, altered basal HPA activity seems to be an endophenotype that cuts across 
disorders, with lower CORT levels consistently observed for post-traumatic stress disorder 
(Yehuda, 2009), whereas elevated plasma CORT levels are found in a subset of depressive 
patients (Checkley, 1996), which possibly reflect the melancholic clinical subtype of 
depression (Gold and Chrousos, 2002). From animal studies, the perspective arises that 
the adaptive- or maladaptiveness of the early life programming of HPA activity is highly 
dependent upon the match or mismatch with the later life environment (Heiming and 
Sachser, 2010; Nederhof and Schmidt, 2012; Van der Doelen et al., 2013), likely due to the 
specific demands of a given stressful context (Myers et al., 2014). Indeed, ELS has been 
(Stocco, 2001), whereas 3βHSD1 participates in the CORT synthesis pathway (Zhao et al., 
1991). In contrast, we found no effect of ELS, 5-HTT gene variation or their interaction on 
the adrenal mRNA levels of tyrosine hydroxylase (Figure 3C), the rate-limiting enzyme in 
(nor)adrenalin biosynthesis (Zigmond et al., 1989). Furthermore, adrenal weight 
(percentage of body weight) was not found to be affected by ELS, 5-HTT genotype or 
their interaction (Supplementary Figure 7).
Adrenal in vitro assay
As we found that the interaction of ELS and 5-HTT gene variation affected plasma CORT 
but not ACTH levels, as well as adrenal gene expression of the ACTH receptor, we 
hypothesized that the basal CORT levels were effectuated by programming of adrenal 
ACTH sensitivity. To provide a proof of concept, we performed an in vitro experiment with 
adrenal glands derived from adult male 5-HTT+/+, 5-HTT+/− and 5-HTT−/− rats without any 
early life environmental manipulation (standard animal facility rearing, AFR). As the AFR 
and MS0 groups are both considered to be control groups, we expected that, upon 
administration of ACTH, adrenal tissue derived from AFR 5-HTT−/− rats would show a 
greater in vitro release of CORT than adrenal tissue of AFR 5-HTT+/+ rats. The basal plasma 
CORT levels of AFR 5-HTT−/− rats were indeed, just as for the MS0 group, found to be higher 
than that of 5-HTT+/+ rats (p < 0.05, Supplementary Figure 8).
 For the in vitro adrenal assay, ANOVA-RM revealed that the adrenal explants showed a 
significant CORT response after the application of 10−12 M ACTH to the medium (time, F5,75 
= 11.92, p < 0.001), with furthermore no main effect of 5-HTT genotype, but a significant 
interaction of time x 5-HTT genotype (F10,75 = 1.96, p < 0.05). Unfortunately, Mauchly’s test 
indicated a violation of sphericity and we therefore had to apply Greenhouse-Geisser 
correction, after which the effect of time remained significant (F2.09,31.36 = 11.92, p < 0.001) 
but the interaction of time × 5-HTT genotype did not (F4.18,31.36 = 1.96, p < 0.05). However, 
as we had an a priori hypothesis, we used one-sided t-tests to confirm that immediately 
after application of ACTH (fractions 3 and 4) 5-HTT−/− adrenal tissue shows a significantly 
higher CORT response than 5-HTT+/+ adrenal tissue (p < 0.05) (Figure 4). An area under the 
curve analysis was used to quantify the total CORT release upon ACTH stimulation, which 
also showed a higher CORT response of adrenal tissue derived from 5-HTT−/− compared 
with 5-HTT+/+ rats (Supplementary Figure 9).
Discussion
In this study, we show for the first time that ELS and 5-HTT genotype interact to program 
basal CORT levels and that this is paralleled by an equivalent GxE programming of adrenal 
mRNA levels of the ACTH-receptor, steroidogenic acute regulatory protein, 3β-HSD1 and 
11β-hydroxylase, which regulate the sensitivity of the adrenal glands to synthesize and 
release CORT upon stimulation by ACTH. In contrast to the adrenal gland, gene expression 
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in PVN CRF gene expression with unaltered basal CORT levels (Plotsky and Meaney, 1993; 
Huot et al., 2004; Plotsky et al., 2005). These strain differences, in addition to 5-HTT gene 
variation, show that the effects of ELS are highly dependent on genetic variation.
 Our GxE interaction findings on plasma CORT and adrenal mRNA levels consist of a 
strong and opposite regulation of 5-HTT+/+ and 5-HTT−/− rats by the exposure to ELS. In 
contrast, 5-HTT+/− rats seem to be unaffected. Yet, it should be noted that 5-HTT+/− rats do 
consistently display an intermediate phenotype on these measures consistent with a 
gene dosage effect. Although 5-HTT+/− rodents have been proposed as the foremost 
model for human 5-HTTLPR S-allele carriers, 5-HTT−/− rodents are regarded as a robust 
model for the S-allele plus a history of stress exposure (Kalueff et al., 2010). Indeed, we have 
shown previously that when 5-HTT+/− rats are exposed in adulthood to an additional 
stressor the experience of early life adversity directs the stress coping behaviour of 
5-HTT+/− rats towards that as displayed by 5-HTT−/− rats (Van der Doelen et al., 2013). 
Therefore, the effects of ELS on the HPA-axis of 5-HTT+/− rats might only become apparent 
with exposure to additional stressors in later life.
 For the interpretation of the effects of ELS on HPA-axis programming, we have 
considered the role of alterations in the care that the mother rats provide to their pups. 
The group of Michael Meaney and others have namely shown that a very specific part of 
maternal care, the licking and grooming of pups, can influence the programming of the 
HPA-axis into adulthood (Liu et al., 1997; Weaver et al., 2004; Macrì and Würbel, 2006). 
However, the exposure of ELS was not found to affect the frequency of licking and 
grooming displayed by the mothers. In contrast, we found that ELS increased the 
frequency of ABN, but this maternal behaviour is not known to affect HPA-axis 
programming (Liu et al., 1997; Weaver et al., 2004; Macrì and Würbel, 2006). Therefore, we 
conclude that the ELS-induced programming of the HPA-axis is not mediated by 
alterations in maternal care. The increased ABN due to maternal separation could be 
considered as an expression of nutritional compensation, although it did not prevent a 
decreased body weight from PND 30 onwards. The isolated, negative effects of ELS and 
5-HTT deficiency on body weight development have both been documented before 
(Biagini et al., 1998; Homberg et al., 2010c).
 In conclusion, we report here that early life programming of basal HPA-axis activity is 
moderated by 5-HTT genotype and that this interaction seems to be effectuated 
predominantly by the regulation of adrenocortical gene expression. Altered HPA activity 
is an endophenotype that is widely relevant across the spectrum of psychiatric disorders, 
therefore, this study emphasizes the importance of the adrenal gland in stress-related 
psychopathology.
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reported to lead to both hypo- and hyperactivity of the human HPA-axis (Heim et al., 2000; 
Gold and Chrousos, 2002; Halligan et al., 2004; Lovallo et al., 2012), and it seems that these 
divergent effects can be explained by distinguishing between different types of ELS and 
by including their possible interaction with later life adversity (Essex et al., 2011; Carvalho 
Fernando et al., 2012; Goldman-Mellor et al., 2012). Therefore, the life history of stressful life 
events, in addition to the environmental demands of the specific stressful life events that 
triggers a current depressive episode, may influence the relation between HPA-axis measures 
and psychiatric variables. Furthermore, in the case of perinatal stress, the maternal HPA-axis 
may be an important mediator of the consequences for the offspring, which are also 
predicted to depend on 5-HTT genotype (Heiming et al., 2011; Kloke et al., 2013).
 Interestingly, in our study the interaction between ELS and 5-HTT gene variation 
determines basal HPA-axis output and matches an identical GxE programming of gene 
expression in the adrenal glands. Given that these genes include the ACTH receptor as 
well as several key enzymes involved in the biosynthesis of CORT and that plasma ACTH 
levels are simultaneously unaltered, we propose that the interaction between ELS and 
5-HTT genotype programs the sensitivity of the adrenals to translate a stimulation of 
ACTH into the synthesis and release of CORT. In support, as 5-HTT−/− rats without a history 
of ELS (MS0/AFR) show increased basal CORT and adrenal ACTH-R mRNA compared with 
5-HTT+/+ rats, their adrenals also show an increased CORT release upon in vitro stimulation 
with ACTH. These findings strongly suggest that the ELS x 5-HTT genotype effect on basal 
CORT levels would influence stress-induced HPA-axis output activity as well. In addition, 
the limited adaptations within the HPA-axis (pituitary, PVN) to the programming of the 
adrenal glands found in this study predict that CORT would influence extra-hypothalamic 
sites (for example, hippocampus, amygdala and prefrontal cortex) involved in HPA 
regulation/programming.
 As no previous studies have assessed the rodent HPA-axis after combining ELS 
exposure and 5-HTT knockout, our results have to be considered independently too for 
these factors to compare them to the literature. In our 5-HTT−/− rats, we confirm previous 
findings in 5-HTT−/− mice showing decreased GR mRNA levels in the PVN and unaltered 
pituitary CRF1R mRNA, adrenal tyrosine hydroxylase mRNA, plasma ACTH and adrenalin 
levels. We however could not replicate the finding that 5-HTT−/− mice show decreased CRF 
mRNA in the PVN and GR mRNA in the pituitary gland (Li et al., 1999; Tjurmina et al., 2002; 
Jiang et al., 2009). Regarding basal plasma CORT, both lower and unaltered levels have been 
reported in 5-HTT−/− mice (Li et al., 1999; Lanfumey et al., 2000; Tjurmina et al., 2002, 2004; 
Bartolomucci et al., 2010; Jansen et al., 2010; Van den Hove et al., 2011; Hohoff et al., 2013; Spinelli 
et al., 2013), complicating a comparison with the present data. For ELS exposure, we replicate 
here previous studies that showed that maternal separation leads to higher baseline plasma 
CORT levels in Wistar and Sprague–Dawley rats (Biagini et al., 1998; Lajud et al., 2012; 
Cotella et al., 2013), with unaltered CRF mRNA levels in the PVN of Sprague–Dawley rats 
(Bravo et al., 2011). In Long–Evans rats, however, maternal separation leads to an increase 
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Supplementary methods
Maternal separation
Litters were randomly allocated to one of two rearing conditions (from PND 2 to 14): 
maternal separation for 180 min (MS180) or a control treatment with immediate reunion of 
mother and pups (MS0). MS180 was started daily between 08.30 and 09.00 a.m., and 
consisted of the following procedure: The mother was removed from the home cage and 
placed into an identical cage until the end of the separation period. Pups were then 
removed from the nest as complete litters and placed into a cage (24 x 15 x 14 cm) with 
only sawdust bedding, and then transferred to an adjacent room. There, the cages were 
placed on heat pads, which were set to maintain a bedding temperature of 31-33°C for 
PND 2-7 and 29-31°C for PND 8-14. At the end of the separation period, litters were returned 
to their home cage by first rolling them in the home cage bedding material and then 
placing them in the nests. This was followed by reunion with the mothers. During PND 
0-22, half of the bedding material of the home cages was refreshed every week.
Gene Primer pair Reference  sequence
Crh Fw 5’-CCGGGCAGAGCAGTTAGC-‘3 NM_031019.1
Rev 5’-CAACATTTCATTTCCCGATAATCTC-‘3
Crhr1 Fw 5’-TGCCAGGAGATTCTCAACGAA-‘3 NM_030999.3
Rev 5’-AAAGCCGAGATGAGGTTCCAG-‘3
Cyp11b1/ Cyp11b3 Fw 5’-AAAATGTATCAAGAATGTGTATCGC-‘3 NM_012537.3/ 
NM_181824.1
Rev 5’-AAGGAGATTGCTGTCGTGTC-‘3
Fkbp5 Fw 5’-GAACCCAATGCTGAGCTTATG-‘3 NM_001012174.1
Rev 5’-ATGTACTTGCCTCCCTTGAAG-‘3
Gapdh Fw 5’-GGTGTGAACGGATTTGGC-‘3 NM_017008.4
Rev 5’- CTGGAAGATGGTGATGGGTT-‘3
Hprt1 Fw 5’-CAGACCGCTTTTCCCGC-‘3 NM_012583.2
Rev 5’-CCCCCTTCAGCACACAGAG-‘3
Hsd3b1 Fw 5’-CCAGGGCATCTCTGTTGTCAT-‘3 NM_001007719.3
Rev 5’-AGGCTGGCACACTGGCTTC-‘3
Mc2r Fw 5’-CACACAGAGCGACAAACCTT-‘3 NM_001100491.1
Rev 5’-GGATGGTGCTTGCTGTTGAC-‘3
Nr3c1 Fw 5’-TCGTCAAAAGGGAAGGGAACT-‘3 NM_012576.2
Rev 5’-TGGAAGCAGTAGGTAAGGAGA-‘3
Nr3c2 Fw 5’-AACCGCCTGGCAGCGAAACA-‘3 NM_013131.1
Rev 5’-GGCTGATCTGGCGCATCCCC-‘3
Pomc Fw 5’-GAGCAGCCAGTGCCAGGA-‘3 NM_139326.2
Rev 5’-TCAAGGGCTGTTCATCTCCG-‘3
Rn18S Fw 5’-GTAACCCGTTGAACCCCATT-‘3 NR_046237.1
Rev 5’-CCATCCAATCGGTAGTAGCG-‘3
Star Fw 5’-CAACTGGAAGCAACACTCTACA-‘3 NM_031558.3
Rev 5’-CACTTCATCTCCATTCTCCTGC-‘3
Th Fw 5’-ACTATGCCCACCCCCAGC-‘3 NM_012740.3
Rev 5’- GCATTCCCATCCCTCTCCTC-‘3
Table S1 Primer pairs used for quantitative real-time PCR. Primers were designed using NCBI 
Primer-Blast (www.ncbi.nlm.nih.gov/tools/primer-blast/) and synthesized by Biolegio BV (Nijmegen, 
The Netherlands). The primer pair for 11β-hydroxylase does not discern between the isoforms 
CYP11B1 and CYP11B3 and will thus be referred to as CYP11B1/3. With standard curve analysis all 
primer pairs were confirmed to have reaction efficiencies of > 1.8. The efficiency of the primer 
pairs was determined separately for cDNA samples of the paraventricular nucleus of the 
hypothalamus (PVN), the pituitary (PIT) and adrenal (ADR) glands.
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Figure S1 Body weight (± SEM) development from weaning, postnatal day (PND) 22, until 
adulthood (PND79). Independently, early life stress (ELS) and serotonin transporter (5-HTT) genotype 
affected body weight. The maternally separated (MS180, n = 50) animals developed a significantly 
lower body weight compared to control animals (MS0, n = 45) from PND30 onwards (A). Furthermore, 
while serotonin transporter (5-HTT) homozygous knockout (5-HTT-/-, n = 24) rats had significantly 
lower body weight than 5-HTT heterozygous knockout (5-HTT+/-, n = 42) and wild-type (5-HTT+/+, 
n = 29) rats at every time point (B). *p < 0.05.
Figure S2 Glucocorticoid receptor (GR) mRNA levels in the paraventricular nucleus of the hypo- 
thalamus of serotonin transporter (5-HTT) homozygous knockout (5-HTT-/-), heterozygous knockout 
(5-HTT+/-) and wild-type (5-HTT+/+) rats (n = 5-9) exposed to daily 3 h separations (MS180) or a control 
treatment (MS0). Factorial ANOVA revealed a main effect of 5-HTT genotype (G: p < 0.05) and 
post-hoc testing showed that 5-HTT-/- rats have significantly lower GR mRNA levels than 5-HTT+/+ rats 
(p < 0.05). Data were normalized to the average of the MS0-5-HTT+/+ group.
Figure S3 Corticotropin-releasing factor (CRF), mineralocorticoid receptor (MR) and FK506-binding 
protein 51 (FKBP5) mRNA levels in the paraventricular nucleus of the hypothalamus of serotonin 
transporter (5-HTT) homozygous knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and wild- 
type (5-HTT+/+) rats (n = 5-9) exposed to 3 h daily separations (MS180) or a control treatment (MS0). 
Data were normalized to the average of the MS0-5-HTT+/+ group.
60 61
CHAPTER 3 THE HPA-AXIS AND ADRENAL PROGRAMMING
3
Figure S4 Pro-opiomelanocortin (POMC), glucocorticoid receptor (GR) and mineralocorticoid 
receptor (MR) mRNA levels in the pituitary glands of serotonin transporter (5-HTT) homozygous 
knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) rats (n = 5-9) exposed 
to 3 h daily separations (MS180) or a control treatment (MS0). Data were normalized to the average 
of the MS0-5-HTT+/+ group.
Figure S5 Corticotropin-releasing factor receptor 1 and FK506-binding protein 51 (FKBP5) mRNA 
levels in the pituitary glands of serotonin transporter (5-HTT) homozygous knockout (5-HTT-/-), 
heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) rats (n = 5-9) exposed to daily 3 h 
separations (MS180) or a control treatment (MS0). Factorial ANOVA revealed a main effect of early life 
treatment (E: p < 0.05), with 5-HTT+/+ and 5-HTT-/- rats showing decreased FKBP5 mRNA levels after 
exposure to early life stress. Data were normalized to the average of the MS0-5-HTT+/+ group.
Figure S6 Steroidogenic acute regulatory protein (StAR) and 3β-hydroxysteroid dehydrogenase 1 
(3β-HSD1) mRNA levels in the adrenal glands of serotonin transporter (5-HTT) homozygous knockout 
(5-HTT-/-), heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) rats (n = 7) exposed to 3 h daily 
separations (MS180) or a control treatment (MS0). The mRNA levels of both StAR and 3β-HSD1 were 
found to be significantly affected by the interaction of 5-HTT genotype and ELS (p < 0.05, p < 0.001 
respectively). Data were normalized to the average of the MS0-5-HTT+/+ group. *: p < 0.05, **: p < 0.01.
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Figure S7 Adrenal weight expressed as percentage of body weight of serotonin transporter 
(5-HTT) homozygous knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) 
rats (n = 5-9) exposed to 3 h daily separations (MS180) or a control treatment (MS0).
Figure S9 Plasma corticosterone (CORT) response to 10-12 M adrenocorticotropic hormone, of 
adrenal tissue derived from serotonin transporter (5-HTT) homozygous knockout (5-HTT-/-), 
heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) rats (n = 6) which were reared in standard 
animal facility conditions. The total amount of secreted CORT, i.e. the area under the curve is shown, 
which was not found to be significantly altered by 5-HTT genotype (F2,17 = 2,368, p > 0.05). However, 
as it was hypothesized that adrenal tissue derived from AFR 5-HTT-/- rats would show a significantly 
higher CORT response than adrenal tissue derived from AFR 5-HTT+/+ rats we also performed a 
one-sided t-test, confirming the a priori hypothesis (p < 0.05).
Figure S8 Plasma corticosterone (CORT) levels of serotonin transporter (5-HTT) homozygous 
knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) rats (n = 7) which 
were reared in standard animal facility conditions. The plasma CORT levels were significantly affected 
by 5-HTT genotype (F2,20 = 5.029, p < 0.05), with 5-HTT
-/- rats showing higher levels than 5-HTT+/- 
(p = 0.053) and 5-HTT+/+ rats (p < 0.05).
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Introduction
Vulnerability to stress-related psychiatric disease is determined by a complex interplay of 
genome and environment. The moderation of the effects of stressful life events by the 
serotonin transporter (5-HTT) gene-linked polymorphic region (5-HTTLPR) is a well-known 
example of such a gene x environment (GxE) interaction (Caspi et al., 2003). Specifically, 
the short (S) allele of 5-HTTLPR has been associated with a significantly increased risk to 
develop depression in interaction with adverse events such as childhood abuse (Karg et 
al., 2011, but also see Risch et al., 2009). Compared to L/L homozygotes, individuals with 
the S-allele have an approximate two-fold reduction in the promoter activity of the 5-HTT 
gene (Heils et al., 1996; Lesch et al., 1996; Greenberg et al., 1999). The consequences of 
lower 5-HTT availability can be studied by use of homozygous and heterozygous 5-HTT 
knockout (5-HTT-/-, 5-HTT+/-) rodents. The 5-HTT+/- rodents are considered to be the superior 
genotype model of the S-allele, as they display a two-fold reduction in 5-HTT availability 
(Bengel et al., 1998; Homberg et al., 2007), and increased sensitivity to stressful events 
(Carola et al., 2008; Narayanan et al., 2011; Van der Doelen et al., 2013), just as 5-HTTLPR 
S-allele carriers. Yet, at baseline, 5-HTT-/- rodents show superior behavioural similarity with 
S-allele healthy controls, as expressed by anxiety- and depressive-like behaviour (Holmes 
et al., 2003a; Lira et al., 2003a; Olivier et al., 2008a; Schipper et al., 2011b). Therefore, it has 
been argued that both 5-HTT+/- and 5-HTT-/- rodents are useful to study the underlying 
biology of ELS x 5-HTTLPR interaction (Caspi et al., 2010; Kalueff et al., 2010; Homberg and 
Van den Hove, 2012).
 One of the candidate biological systems that could underlie this depressogenic GxE 
interaction is the stress-responsive hypothalamo-pituitary-adrenal (HPA) axis. A stress 
response of the HPA-axis is initiated by parvocellular neurons in the paraventricular 
nucleus (PVN) of the hypothalamus, by secreting corticotropin-releasing factor (CRF) at 
the median eminence to stimulate the anterior pituitary to synthesize and release adreno-
corticotropic hormone (ACTH), which itself stimulates the synthesis and release of gluco-
corticoids (cortisol in humans, corticosterone in rodents) from the adrenal cortex. The 
HPA-axis is regulated through direct feedback action of glucocorticoids at the level of the 
pituitary and the PVN, but importantly also by extra-hypothalamic brain areas such as the 
medial prefrontal cortex, hippocampus and extended amygdala (Ulrich-Lai and Herman, 
2009). This feedback action is mediated via the mineralocorticoid and glucocorticoid 
receptors (MR, GR), with MR mainly involved in maintaining basal HPA activity and GR with 
recovery from stress-induced activity. Glucocorticoids furthermore act via these receptors on 
peripheral tissues as well as the brain to affect physiology and behaviour, and to facilitate 
an integrative stress response (De Kloet et al., 1998, 2005; Champagne et al., 2009).
 In depression, about 50% of patients display hyperactivity of the HPA-axis as represented 
by basal hypercortisolemia and resistance to GR-mediated suppression of glucocorticoid 
levels (Checkley, 1996; Pariante and Miller, 2001). In contrast, HPA hypoactivity has been 
Abstract
The short allelic variant of the serotonin transporter (5-HTT) promoter-linked polymorphic 
region (5-HTTLPR) has been associated with the etiology of major depression by 
interaction with early life stress (ELS). A frequently observed endophenotype in depression 
is the abnormal regulation of levels of stress hormones such as glucocorticoids. It is 
hypothesized that altered central glucocorticoid influence on stress-related behaviour 
and memory processes could underlie the depressogenic interaction of 5-HTTLPR and 
ELS. One possible mechanism could be the altered expression of the genes encoding the 
glucocorticoid and mineralocorticoid receptors (GR, MR) and their inhibitory regulator 
FK506-binding protein 51 (FKBP5) in stress-related forebrain areas. To test this notion, we 
exposed heterozygous (5-HTT+/-) and homozygous (5-HTT-/-) serotonin transporter 
knockout rats and their wildtype littermates (5-HTT+/+) to daily 3 h maternal separations 
from postnatal day 2 to 14. In the medial prefrontal cortex (mPFC) and hippocampus of 
the adult male offspring, we found that GR, MR, and FKBP5 mRNA levels were affected by 
ELS x 5-HTT genotype interaction. Specifically, 5-HTT+/+ rats exposed to ELS showed 
decreased GR and FKBP5 mRNA in the dorsal and ventral mPFC, respectively. In contrast, 
5-HTT+/- rats showed increased MR mRNA levels in the hippocampus and 5-HTT-/- rats 
showed increased FKBP5 mRNA in the ventral mPFC after ELS exposure. These findings 
indicate that 5-HTT genotype determines the specific adaptation of GR, MR, and FKBP5 
expression in response to early life adversity. Therefore, altered extra-hypothalamic gluco-
corticoid signaling should be considered to play a role in the depressogenic interaction of 
ELS and 5-HTTLPR.
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control, learning and memory, and fear and anxiety output (De Kloet et al., 1998, 2005; 
LeDoux, 2000; Amat et al., 2005; Kim et al., 2013).
Materials and Methods
Animals
The experiments were approved by the Committee for Animal Experiments of the 
Radboud University Nijmegen, The Netherlands, and all efforts were made to minimize 
animal suffering, to reduce the number of animals and to utilize alternatives to in vivo 
techniques. Serotonin transporter knockout rats (Slc6a41Hubr) were generated by N-eth-
yl-N-nitrosurea (ENU)-induced mutagenesis (Smits et al., 2006). Experimental animals 
(5-HTT-/-, 5-HTT+/- and 5-HTT+/+ rats) were derived from crossing 3 month old 5-HTT+/- rats 
that were outcrossed for at least twelve generations with commercial (Harlan, Ter Horst, 
The Netherlands) wild-type Wistar rats. The pregnant dams were housed in standard 
polypropylene cages (40 x 20 x 18 cm) with sawdust bedding and ad libitum access to 
water and rodent chow (Sniff Spezialdiäten, Soest, Germany) in a temperature (21 ± 1 °C) 
and humidity-controlled room (45-60% relative humidity), with a 12 : 12 h light : dark cycle 
(lights on at 07.00 a.m.). The dams were inspected daily for delivery at 5.00 p.m. and day of 
birth was designated as postnatal day (PND) 0. At PND1, two paper towels (22,5 x 24,5 cm) 
were supplied to the mother for nest construction. Further, the litters were culled to a 
maximum of 10 pups (one litter had only 9 pups, another only 8 pups), with gender ratios 
in favor of a male majority (5:5 to maximally 7 : 3).
Early life stress
We used repeated and prolonged maternal separation as a model for ELS, as this paradigm 
has previously been shown to affect the HPA-axis functioning and stress coping behaviour 
of the offspring (Plotsky and Meaney, 1993; Francis et al., 2002; Ladd et al., 2004; Levine, 
2005; Plotsky et al., 2005; Macrì and Würbel, 2006; Van der Doelen et al., 2014a). Litters were 
randomly allocated to one of two rearing conditions (from PND 2 to 14): maternal 
separation for 180 min (MS180) or a control treatment with immediate reunion of mother 
and pups (MS0). MS180 was started daily between 08.30 and 09.00 a.m., and consisted of 
the following procedure: The mother was removed from the home cage and placed into 
an identical cage until the end of the separation period. Pups were then removed from 
the nest as complete litters and placed into a cage (24 x 15 x 14 cm) with clean sawdust 
bedding, and then transferred to an adjacent room. There, the cages were placed on heat 
pads, which were set to maintain a bedding temperature of 31-33 °C for PND 2-7 and 29-31 
°C for PND 8-14. At the end of the separation period, litters were returned to their home 
cage by placing them in the nests and sprinkling soiled home cage bedding over them. 
This was followed by reunion with the mothers. We have previously reported that this 
observed for atypical depression and post-traumatic stress disorder, the latter being 
associated with increased GR sensitivity (Gold and Chrousos, 2002; Yehuda, 2009). Further, 
single nucleotide polymorphisms and expression levels of the genes encoding GR (NR3C1) 
and MR (NR3C2) have been associated with depression (Webster et al., 2002; Van Rossum 
et al., 2006; Klok et al., 2011a, 2011b; Medina et al., 2013; Qi et al., 2013)which might be 
caused by impaired glucocorticoid signaling. Glucocorticoids act through the 
glucocorticoid receptor (GR. Specifically, in major depression postmortem studies have 
documented decreased hippocampal GR and MR mRNA levels (Webster et al., 2002; Klok 
et al., 2011a). The decrease in hippocampal MR expression in major depression could be 
restricted to the anterior hippocampus (Medina et al., 2012). Furthermore, lower MR mRNA 
levels in different areas of the prefrontal cortex have been reported for depressed 
compared to non-depressed subjects (Klok et al., 2011a; Qi et al., 2013).
 Therefore, there is convincing evidence that altered glucocorticoid signaling through 
altered expression of GR and MR in forebrain areas is highly relevant in the pathophysiol-
ogy of depression (Holsboer, 2000).
 Recently, FK506-binding protein 51 (FKBP5), a co-chaperone of steroid hormone 
receptors, has emerged as an important regulator of stress-induced GR-mediated effects 
(Binder, 2009). Genetic variation of FKBP5 has additionally been shown to interact with 
early life stress (ELS) to epigenetically program GR-induced transcription of FKBP5, leading 
to increased risk for the development of stress-related psychiatric disorders (Klengel et al., 
2013). Furthermore, the expression levels of Fkbp5 and Nr3c1 in the adult rat brain have 
recently been reported to be sensitive to chronic stress (CS) exposure and antidepressant 
treatment (Guidotti et al., 2013), while Fkbp5 knockout mice seem to be less vulnerable to 
CS exposure (Hartmann et al., 2012). In addition, CS has been shown to lead to a disruption 
of the extra-hypothalamic control of HPA function (Radley et al., 2013).
 Altogether, altered central glucocorticoid signaling is a plausible contributing factor 
to the increased vulnerability of childhood maltreatment-exposed 5-HTTLPR S-allele 
carriers to psychopathology. Previously, we have shown that our animal model of ELS x 
5-HTT genotype interaction displays differential susceptibility to inescapable stress and 
altered activity of the HPA-axis (Van der Doelen et al., 2013, 2014a). In the HPA-axis, we 
predominantly found GxE programming of the adrenal gland, while gene expression in 
the pituitary and PVN was largely unaffected (Van der Doelen et al., 2014a). Therefore, we 
hypothesized that if there are adaptations in the expression of GR, MR, and/or FKBP5 in our 
animal model of ELS x 5-HTT genotype interaction, these adaptations would take place in 
extra-hypothalamic brain regions. To test this hypothesis we exposed 5-HTT heterozygous 
(5-HTT+/-) and homozygous (5-HTT-/-) knockout rats to ELS, i.e. maternal separation, and 
examined the expression of GR, MR, and FKBP5 in the medial prefrontal cortex, 
hippocampus, amygdala, and bed nucleus of the stria terminalis. In addition to their 
regulatory function of the HPA-axis (Ulrich-Lai and Herman, 2009), these brain areas are 
known for their involvement in stress-related behavioural processes such as cognitive 
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buffer with 10 mM DTT, 100 U Superscript II (Life Technologies), 0.5 mM dNTPs (Roche 
Applied Science) and 20 U of rRNasin (Promega Corp., Fitchburg, WI, USA) at 37 °C for 75 
min. In Milan, RNA was analyzed using the iScriptTM one-step RT-PCR kit for probes 
(Bio-Rad), with RT-PCR performed in multiplexed reactions with a normalizing internal 
control (36B4) by use of the CFX384 real time system (Bio-Rad). Thermal cycling was 
initiated with an incubation at 50 °C for 10 min (RNA retrotranscription), followed by 5 min 
at 95 °C (TaqMan polymerase activation) and 39 reaction cycles with 10 s at 95 °C and 30 s 
at 60°C. In Nijmegen, RT-PCR was performed with the CFX96 real time system (Bio-Rad). 
Prior to analysis of the relative expression of Nr3c1, Nr3c2 and Fkbp5, it was evaluated 
whether Rn18S, Gapdh or Hprt1 would be the best internal control gene (also see Derks et 
al., 2008). Gapdh expression was found to be unaffected by our experimental design in all 
brain areas, and was therefore used as the internal control for this study. Furthermore, all 
primer pairs were tested for reaction efficiency. For the reactions a total volume of 25 µl of 
buffer solution was used containing 5 µl of template cDNA, 12.5 µl Power SYBR Green 
Master mix (Applied Biosystems, Foster City, CA, USA), 1.5 µl Rnase-free water and 0.6 µM 
of each primer. The cycling protocol started with 10 min at 95 °C, followed by 39 reaction 
cycles with 15 s at 95 °C and 1 min at 60 °C. The procedure was concluded with a melting 
curve protocol, from 65 °C to 95 °C, measuring fluorescence every 0.5 °C, to control for 
product specificity. Primers and probe sequences used were purchased from Eurofins 
MWG-Operon (Ebersberg, Germany) and Biolegio (Nijmegen, The Netherlands). All RT-PCR 
analyses were carried out in triplicate, with newly synthesized cDNA. Relative target gene 
expression was calculated by the 2-ΔCt method (Schmittgen and Livak, 2008). The following 
primer and probe sequences were used; Nr3c1-Fw: 5’-GAAAAGCCATCGTCAAAA-GGG-‘3, 
Nr3c1-Rev: 5’-TGGAAGCAGTAGGTAAGGAGA-‘3, Nr3c1-Probe: 5’-AGCTTTGTCAGTTGGTA-
AAACCGTTGC-‘3, Nr3c2-Fw: 5’-TCGCTTTGAGTTGGAGATCG-‘3, Nr3c2-Rev: 5’-ACGAATT-
GAAGGCTGATCTGG-‘3, Nr3c2-Probe: 5’-AGTCTGCCATGTATGAACTGTGCCA-‘3, Fkbp5-Fw: 
5’-GAACCCAATGCTGAGCTTATG-‘3, Fkbp5-Rev: 5’-ATGTACTTGCCTCCCTTGAAG-‘3, Fkbp5-Probe: 
5’-TGTCCATCTCCCAGGATTCTTTGGC-‘3, 36B4-Fw: 5’-TTCCCACTGGCTGAAAAGGT-‘3, 36B4-Rev: 
5’-CGCAGCCGCAAATGC-‘3, 36B4-Probe: 5’-AAGGCCTTCCTGGCCGATCCATC, Gapdh-Fw: 
5’-GGTGTGAACGGATTTG-GC-‘3, Gapdh-Rev: 5’-CTGGAAGATGGTGATGGGTT-‘3.
Statistical analysis
All statistical tests have been carried out using SPSS (version 20, IBM corporation, Armonk, 
NY, USA). The results are presented as the mean with the standard error of the mean (SEM). 
The RT-PCR 2-ΔCt data have been normalized to the average of the MS0-wild-type group 
and have been examined with factorial ANOVA. If a significant main effect (“genotype”, 
“early life stress”) or interaction (“genotype x early life stress”) was found, appropriate a 
posteriori tests were performed (one-way ANOVA and independent samples t-test). 
Statistical significance was set at p < 0.05. Group sizes are available in the supplementary 
material.
procedure affects maternal care behaviour across PND2-8 (Van der Doelen et al., 2014a). 
During PND 0-22, half of the bedding material of the home cages was refreshed every 
week. At PND 14, ear punches were taken of the pups for identification and genotyping, 
which was performed by Kbiosciences (Hoddesdon, United Kingdom). The procedure of 
genotyping has been described previously (Homberg et al., 2007). At PND 22, the pups 
were weaned and housed in groups of 2-3 littermates of the same sex and rearing, under 
the same conditions as mentioned above.
Tissue collection
For the collection of tissues only adult (PND85-95) male rats were used. These rats were 
derived of 13 litters that were subjected to MS180 and 12 litters that received the control 
treatment (MS0). Of every litter, where possible, a single rat was selected of all three 
genotypes. The rats were sacrificed between 9.00 a.m. and 2.00 p.m. by acute decapitation. 
Across this time period, the rats were randomized for their genotype and early life 
treatment. Immediately after decapitation, the brains were isolated, frozen in aluminum 
foil on dry ice and stored at -80 °C. In a cryostat (-15 °C), the brains were prepared in 420 
µm-thick coronal slices in order to obtain punches from dorsal and ventral parts (prelimbic, 
infralimbic respectively) of the medial prefrontal cortex (mPFC, Bregma +3.72 and +3.30 
mm), the anterodorsal part of the bed nucleus of the stria terminalis (BNST, Bregma +0.24 
and -0.18 mm), central amygdala (Bregma -1.72 and -2.14 mm) and dorsal (Bregma -2.14 
and -2.56 mm) and ventral hippocampus (Bregma -4.80 and -5.22 mm). The brain areas 
were bilaterally punched out with a Miltex 1.5 (hippocampal samples) or 1.0 mm (other 
areas) biopsy puncher (Integra Miltex, York, PA, USA), collected in sterile vials, immediately 
placed on dry ice and stored at -80 °C. 
RNA isolation and gene expression analysis by quantitative  
real-time PCR
Total RNA was isolated by a single step of guanidinium isothiocyanate/phenol extraction 
using PureZol RNA isolation reagent (Bio-Rad, Hercules, CA, USA) according to 
manufacturer’s instructions. RNA concentrations were measured and RNA purity checked 
(A260/280 ratio between 1.8 and 2.0) with a NanoDrop 1000 spectrophotometer (Thermo 
Fisher Scientific, Waltham, MA, USA). Samples were treated with DNase to avoid DNA 
contamination. As the study was a collaborative effort, real-time PCR (RT-PCR) was 
performed both in Milan (mPFC and hippocampal samples) and Nijmegen (anterodorsal 
BNST and central amygdala). To exclude possible differential results depending on the 
methods, adrenal gene expression was assessed in both labs and yielded identical 
statistical conclusions as previously published (Van der Doelen et al., 2014a). In Nijmegen 
first strand cDNA synthesis was performed by incubating 40 ng of RNA dissolved in 12 µl 
of Rnase-free water containing 0.25 mU random hexamer primers (Roche Applied Science, 
Penzberg, Germany) at 70 °C for 10 min, followed by double-strand synthesis in 1st strand 
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 Further, GR mRNA levels in the ventral hippocampus (F1,30 = 9.62, p < 0.01) (Figure 1E) 
and the anterodorsal BNST (F1,26 = 5.92, p < 0.05) (Figure 1F) were affected by a main effect 
of ELS (MS0 > MS180), while ventral mPFC GR mRNA levels were found to be affected by a 
main effect of 5-HTT genotype (F2,29 = 11.62, p < 0.001), leading to higher GR expression in 
the ventral mPFC of 5-HTT-/- rats in comparison to 5-HTT+/+ rats (p < 0.001) (Figure 1D). The 
GR mRNA levels in the central amygdala were not found to be affected by ELS, 5-HTT 
genotype or their interaction (Figure 1C).
MR mRNA levels
MR mRNA levels in the dorsal hippocampus (F2,26 = 14.09, p < 0.001) as well as the ventral 
hippocampus (F2,29 = 7.10, p < 0.01) were found to be significantly affected by the 
interaction of ELS and 5-HTT genotype. These interaction effects were found together 
with main effects of ELS (F1,29 = 11.59, p < 0.01) and 5-HTT genotype (F2,29 = 26.92, p < 0.001) 
in the ventral hippocampus and a main effect of 5-HTT genotype (F2,26 = 9.87, p < 0.01) 
in the dorsal hippocampus.
Results
GR mRNA levels
GR mRNA levels were found to be significantly affected by the interaction of ELS and 
5-HTT genotype in the dorsal mPFC (F2,31 = 7.08, p < 0.01) and dorsal hippocampus (F2,33 = 
4.57, p < 0.05). In the dorsal hippocampus, a significant main effect of 5-HTT genotype 
(F2,33 = 4.57, p < 0.05) was found in addition.
 The exposure to ELS selectively decreased GR expression in the dorsal mPFC of 
5-HTT+/+ rats (p < 0.01), leading to significantly lower GR mRNA levels for 5-HTT+/+ rats in 
comparison to 5-HTT+/- (p < 0.01) and 5-HTT-/- rats within the MS180 group (p < 0.05) 
(Figure 1A). In the dorsal hippocampus, 5-HTT-/- rats displayed higher GR mRNA levels 
compared to 5-HTT+/- and 5-HTT+/+ rats within the MS0 group (p < 0.01), but this effect of 
5-HTT deficiency was not present in the case of ELS exposure (MS180 group) (Figure 1B).
Figure 1 Glucocorticoid receptor (GR) mRNA levels in the dorsal medial prefrontal cortex (mPFC) 
(A), dorsal hippocampus (B), central amygdala (C), ventral mPFC (D), ventral hippocampus (E) and 
the anterodorsal bed nucleus of the stria terminalis (BNST) (F) of serotonin transporter (5-HTT) 
homozygous knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) rats 
exposed to daily 3 h separations (MS180) or a control treatment (MS0). GR mRNA levels in the dorsal 
mPFC and dorsal hippocampus were found to be affected by a significant interaction of early life 
stress (ELS) and 5-HTT genotype (p < 0.01, p < 0.05, respectively), with asterisks indicating significant 
pairwise comparisons (*: p < 0.05, **: p < 0.01 and ***: p < 0.001). Furthermore, GR mRNA levels were 
affected by independent effects of 5-HTT genotype (G, p < 0.05) in the ventral mPFC and ELS (E, p < 
0.05) in the ventral hippocampus and anterodorsal BNST. Post-hoc analysis revealed GR mRNA levels 
in the ventral mPFC to be higher for 5-HTT-/- rats compared to 5-HTT+/+ rats (p < 0.001). Data were 
normalized to the average of the MS0-5-HTT+/+ group.
Figure 1 Continued.
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 In the central amygdala, ventral mPFC, and anterodorsal BNST MR mRNA levels were 
not found to be affected by ELS, 5-HTT genotype or their interaction (Figure 2C, D, F).
FKBP5 mRNA levels
FKBP5 mRNA levels were found to be significantly affected by the interaction of ELS and 
5-HTT genotype in the dorsal mPFC (F2,31 = 7.08, p < 0.01) and ventral mPFC (F2,33 = 4.57, 
p < 0.05). In addition, main effects of ELS in the dorsal mPFC (F1,29 = 8.87, p < 0.01) and 
5-HTT genotype in the ventral mPFC (F2,29 = 7.89, p < 0.01) were identified.
 For the dorsal mPFC, within the MS0 group 5-HTT-/- rats displayed increased FKBP5 
mRNA levels compared to 5-HTT+/+ rats (p < 0.05). After exposure to ELS however, FKBP5 
expression decreased only in 5-HTT-/- rats (p < 0.01), and no difference was found between 
5-HTT-/- and 5-HTT+/+ rats (Figure 3A). In contrast, FKBP5 mRNA levels in the ventral mPFC 
were found to be increased for 5-HTT-/- rats (p < 0.01), but decreased for 5-HTT+/+ rats 
(p < 0.05), after exposure to ELS. Therefore, within the MS180 group 5-HTT-/- and 5-HTT+/- 
 For the dorsal hippocampus, MR mRNA levels were selectively increased for 5-HTT+/- 
rats due to exposure to ELS (p < 0.01), leading to significantly higher MR expression for 
5-HTT+/- rats compared to 5-HTT+/+ (p < 0.01) and 5-HTT-/- rats (p < 0.001) (Figure 2B). In the 
ventral hippocampus, MR mRNA levels were significantly lower for 5-HTT-/- rats in 
comparison to 5-HTT+/+ (p < 0.05) and 5-HTT+/- rats (p < 0.05). The exposure to ELS led to a 
selective increase of MR expression for 5-HTT+/- rats (p < 0.01), leading to significantly 
higher MR mRNA levels for 5-HTT+/- rats compared to 5-HTT+/+ rats within the MS180 group 
(p < 0.01) and further increasing the significantly lower MR expression in the ventral 
hippocampus of 5-HTT-/- rats compared to 5-HTT+/- rats (p < 0.001) (Figure 2E).
 In the dorsal mPFC, MR mRNA levels were found to be affected by main effects of 
both ELS (F1,32 = 4.26, p < 0.05) and 5-HTT genotype (F2,32 = 13.01, p < 0.001). The exposure 
to ELS led to a decrease in MR expression (MS0 > MS180), while 5-HTT+/- and 5-HTT-/- rats 
were both found to display higher MR mRNA levels than 5-HTT+/+ rats (p < 0.01 and p < 0.001, 
respectively) (Figure 2A).
Figure 2 Mineralocorticoid (MR) mRNA levels in the dorsal medial prefrontal cortex (mPFC) (A), 
dorsal hippocampus (B), central amygdala (C), ventral mPFC (D), ventral hippocampus (E) and the 
anterodorsal bed nucleus of the stria terminalis (BNST) (F) of serotonin transporter (5-HTT) 
homozygous knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) rats 
exposed to daily 3 h separations (MS180) or a control treatment (MS0). MR mRNA levels in the dorsal 
and ventral hippocampus were found to be affected by a significant interaction of early life stress 
(ELS) and 5-HTT genotype (p < 0.001, p < 0.01, respectively), with asterisks indicating significant 
pairwise comparisons (*: p < 0.05, **: p < 0.01 and ***: p < 0.001). Furthermore, MR mRNA levels were 
affected by independent effects of 5-HTT genotype (G, p < 0.001) and ELS (E, p < 0.05) in the dorsal 
mPFC. Post-hoc analysis revealed MR mRNA levels in the dorsal mPFC to be higher for both 5-HTT+/- 
and 5-HTT-/- rats compared to 5-HTT+/+ rats (p < 0.01 and p < 0.001, respectively). Data were 
normalized to the average of the MS0-5-HTT+/+ group.
Figure 2 Continued.
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Discussion
In this study, we found that ELS exposure differentially induced adaptations of GR, MR, and 
FKBP5 mRNA levels at extra-hypothalamic sites in adult 5-HTT+/+, 5-HTT+/- and 5-HTT-/- rats. 
It remains to be experimentally determined how these findings could be related to the 
altered activity of the HPA-axis (Van der Doelen et al., 2014) and stress coping behaviour 
(Van der Doelen et al., 2013) that we previously reported of our animal model of ELS x 
5-HTTLPR interaction. Moreover, as we and others have recently shown (Daskalakis et al., 
2012; Van der Doelen et al., 2013; Santarelli et al., 2014), the exposure to stress does not 
necessarily need to have negative consequences, but can rather induce phenotypic 
changes that have adaptive value in coping with later life stressors. As such, these findings 
support the recently postulated match/mismatch hypothesis (Champagne et al., 2009; 
Nederhof and Schmidt, 2012), which states that individuals can use the experience of past 
stressors to adaptively respond to future challenges (predictive adaptive response) 
rats showed significantly higher FKBP5 mRNA levels compared to 5-HTT+/+ rats (p < 0.001 
and p < 0.01, respectively) (Figure 3D).
 Further, FKBP5 mRNA levels in the ventral hippocampus were found to be significantly 
affected by main effects of both ELS (F1,26 = 5.85, p < 0.05) and 5-HTT genotype (F2,26 = 
5.09, p < 0.05). The exposure to ELS led to a decrease in FKBP5 expression (MS0 > MS180), 
while 5-HTT-/- rats were found to display significantly lower FKBP5 mRNA levels than 
5-HTT+/- rats (p < 0.05) (Figure 3E).
 In the dorsal hippocampus, central amygdala and anterodorsal BNST FKBP5 mRNA levels 
were not found to be affected by ELS, 5-HTT genotype or their interaction (Figure 3B, C, F).
Figure 3 FK506-binding protein 51 (FKBP5) mRNA levels in the dorsal medial prefrontal cortex 
(mPFC) (A), dorsal hippocampus (B), central amygdala (C), ventral mPFC (D), ventral hippocampus (E) 
and the anterodorsal bed nucleus of the stria terminalis (BNST) (F) of serotonin transporter (5-HTT) 
homozygous knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) rats 
exposed to daily 3 h separations (MS180) or a control treatment (MS0). FKBP5 mRNA levels in the 
dorsal and the ventral mPFC were found to be affected by a significant interaction of early life stress 
(ELS) and 5-HTT genotype (p < 0.01, p < 0.05, respectively), with asterisks indicating significant 
pairwise comparisons (*: p < 0.05, **: p < 0.01 and ***: p < 0.001). Furthermore, FKBP5 mRNA levels 
were affected by independent effects of 5-HTT genotype (G, p < 0.05) and ELS (E, p < 0.05) in the 
ventral hippocampus. Post-hoc analysis revealed FKBP5 mRNA levels in the ventral hippocampus to 
be lower for 5-HTT-/- rats compared to 5-HTT+/- rats (p < 0.05). Data were normalized to the average 
of the MS0-5-HTT+/+ group.
Figure 3 Continued.
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(Roozendaal and McGaugh, 1997; De Kloet et al., 1998), while MR is important for 
maintaining basal HPA activity and memory retrieval (De Kloet et al., 1998; Dorey et al., 
2011). Essential to this functional segregation is the 10-fold higher affinity of glucocorticoid 
binding by MRs compared to GRs. Low basal corticosterone levels therefore predominantly 
occupy MR, while GR is activated by stress-induced as well as ultradian peaks of 
glucocorticoid levels (De Kloet et al., 1998; Lightman et al., 2008). To explore the relevance 
of a functional GR/MR disbalance in ELS x 5-HTTLPR interactions, we will discuss our 
findings here in terms of the balance between programmed expression levels of GR and MR.
 In addition to the selective effects of ELS on different 5-HTT genotypes, the exposure 
to ELS was found to lead in all genotypes to decreased MR mRNA levels in the dorsal 
mPFC, decreased GR mRNA levels in the anterodorsal BNST and decreased GR and FKBP5 
mRNA levels in the ventral hippocampus. As FKBP5 has mainly been characterized as an 
inhibitory co-chaperone for GR and not MR (Binder, 2009), it is assumed at present that 
FKBP5 chiefly regulates GR function. In the ventral hippocampus, ELS exposure decreased 
both GR and FKBP5 mRNA levels, and it can therefore be assumed that GR/MR balance in 
the ventral hippocampus is not affected by a general effect of ELS.
 For the anterodorsal BNST, it seems that ELS exposure only leads to a decrease in GR 
mRNA in 5-HTT+/+ rats, although the ELS x 5-HTT genotype interaction was not found to 
significantly affect anterodorsal BNST GR mRNA levels. In the 5-HTT+/+ rats, ELS exposure 
furthermore selectively decreased ventral mPFC FKBP5 and dorsal mPFC GR mRNA levels. 
The former could affect local GR/MR balance, but the latter would be expected to 
counterbalance the general ELS effect of decreased dorsal mPFC MR mRNA levels. 
Therefore, after ELS exposure, transcriptional GR/MR balance in 5-HTT+/+ rats only seems to 
be affected in the anterodorsal BNST and the ventral mPFC, with a relative increase in MR 
over GR transcription in the anterodorsal BNST and the opposite in the ventral mPFC.
 For 5-HTT+/- rats, ELS exposure led to increased MR mRNA levels in both the dorsal 
and ventral hippocampus, while increased dorsal mPFC MR expression is present both 
under control conditions and after ELS exposure in 5-HTT+/- rats. The latter should 
compensate for the general ELS effect of decreased dorsal mPFC MR mRNA levels. As 
such, after ELS exposure, GR/MR disbalance in 5-HTT+/- seems to be limited to the 
hippocampus, with a relative increase in MR over GR transcription.
 For 5-HTT-/- rats, baseline observations included increased GR mRNA in the dorsal 
hippocampus and ventral mPFC, decreased FKBP5 and MR mRNA in the ventral 
hippocampus, and increased FKBP5 and MR mRNA in the dorsal mPFC. The latter, just as 
for 5-HTT+/- rats, would be expected to compensate for the general ELS effect of decreased 
dorsal mPFC MR mRNA levels. Further, after exposure to ELS, the increased GR and FKBP5 
mRNA levels in respectively the dorsal hippocampus and mPFC were found to be 
abolished. In addition, ELS exposure led to an increase in ventral mPFC FKBP5 mRNA levels 
selectively in 5-HTT-/- rats, which would be expected to counterbalance the increased 
ventral mPFC GR mRNA levels observed under control conditions. Therefore, transcrip-
(Gluckman et al., 2007). The match/mismatch hypothesis predicts that such phenotypic 
changes are beneficial when the individuals face similar environments later in life (match), 
but could be maladaptive if the environment changes significantly (mismatch). The 
match/mismatch hypothesis is not compatible with a deterministic view as it implies that 
the prior life history and the specific demands of current/future stressors (Myers et al., 
2014) will dictate whether a given phenotype is adaptive or maladaptive. Therefore, it 
remains to be elucidated under which specific conditions the differential expression of GR, 
MR, and FKBP5 mRNA levels in our animal model of ELS x 5-HTTLPR interaction will turn 
out to be adaptive or maladaptive. For now, we will discuss the current findings from 
different perspectives in the following sections.
ELS x 5-HTT genotype: anatomical specificities
Interestingly, the effects of ELS x 5-HTT genotype interaction showed a gene-dependent 
anatomical distinction, with MR mRNA levels affected only in the hippocampus, FKBP5 
mRNA only in the mPFC and GR mRNA only in the dorsal regions of the mPFC and 
hippocampus. In contrast to these higher order/processing areas of the limbic system, for 
the extended amygdala areas (central amygdala and anterodorsal BNST) we found that 
ELS exposure, irrespective of genotype, affected only GR mRNA levels in the anterodorsal 
BNST. The influence of ELS x 5-HTT genotype interaction was therefore clearly stronger in 
the mPFC and hippocampus compared to the central amygdala and anterodorsal BNST.
 Another interesting observation is that the effects of ELS and 5-HTT genotype on GR, 
MR, and FKBP5 expression were markedly different for dorsal vs. ventral subregions of both 
mPFC and hippocampus. The dorsal and ventral mPFC punches in this study correspond 
to the functionally distinct prelimbic and infralimbic cortices, which have been linked to 
opposite roles in the control of fear responses (Sotres-Bayon and Quirk, 2010). Here, we 
found that the dorsal and ventral mPFC of 5-HTT-/- rats also showed opposite regulation of 
FKBP5 mRNA levels after ELS exposure. Regarding the hippocampus, it has been argued 
that the dorsal regions perform primarily cognitive functions, while ventral subregions are 
related to stress, emotion and affect (Fanselow and Dong, 2010). In our model, we found 
that the ventral hippocampus showed more alterations in GR, MR, and FKBP5 mRNA levels 
by the interaction of ELS and 5-HTT genotype than the dorsal hippocampus, although the 
latter was certainly not unaffected. The physiological and behavioural consequences of 
distinct programming of dorsal vs. ventral mPFC and hippocampus subregions should be 
investigated further, both in our and other animal models of stress-related diseases.
ELS x 5-HTT genotype: GR/MR balance
The balance between GR and MR functioning has been proposed to be central to 
stress-related psychopathology, as GR and MR serve such complementary glucocorticoid 
functions during the stress response (De Kloet et al., 2005). For instance, hippocampal GR 
is involved in the consolidation of emotional memory and disinhibition of the HPA-axis 
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studies. In major depression, decreased MR mRNA in the anterior cingulate cortex (ACC) 
has been documented recently (Qi et al., 2013). On the basis of structure and function, the 
dorsal part of the ACC is thought to be homologous to the rodent prelimbic cortex 
(Uylings et al., 2003). In our study, a part of this cortical area was captured by the dorsal 
mPFC punches and we found indeed that ELS exposure led to decreased MR expression 
in these samples. However, 5-HTT deficiency was found to be associated with increased 
MR mRNA levels in this area. In the case of the hippocampus, depressed subjects have 
been reported to display decreased GR and MR mRNA levels (Webster et al., 2002; Klok et 
al., 2011a). In addition, a recent study found decreased MR mRNA selectively in the anterior 
hippocampus (Medina et al., 2012), which corresponds to the rodent ventral hippocampus 
(Fanselow and Dong, 2010). In our study, we found that ELS was indeed associated with 
decreased GR mRNA and 5-HTT knockout with decreased MR mRNA in the ventral 
hippocampus. However, the interaction of ELS and 5-HTT genotype resulted in an increase 
of MR mRNA in the ventral hippocampus in 5-HTT+/- rats, which does not fit the increased 
risk for depression associated with the GxE interaction.
 Exposure to childhood abuse has been associated with reduced hippocampal GR 
expression (McGowan et al., 2009), but this has not been reported (thus far) for childhood 
neglect. Indeed, childhood abuse is more frequently studied, in part due to the higher 
level of heterogeneity in cases of childhood neglect, although both types of maltreatment 
are convincingly associated with psychopathology (Teicher and Samson, 2013). We 
observed that the offspring that had been subjected to the maternal separation (MS) 
paradigm showed a reduction in GR mRNA levels in the ventral hippocampus. Whereas 
MS is an established model for ELS exposure, it however is likely a better approximation of 
the human situation of childhood neglect compared to that of childhood abuse. In the 
laboratory setting, the mother rat is observed to be frequently away from the nest for 
periods of 20-25 minutes (Jans and Woodside, 1990; Francis et al., 2002). In seminaturalistic 
conditions, subordinate mothers are often forced to build their nests far from nutritional 
sources, and this environmental challenge has been reported to lead to periods of 
separation for 2-3 h (Calhoun, 1962; Meaney, 2001). Therefore, the daily 3 h separations are 
considered to be a ethologically relevant stressor for the offspring, which results in a 
deprivation of maternal care, and which has not been observed to lead to abusive 
behaviour of the mother rat. Consequently, our finding of that rats subjected to MS display 
reduced GR mRNA levels in the ventral hippocampus may indicate that this phenotype is 
not specific to childhood abuse, but may also apply to childhood neglect. 
Study limitations and comparison to rodent literature
There are some limitations of the current study that should be mentioned. First, we 
examined here the expression of GR, MR, and FKBP5 at the mRNA level, but do not 
complement this with reporting the levels of the corresponding proteins, the functional 
end products of the genes. Secondly, we have used real-time PCR in combination with 
tional GR/MR balance in 5-HTT-/- rats after ELS exposure seems to be only affected in the 
ventral hippocampus, by the decreased expression of both MR and FKBP5 in this area. In 
contrast to 5-HTT+/- rats, this putatively disturbed hippocampal GR/MR balance would be 
predicted to lead to a relative increase of GR over MR function.
 Overall, we observe a strong moderation by 5-HTT genotype of ELS-induced 
disbalances between GR and MR mRNA levels. We acknowledge that it remains to be 
empirically proven whether transcriptional GR/MR disbalances ultimately lead to 
functional GR/MR disbalance in our model, and, as the regulation of GR/MR/FKBP5 
expression is highly dynamic, it remains to be determined how stable these transcription-
al disbalances would be.
ELS x 5-HTT genotype: possible functional consequences
As said above, the interaction of ELS and 5-HTT genotype resulted in differential adult 
expression patterns of GR, MR, and FKBP5 mRNA levels in the mPFC and hippocampus of 
5-HTT+/+, 5-HTT+/- and 5-HTT-/- rats. From a genetic perspective, the 5-HTT+/- rats can be 
considered as the best model for human 5-HTTLPR S-allele carriers (Homberg et al., 2007). 
Only in these rats, the exposure to ELS led to an increase of MR mRNA levels in the dorsal 
as well as ventral hippocampus. The hippocampal MR has previously been shown to be 
involved in the stress-induced switching between learning/coping strategies (Oitzl and 
De Kloet, 1992; Schwabe et al., 2009). Therefore, the ELS-induced elevation of hippocampal 
MR expression in 5-HTT+/- rats could increase the use of habit-based learning strategies 
under stressful conditions (Schwabe et al., 2009). Furthermore, increased MR mRNA levels 
could increase the inhibitory regulation of the hippocampus on basal HPA activity (De 
Kloet et al., 1998). In 5-HTT+/+ rats, ELS led to decreased GR mRNA levels in the dorsal mPFC 
and decreased FKBP5 mRNA levels in the ventral mPFC. These alterations could affect the 
feedback control exerted by the mPFC over HPA activity (McKlveen et al., 2013). 
Furthermore, given the inhibitory regulation of FKBP5 on GR activity (Binder, 2009), GR 
function could be relatively decreased in the dorsal mPFC, but increased in the ventral 
mPFC of 5-HTT+/+ rats exposed to ELS. This could result in an increased relative influence of 
stress-induced glucocorticoids on extinction vs. expression of fear memory (Gourley et al., 
2009; Sotres-Bayon and Quirk, 2010). In contrast, ELS-exposed 5-HTT-/- rats showed a 
downregulation of FKBP5 mRNA in the dorsal mPFC and an up-regulation of FKBP5 mRNA 
in the ventral mPFC. Possibly, these changes also lead to an opposite effect in the relative 
impact of stress-induced glucocorticoids on emotional memory processing compared to 
ELS-exposed 5-HTT+/+ rats. Interestingly, naïve 5-HTT-/- rodents already display impaired 
fear extinction recall (Wellman et al., 2007; Nonkes et al., 2012a).
Translation of findings
As ELS and ELS x 5-HTT genotype interaction are associated with depression, we expected 
to find similar changes in the transcription of GR, MR, and FKBP5 as reported in clinical 
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Supplementary material: group sizesbiopsy punching as a quantitative approach instead of in situ hybridization. Due to this 
approach we had to make a selection of brain areas and lose anatomical resolution. We 
could therefore for instance not assess mRNA levels in separate cortical layers, or in the 
hippocampal subregions, e.g. the Cornu Ammonis (CA) areas and dentate gyrus (DG). 
Thirdly, to limit the amount of social stress, the rats were housed with their littermates 
after weaning. The rats were therefore housed in same-treatment groups (MS0/MS180), 
potentially constituting differential living environments on top of the early life treatment, 
which together may have led to the observed adaptations in gene expression.
 MS has been shown before to lead to increased GR-immunoreactivity (GR-ir) in the 
CA1 region, but not the DG of the dorsal hippocampus of Sprague-Dawley rats (Biagini et 
al., 1998). In this rat strain, decreased total hippocampal GR mRNA levels have also been 
reported (Maniam and Morris, 2010). In Long-Evans rats, MS has been observed to lead to 
decreased GR mRNA and increased MR mRNA levels in the dorsal hippocampus (Ladd et 
al., 2004, 2005). Furthermore, Long-Evans rats that have experienced low quality of 
maternal care as pups (low levels of licking and grooming), a different but related model 
of early life adversity, display decreased hippocampal GR-ir (total hippocampus) and GR 
mRNA levels (dorsal hippocampus) (Liu et al., 1997; Weaver et al., 2004). In all of these 
studies, the ventral hippocampus has not been studied in isolation for the expression of 
GR and MR. Here, we have found that MS induces a decrease of GR mRNA levels in the 
ventral hippocampus of all 5-HTT genotypes. We observed that not 5-HTT+/+ rats, but the 
putatively more stress-sensitive 5-HTT+/- and 5-HTT-/- rats displayed increased MR mRNA 
and decreased GR mRNA in the dorsal hippocampus, respectively. Our rats have a Wistar 
background, and given the present literature, it is possible that the genetic background of 
rat strains modulates the effects of ELS exposure (MS) on the expression of GR and MR (see 
also Ellenbroek and Cools, 2000). Previously, Wistar rats exposed to MS have been shown 
to exhibit decreased GR-ir of the total hippocampus (Aisa et al., 2007), while others did not 
find alterations of GR and MR mRNA levels (Wang et al., 2013), and unaltered GR-ir in the 
dorsal hippocampus (Renard et al., 2010; Vivinetto et al., 2013).
Conclusions
In conclusion, we report here that ELS and 5-HTT genotype interactively affect the 
expression of GR, MR, and FKBP5 in a brain area-specific way, with further distinction for 
dorsal vs. ventral subregions of the mPFC and hippocampus. These results could be a 
starting point for studies aiming to elucidate the role of altered extra-hypothalamic 
glucocorticoid signaling in the depressogenic interaction of ELS and 5-HTTLPR in humans.
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dmPFC MS0 MS180
5-HTT+/+ 5-HTT+/- 5-HTT-/- 5-HTT+/+ 5-HTT+/- 5-HTT-/-
GR 7 7 5 6 7 5
MR 7 7 6 7 7 4
FKBP5 6 5 5 7 7 5
vmPFC MS0 MS180
5-HTT+/+ 5-HTT+/- 5-HTT-/- 5-HTT+/+ 5-HTT+/- 5-HTT-/-
GR 7 6 5 7 5 5
MR 8 6 6 7 5 5
FKBP5 7 5 6 7 6 4
dHP MS0 MS180
5-HTT+/+ 5-HTT+/- 5-HTT-/- 5-HTT+/+ 5-HTT+/- 5-HTT-/-
GR 8 7 6 6 7 5
MR 6 6 6 5 5 4
FKBP5 7 5 5 5 7 4
vHP MS0 MS180
5-HTT+/+ 5-HTT+/- 5-HTT-/- 5-HTT+/+ 5-HTT+/- 5-HTT-/-
GR 7 7 5 7 6 4
MR 6 8 6 6 5 4
FKBP5 5 7 6 6 4 4
CeA MS0 MS180
5-HTT+/+ 5-HTT+/- 5-HTT-/- 5-HTT+/+ 5-HTT+/- 5-HTT-/-
GR 6 5 6 5 6 4
MR 6 5 6 5 6 4
FKBP5 6 5 6 5 6 4
adBNST MS0 MS180
5-HTT+/+ 5-HTT+/- 5-HTT-/- 5-HTT+/+ 5-HTT+/- 5-HTT-/-
GR 8 6 4 5 6 3
MR 8 6 4 5 6 3
FKBP5 8 6 4 5 6 3
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Introduction
The risk to develop depression is largely determined by both genetic and environmental 
factors, particularly adverse childhood events (Heim et al., 2004). A common polymorphism 
(5-HTTLPR) in the serotonin transporter (5-HTT, SLC6A4) gene has been shown to moderate 
the impact of stressful life events on the occurrence of major depression (Caspi et al., 2003; 
Karg et al., 2011, but also see Risch et al., 2009). Individuals with the short (S) allele of the 
5-HTTLPR polymorphism seem to be especially sensitive to the experience of early life 
stress (ELS) (Karg et al., 2011). Importantly, the increased sensitivity of S-allele carriers to the 
environment is not restricted to adverse events, as S-allele carriers show increased benefit 
from positive, supportive environments (Kaufman et al., 2004; Pluess et al., 2010; Van 
IJzendoorn et al., 2012). Thereby, the 5-HTTLPR polymorphism seems to be consistent with 
the differential susceptibility model, which postulates that gene (5-HTTLPR) x environment 
interactions are for better and worse (Belsky et al., 2007; Ellis et al., 2011; Homberg and 
Lesch, 2011).
 The depressogenic ELS x 5-HTTLPR interaction is likely influenced by additional 
interactions with other genetic and environmental factors (Heiming and Sachser, 2010; 
Uher, 2010; Van der Doelen et al., 2013). One example is the epistasis between the 5-HTTLPR and 
polymorphisms in the CRH1R gene, which influences the impact of childhood maltreatment 
on depressive symptoms (Ressler et al., 2010; Cicchetti et al., 2011). CHR1R is one of two 
genes encoding a receptor for corticotropin-releasing factor (CRF), or hormone (CRH).
 CRF/CRH is a 41 amino acid peptide, which has an initiating and coordinating role in 
the physiological and behavioural stress response (Vale et al., 1981; Sutton et al., 1982). The 
activity of CRF neurons in the paraventricular nucleus of the hypothalamus (PVN) is 
important in the neurobiology of depression, as these neurons drive the activity of the 
hypothalamic-pituitary-adrenal (HPA) axis. In depression, a subset of patients exhibit 
hyperactivity of the HPA axis, resulting in elevated levels of glucocorticoids, which is 
thought to be driven by the increased activity of the CRF neurons in the PVN (Arborelius 
et al., 1999). Furthermore, postmortem studies have found an increased number of CRF 
neurons and CRF mRNA content in the PVN of depressed subjects (Raadsheer et al., 1994; 
Raadsheer et al., 1998; Wang et al., 2008). In addition, these patients display increased 
levels of CRF in their cerebrospinal fluid, which can be reduced by treatment with antide-
pressants or electroconvulsive shocks (Nemeroff et al., 1984; Nemeroff et al., 1991; Heuser 
et al., 1998). Notably, the intracerebroventricular administration of CRF in experimental 
animals produces responses reminiscent of symptoms of major depression; anhedonia, 
anxiety, decreased food intake, decreased sexual activity and disturbed sleep and 
locomotion (Bale and Vale, 2004; Binder and Nemeroff, 2010).
 We have previously shown in rats that ELS and 5-HTT genotype interact to program 
the adult HPA-axis, but we did not find altered CRF mRNA levels in the PVN (Van der 
Doelen et al., 2014a). However, CRF is not only found in the PVN. It is also expressed in 
Abstract
The interaction between childhood maltreatment and the serotonin transporter (5-HTT) 
gene-linked polymorphic region (5-HTTLPR) has been associated with increased risk to 
develop major depression. This gene x environment (GxE) interaction has furthermore 
been linked with increased levels of anxiety and glucocorticoid release upon exposure to 
stress. Both endophenotypes are regulated by the neuropeptide corticotropin-releasing 
factor or hormone (CRF/CRH), which is expressed by the paraventricular nucleus of the 
hypothalamus (PVN), bed nucleus of the stria terminalis (BNST) and the central amygdala 
(CeA). Therefore, we hypothesized that altered regulation of the expression of CRF in these 
areas represents a major neurobiological mechanism underlying the interaction of early 
life stress (ELS) and 5-HTT gene variation. The programming of gene transcription by GxE 
interactions has been proposed to involve epigenetic mechanisms such as DNA 
methylation. In this study, we report that ELS and 5-HTT genotype interact to affect DNA 
methylation of the Crf gene promoter in CeA of adult male rats. Furthermore, we found 
that DNA methylation of a specific site in the Crf promoter significantly correlated with 
CRF mRNA levels in the CeA. Moreover, CeA CRF mRNA levels correlated with stress coping 
behaviour in a learned helplessness paradigm. Together, our findings warrant further 
investigation of the link of Crf promoter methylation and CRF expression in the CeA with 
behavioural changes that are relevant for psychopathology. 
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selective serotonin re-uptake inhibitors can reverse stress-induced elevations of Crf 
transcription (Stout et al., 2002; Pan et al., 2013).
 Based on the literature described above, we hypothesized that ELS and 5-HTT gene 
variation interact to affect DNA methylation of the Crf promoter region in the adult rat 
brain. As basal and stress-induced expression levels of CRF are expected to be programmed 
by Crf promoter methylation, this could represent an interesting target for intervening in 
ELS x 5-HTTLPR-related psychopathology. To test our hypothesis, we used an animal 
model of ELS x 5-HTTLPR interaction. Specifically, we performed a Crf promoter DNA 
methylation assay on PVN, CeA and BNSTov biopsies of adult heterozygous and 
homozygous 5-HTT knockout rats (5-HTT+/-, 5-HTT-/-), and their wild-type (5-HTT+/+) 
littermates exposed to ELS (maternal separation paradigm) or a control treatment. We 
have performed these analyses for a cohort of rats that was not exposed to any additional 
stressors (adult naïve cohort) and a cohort which was examined for stress coping 
behaviour in the learned helplessness (LH) paradigm (adult stress cohort). Furthermore, to 
study Crf expression, we performed quantitative real-time PCR analyses for both cohorts, 
and applied CRF immunohistochemistry to brains derived from the naïve cohort.
Materials and Methods
Animals
The experimental procedures were approved by the Committee for Animal Experiments 
of the Radboud University Nijmegen, The Netherlands, and all efforts were made to 
minimize animal suffering and to reduce the number of animals used. Serotonin 
transporter knockout rats (Slc6a41Hubr) were generated by N-ethyl-N-nitrosurea 
(ENU)-induced mutagenesis (Smits et al., 2006). Experimental animals (5-HTT+/+, 5-HTT+/- 
and 5-HTT-/- rats) were derived from crossing 3 month old 5-HTT+/- rats that were outcrossed 
for at least twelve generations with commercial (Harlan, Ter Horst, The Netherlands) 
wild-type Wistar rats. The pregnant dams were housed in standard polypropylene cages 
(40 x 20 x 18 cm) with sawdust bedding and ad libitum access to water and rodent chow 
(Sniff Spezialdiäten, Soest, Germany) in a temperature (21 ± 1 °C) and humidity-controlled 
room (45-60% relative humidity), with a 12 : 12 h light : dark cycle (lights on at 07.00 a.m.). 
The dams were inspected daily for delivery of pups at 5.00 p.m. and day of birth was 
designated as postnatal day (PND) 0. At PND1, two paper towels (22.5 x 24.5 cm) were 
supplied to the mother for nest construction. Further, the litters were culled to a maximum 
of 10 pups, with gender ratios in favor of a male majority to maximally 7 : 3.
Early life stress
We used repeated and prolonged maternal separation as a model for ELS. Litters were 
randomly allocated to one of two rearing conditions (from PND 2 to 14): maternal separation 
for 180 min (MS180) or a control treatment with immediate reunion of mother and pups 
higher order brain regions, including the amygdala and the bed nucleus of the stria 
terminalis (BNST). Both regulate the activity of the HPA-axis, as well as autonomic and 
behavioural responses to stress (Ulrich-Lai and Herman, 2009; Walker et al., 2009). The 
central amygdaloid nucleus (CeA) and the oval subdivision of the BNST (BNSTov) contain 
the major populations of CRF neurons in the rat amygdala and BNST, respectively 
(Merchenthaler et al., 1982; Morin et al., 1999; Sterrenburg et al., 2012). Modulation of CRF 
expression in the CeA affects basal and stress-induced anxiety-like behaviour in rodents 
(Regev et al., 2011; Flandreau et al., 2012; Regev et al., 2012; Callahan et al., 2013). Furthermore, 
CRF overexpression in the CeA has been reported to lead to increased CRF mRNA in the 
PVN and increased stress-induced HPA activity (Keen-Rhinehart et al., 2009; Flandreau et 
al., 2012; Callahan et al., 2013). In the BNSTov, modulation of CRF expression has been 
shown to affect conditioned anxiety, as well as depression-like behaviour, but not HPA 
activity (Regev et al., 2011; Sink et al., 2013). Yet, the CRF populations in the CeA and BNSTov 
seem to have complementary functions in fear conditioning (Walker et al., 2009), and are 
responsive to exposure to acute and chronic stress paradigms (Rouwette et al., 2011; 
Sterrenburg et al., 2011).
 During a stress response, CRF mRNA levels in the PVN, CeA and BNSTov are frequently 
found to be up-regulated (Kovács and Sawchenko, 1996; Ma et al., 1997; Makino et al., 1999; 
Rouwette et al., 2011). Prominent examples of transcription factors involved in Crf expression are 
AP-1, nerve growth factor induced gene B (NGFI-B), and cyclic AMP (cAMP) response 
element binding protein (CREB) (Itoi et al., 1996; Kovács and Sawchenko, 1996; Murphy and 
Conneely, 1997; Yao et al., 2007). The proximal promoter region of Crf contains a cAMP 
response element (CRE), as well as a putative AP-1 binding site (Yao and Denver, 2007).
 DNA methylation is an epigenetic mechanism that occurs at cytosine-phosphate- 
guanine (CpG) sites and is associated with the repression of gene transcription (Moore et 
al., 2013). Importantly, the epigenetic programming of gene transcription is considered to 
be a key interface for gene X environment (GxE) interactions (Bale et al., 2010; Meaney, 
2010; Van IJzendoorn et al., 2010; Bogdan et al., 2013). Indeed, exposure to ELS has been 
shown to regulate DNA methylation and transcription of the glucocorticoid receptor gene 
in the hippocampus of rats (Weaver et al., 2004) and humans (McGowan et al., 2009), and 
the Crf and arginine vasopressin genes in the PVN of mice (Mueller and Bale, 2008; 
Murgatroyd et al., 2009; Chen et al., 2012).
 A frequently used rodent model of ELS is the prolonged and repeated separation of 
newborn pups from their mother (maternal separation) (Pryce et al., 2005; Macrì and 
Würbel, 2006). Maternal separation has been reported to affect the basal and stress-induced 
expression of CRF in the PVN, CeA and BNSTov (Ladd et al., 2005; Plotsky et al., 2005; Aisa 
et al., 2007; Desbonnet et al., 2008; Veenema et al., 2008; Bravo et al., 2010; Chen et al., 2012; 
Pierce et al., 2014). The brain’s 5-HT system seems to have a significant impact on the 
regulation of the Crf gene as well. The modulation of neuronal 5-HT content for instance 
affects CRF mRNA levels in the PVN (Jørgensen et al., 2002), while the administration of 
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with a Miltex 1.0 mm biopsy puncher (Integra Miltex, York, PA, USA), collected in sterile 
vials, immediately placed on dry ice and stored at -80 °C. Half of the punches were used for 
RNA isolation, the other half for the isolation of genomic DNA. The punches were distributed 
by systematic randomization, accounting for lateralization and Bregma position.
 Prior to transcardial perfusion, rats received an intraperitoneal injection of sodium 
pentobarbital (50 mg/kg body weight). The perfusion was performed with phos-
phate-buffered saline (PBS, pH 7.4) and a clamp on the abdominal aorta, followed by 
fixation of the brain with 4% paraformaldehyde (PFA) in PBS. The fixated brains were 
immediately isolated, postfixated in fresh 4% PFA, transferred to a 30% sucrose solution in 
PBS. The sucrose solution was refreshed every two days until the brains were completely 
submerged. Then, the brains were frozen by use of dry ice and were cut in 25 µm-thick 
coronal slices on a freezing microtome (Microm, Walldorf, Germany). The sections were stored 
in a sterile antifreeze solution (0.05 M PBS, 30% ethylene glycol, 20% glycerol) at -20 °C.
DNA methylation assay
The DNA methylation assay was performed as described previously (Sterrenburg et al., 
2011). Briefly, genomic DNA was isolated from punches of the BNSTov, PVN and CeA by use 
of the DNeasy blood & tissue kit (Qiagen, Valencia, CA, USA) and according to the 
manufacturer’s instructions. Bisulfite conversion of the DNA samples and pyrosequencing 
of the promoter region and the initial part of exon 1 of the Crf gene were performed by 
EpigenDX (Hopkinton, MA, USA) (Kim et al., 2007). The Crf promoter region contains 
important CpG-containing regulatory sites, such as binding sites for transcription factors 
as CREB and AP-1 (Yao et al., 2007).
CRF expression
The expression of CRF (mRNA, protein) was studied by the use of quantitative real-time 
PCR (brain punches, cohort 1 +2) and immunohistochemistry (fixated brain sections, 
cohort 1). A detailed description of both techniques is available in the supplementary 
material.
Statistical analysis
All statistical tests have been carried out using SPSS (version 20, IBM corporation, Armonk, 
NY, USA)). The results are presented as the mean with the standard error of the mean 
(SEM). The RT-PCR 2-ΔCt data have been expressed as a ratio compared to the average of 
the MS0-wild-type group. All data have been examined with factorial ANOVA. If a 
significant main effect of genotype or interaction (“genotype x early life stress”) was found, 
post-hoc testing was performed. For the correlational analysis between CRF mRNA and 
DNA methylation at the twelve CpG sites as well as the average CpG methylation, 
Bonferroni correction was applied for every brain area (p < 0.05 divided by 13 = p < 0.003846). 
Furthermore, one-tailed Spearman correlation was performed because of the consensus 
(MS0). MS180 was started daily between 08.30 and 09.00 a.m., and was performed as 
follows: The mother was removed from the home cage and placed into an identical cage 
until the end of the separation period. Pups were then removed from the nest as complete 
litters and placed into a cage (24 x 15 x 14 cm) with only sawdust bedding, after which 
they were transferred to an adjacent room. The cages were placed on heat pads, which 
were set to maintain a bedding temperature of 31-33 °C for PND 2-7 and 29-31 °C for PND 
8-14. At the end of the separation period, litters were returned to their home cage by first 
rolling them in the home cage bedding material and then placing them in the nests. This 
was followed by reunion with the mothers. During PND 0-22, half of the bedding material 
of the home cages was refreshed every week. At PND 14, ear punches were taken of the pups 
for identification and genotyping, which was performed by Kbiosciences (Hoddesdon, 
United Kingdom). The procedure of genotyping has been described previously (Homberg 
et al., 2007). At PND 22, the pups were weaned and housed in groups of 2-3 littermates of 
the same sex and rearing, under the same conditions as mentioned above.
Adult stress
For this study, we have made use of two cohorts of male 5-HTT+/+, 5-HTT+/- and 5-HTT-/- rats 
that underwent ELS exposure. Cohort 1 was left undisturbed until sacrifice (PND 85-95) 
and was therefore naïve in terms of adult stress exposure. Cohort 2 was a group of rats 
(PND 77-116) that underwent inescapable foot shocks for 2d, followed 24 h later by a 
shuttle box escape test (LH paradigm). The exposure to inescapable foot shocks induces 
a deficit in active coping behaviour in a subset of vulnerable rats, as measured by escape 
latencies in the shuttle box escape test (Vollmayr and Henn, 2001). Previously, we reported 
that the LH paradigm differentially affects coping behaviour in the current model of ELS x 
5-HTT genotype interaction. Specifically, we found that 5-HTT+/- rats were especially 
sensitive to show successful predictive adaptation to a putative match between early and 
adult life environmental conditions, which was expressed as a reduced latency to escape 
stress (Van der Doelen et al., 2013).
Tissue collection and preparation
Cohort 1 was split into a group of rats that was sacrificed by decapitation and a group of 
rats that was sacrificed by perfusion. Of cohort 2, all rats were sacrificed by decapitation.
 For decapitations, rats were taken from their home cage into a separate room and 
decapitated within 10 s. Immediately after decapitation, the brains were isolated, frozen in 
aluminum foil on dry ice and stored at -80 °C. In a cryostat (-15 °C), the brains were prepared 
in 420 µm-thick coronal slices in order to obtain punches from the anterodorsal part of the 
bed nucleus of the stria terminalis (adBNST, Bregma +0.24 and -0.18 mm), the PVN (Bregma 
-1.32 and -1.74 mm) and the CeA (Bregma -1.72 and -2.14 mm). The adBNST punch contains 
the BNSTov, the major site of CRF expression within the BNST (Merchenthaler et al., 1982; 
Morin et al., 1999, Sterrenburg et al., 2012). The brain areas were bilaterally punched out 
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of a negative relationship between DNA methylation and transcriptional activity (Moore 
et al., 2013) and because the measure of DNA methylation is derived from an ordinal, 
non-linear scale (percentage of methylated versus unmethylated PCR clones). Statistical 
significance was set at p < 0.05. Group sizes are available in the supplementary material. 
Results
DNA methylation of the CRF gene promoter region
We examined the DNA methylation of the promoter region of the Crf gene, which contains 
important sites for the regulation of transcription. All but one of the examined CpGs are 
found upstream of the transcription start site of the gene, indicated by a minus sign 
(Supplementary Figure 1). CpG_-226 resides in the middle of a CRE site, while CpG_-79 is 
located in a putative AP-1 binding site (Yao and Denver, 2007). Furthermore, CpG_-36, 
CpG_-33 and CpG_-15 surround the gene’s TATA box, a sequence 24-30 bp from the Crf 
transcription start site (TSS), which recruits RNA polymerase II and transcription factors 
(Lee and Young, 2000) (Supplementary Figure 1).
 Overall, the DNA methylation levels of the promoter region of the Crf gene were 
found to be highly similar in the two cohorts and across the BNSTov, PVN and CeA (Figure 
1-2). In all three brain areas, DNA methylation was consistently the highest for CpG_-232, 
CpG_-226 and CpG_-212 (60-80%) compared to the downstream CpGs (30-40%), with the 
exception of CpG_-15 (50-60%).
 For both cohorts, DNA methylation levels of the Crf promoter in the CeA were 
significantly affected by the interaction between ELS and 5-HTT genotype (Figure 1-2). 
In cohort 1, methylation of CpG_-36 was found to be significantly affected by the GxE 
interaction (F2,37 = 3.42, p < 0.05) (Figure 1). Post-hoc analysis showed that 5-HTT
-/- rats 
exhibit a higher degree of CpG_-36 DNA methylation compared to 5-HTT+/- (p < 0.05) and 
5-HTT+/+ (p < 0.01) rats under control conditions (MS0). With a history of ELS exposure, this 
5-HTT genotype difference is no longer present, as this leads to a downregulation of 
CpG_-36 methylation in 5-HTT-/- rats (p < 0.01, Figure 1). In cohort 2, the methylation of 
CpG_-226 (F2,87 = 4.18, p < 0.05) and CpG_-147 (F2,87 = 3.60, p < 0.05) were significantly 
affected by ELS x 5-HTT genotype interaction (Figure 2). Here, post-hoc analysis showed a 
significantly higher degree of CpG_-226 methylation in 5-HTT+/- rats compared to 5-HTT+/+ 
rats (p < 0.01) under control conditions (MS0). With a history of ELS exposure, this 5-HTT 
genotype difference is no longer present, as this leads to an up-regulation of CpG_-226 
methylation in 5-HTT+/+ rats (p < 0.05). Furthermore, CpG_-147 methylation was found to 
be selectively decreased in 5-HTT+/- rats by exposure to ELS (p < 0.01, Figure 2).
 In the BNSTov of cohort 1, DNA methylation levels were found to be affected at three 
different CpG sites: CpG_-226, CpG_-33 and CpG_-15 (Figure 1). In cohort 2 however, DNA 
methylation of the Crf promoter in the BNSTov was not found to be significantly affected Fi
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(Figure 2). For cohort 1, factorial ANOVA revealed that DNA methylation at CpG_-226 was 
significantly affected by 5-HTT genotype (F2,36 = 3.68, p < 0.05), while CpG_-33 methylation 
was found to be decreased by ELS exposure (MS0 > MS180, F1,36 = 5.04, p < 0.05). DNA 
methylation at CpG_-15 was found to be significantly affected by ELS x 5-HTT genotype 
interaction (F2,36 = 3.62, p < 0.05). For CpG_-226, post-hoc analysis showed that 5-HTT
-/- 
rats display significantly higher methylation levels compared to 5-HTT+/+ rats (p < 0.05). For 
CpG_-33 and CpG_-15, post-hoc testing did not reveal any significant differences between 
the individual experimental groups.
 For the PVN, DNA methylation of the Crf promoter region was not found to be 
significantly affected by ELS, 5-HTT genotype or their interaction (Figure 1-2).
 
CRF expression 
Of cohort 1, we have previously published the qRT-PCR analysis of CRF mRNA levels in the 
PVN, for which we did not find any significant effect of ELS, 5-HTT genotype or their 
interaction (Van der Doelen et al., 2014a). Here, we report that CRF mRNA levels in the 
BNSTov and CeA of cohort 1, and CRF mRNA levels in the BNSTov, PVN and CeA of cohort 
2 are also not significantly regulated by ELS, 5-HTT genotype or their interaction 
(Supplementary Figure 2-3).
 In addition, we have performed immunohistochemistry to assess CRF expression at 
the protein level in cohort 1. In the BNSTov and CeA, the number and SSD of both CRF-ir 
neurons and CRF-ir boutons were not found to be significantly regulated by ELS, 5-HTT 
genotype or their interaction in the factorial ANOVA analysis (Supplementary Figure 4-5). 
For the PVN however, we found a significant effect of 5-HTT genotype on the number 
(F2,21 = 6.06, p < 0.01), as well as the SSD (F2,21 = 3.79, p < 0.05) of CRF-ir neurons. Post-hoc 
analysis indicated that 5-HTT-/- rats display an increased number of CRF-ir neurons in the 
PVN compared to 5-HTT+/+ rats (p < 0.01). In contrast, 5-HTT-/- rats showed a lower SSD of 
CRF-ir neurons in the PVN compared to 5-HTT+/+ rats, but according to post-hoc analysis 
this difference was not significant (p = 0.07). In contrast to 5-HTT genotype, ELS and ELS x 
5-HTT genotype interaction were not found to have a significant impact on the number 
and SSD of CRF-ir neurons in the PVN (Supplementary Figure 6).
Correlational analysis: Crf promoter methylation and CRF mRNA levels
For both cohorts 1 and 2, the levels of CRF mRNA and DNA methylation of the promoter 
region of the Crf gene were measured in the same subset of animals, which enables an 
analysis of the correlation between transcription and DNA methylation of Crf. The analysis 
was performed by combining cohort 1 and 2 and with all the twelve individual CpGs in 
the Crf promoter region as well as the average methylation of the CpG sites. Bonferroni 
correction for multiple testing was applied (p < 0.05 divided by 13: p < 0.0038).
 For the CeA, a negative correlation between CRF mRNA levels and DNA methylation 
at CpG_-36 was found to be highly significant (rs = -.286, p = 0.0007) (Figure 4). The F
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methylation of CpG_-33, CpG_-15, CpG_+21 and the average methylation of all CpGs also 
showed a negative correlation with CRF mRNA levels in the CeA (p < 0.05), but these 
correlations were not significant after Bonferroni correction.
 For the PVN, negative correlations between CRF mRNA levels and DNA methylation 
at CpG_-95 (rs = -.298, p = 0.0003), CpG_-79 (rs = -.280, p = 0.0007) as well as the average 
methylation of all CpGs (rs = -.246, p = 0.0026) survived Bonferroni correction (Figure 4). 
One might consider that the extreme values of PVN CRF mRNA levels drive the significance 
of the correlations. Yet, these correlations remained significant with omission of the 
extremes of the CRF mRNA levels (p ≤ 0.0031). In addition, methylation of CpG_-232, 
CpG_-212, CpG_-101, CpG_-55, CpG_-36 and CpG_+21 seemed to contribute (p < 0.05) to 
Figure 3 Central amygdala methylation levels of cytosine-phosphate-guanine (CpG)_-36 (cohort 1), 
CpG_-226 and CpG_-147 (cohort 2) of the Crf gene of serotonin transporter (5-HTT) homozygous 
knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) rats exposed to daily 
3 h separations (MS180) or a control treatment (MS0) from postnatal day 2 to 14. Cohort 1 was not 
exposed to stress in adulthood (adult naïve group), while cohort 2 was exposed on three consecutive 
days to footshocks in a learned helplessness paradigm (adult stress group) (Van der Doelen et al., 
2013). Methylation of CpG_-36 (cohort 1), CpG_-226 and CpG_-147 (cohort 2) was found to be 
significantly regulated by the interaction of ELS and 5-HTT genotype (F2,37 = 3.42, p < 0.05, F2,87 = 
4.18, p < 0.05, F2,87 = 3.60, p < 0.05, respectively). Post-hoc analysis of CpG_-36 methylation (cohort 1) 
showed that 5-HTT-/- rats exhibit a higher degree of DNA methylation compared to 5-HTT+/- and 
5-HTT+/+ rats under control conditions (MS0). With a history of ELS exposure (MS180), this 5-HTT 
genotype difference is no longer present, as this leads to a downregulation of CpG_-36 methylation 
in 5-HTT-/- rats. Post-hoc analysis of CpG_-226 methylation (cohort 2) showed that 5-HTT+/- rats 
display a significantly higher degree of DNA methylation compared to 5-HTT+/+ rats under control 
conditions (MS0). With a history of ELS exposure (MS180), this 5-HTT genotype difference is no 
longer present, as this leads to an up-regulation of CpG_-226 methylation in 5-HTT+/+ rats. Post-hoc 
analysis of CpG_-147 methylation (cohort 2) showed that ELS selectively induces a downregulation 
of DNA methylation at this CpG site in 5-HTT+/- rats. *: p < 0.05, **: p < 0.01.
Figure 4 Correlations between DNA methylation of the Crf promoter and CRF mRNA levels in the 
central amygdala (CeA) and paraventricular nucleus of the hypothalamus (PVN). In the CeA, the 
negative relationship (rs = -.286) between CRF mRNA and methylation of the cytosine-phos-
phate-guanine (CpG)_-36 site in the promoter region of the Crf gene was found to be significant (p 
= 0.0007). In the PVN, a significant negative relationship was found between CRF mRNA levels and 
the average (Avg) methylation of the Crf promoter (rs = -.246, p = 0.0026) as well as the methylation 
of the individual CpG sites CpG_-95 (rs = -.298, p = 0.0003) and CpG_-79 (rs = -.280, p = 0.0007).
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Discussion
In this study, we report that ELS and 5-HTT genotype interact in the CeA to program DNA 
methylation of the Crf promoter region in two independent cohorts. Furthermore, 
methylation of CpG_-36, which immediately presides an essential transcription factor 
binding site (TATA box), was found to show a highly significant negative correlation with 
CRF mRNA levels in the CeA. However, we did not find ELS x 5-HTT genotype alterations 
in the expression of CRF (mRNA, protein), suggesting the involvement of additional 
(epigenetic) mechanisms in the regulation of CRF expression. Interestingly, we found 
correlative evidence suggesting that CeA CRF neurons could be involved in stress coping 
behaviour in our ELS x 5-HTT genotype model. Specifically, CeA CRF mRNA levels were 
found to negatively correlate with escape latencies in rats that were subjected to the LH 
paradigm, which has high face and predictive validity for the translation to clinical 
depression (Hammack et al., 2012; Pryce et al., 2011).
 By applying the LH paradigm to our ELS x 5-HTT genotype model, we have previously 
reported that exposure to ELS is associated with increased expression of adaptive, active 
coping behaviour (Van der Doelen et al., 2013). The LH paradigm consisted of exposure to 
inescapable shock (IS) stress for two days, and an escape test on the third day in the same 
context where rats could now escape the foot shocks. As IS exposure induces an escape 
deficit (passive coping) in vulnerable rats, active vs. passive coping behaviour is quantified 
by measuring escape latencies in the escape test. Strikingly, when stratifying for 5-HTT 
genotype, we found that the adaptive effect of ELS exposure was only significant for 
5-HTT+/- rats (Van der Doelen et al., 2013). These behavioural findings support the recently 
postulated match/mismatch hypothesis, which states that exposure to ELS is not 
necessarily pathological, but can be used to adaptively respond to future stress exposure 
(Gluckman et al., 2007; Champagne et al., 2009; Nederhof and Schmidt, 2012). The increased 
sensitivity of 5-HTT+/- rats to benefit from a positive, adaptive match between the early 
and adult life environment is also in support of the differential susceptibility hypothesis 
(Belsky et al., 2009; Ellis et al., 2011). In humans, 5-HTTLPR S-allele carriers have been shown 
to exhibit increased vulnerability to develop psychopathology following exposure to 
adverse environments (Caspi et al., 2003; Karg et al., 2011). In addition, S-allele carriers show 
increased sensitivity to negative environments compared to LL homozygotes by 
displaying stronger physiological responses to stress (Gotlib et al., 2008; Alexander et al., 
2009), increased attentional bias to negatively valenced stimuli (Pergamin-Hight et al., 
2012) and higher levels of neuroticism and negative emotionality (Lesch et al., 1996; Stein 
et al., 2008; Pluess et al., 2011). Whereas the diathesis-stress hypothesis focusses solely on 
the adverse consequences of genetic predispositions, the differential susceptibility 
hypothesis provides a theoretical framework to explain the evolutional survival of ‘risk’ 
genes by emphasizing them as ‘plasticity’ genes with greater sensitivity to adverse as well 
as positive environmental events (Belsky et al., 2007; Bakermans-Kranenburg and Van 
the significant negative correlation between CRF mRNA levels and DNA methylation of 
the Crf promoter in the PVN.
 For the BNSTov, no significant correlations between CRF mRNA levels and DNA 
methylation of the Crf gene promoter region were identified.
Correlational analysis: CRF mRNA levels and stress coping behaviour
Of cohort 2, we have previously reported altered stress coping behaviour (escape 
latencies) as a function of ELS and 5-HTT genotype after previous exposure to inescapable 
shocks (LH paradigm) (Van der Doelen et al, 2013). Several studies have indicated the 
functional involvement of CeA-CRF neurons in the behavioural expression of LH (Homberg 
and Contet, 2009; Hammack et al., 2012).
 Here, a significant ELS x 5-HTT genotype interaction was found for Crf promoter 
methylation in the CeA of both cohort 1 and 2, which was furthermore significantly related 
to the expression of CRF mRNA in the CeA. Therefore, we hypothesize that CeA CRF mRNA 
levels could be involved in the coping behaviour that was observed in the escape test of 
the LH paradigm in cohort 2. In support of this hypothesis, we found that higher CeA CRF 
mRNA levels were associated with lower escape latencies (rs = -.216, p = 0.032) (Figure 5).   
 
Figure 5 Cohort 2: Negative correlation of escape latencies with central amygdala (CeA) cortico-
tropin-releasing factor (CRF) mRNA levels (rs = -2.16, p = 0.032). The rats of cohort 2 were exposed to 
two sessions of inescapable foot shocks, followed 24 h later by a shock escape test where escape 
latencies were automatically recorded. Two hours after the onset of the escape test the rats were 
sacrificed, the brains were isolated and later CRF mRNA levels in micropunches of the CeA were 
determined by quantitative real-time PCR.
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it is clear that our results also warrant replication as well as further experimentation to 
connect the dots between Crf promoter methylation, expression of CRF and behavioural 
changes that are relevant for psychopathology.
 In contrast to the CeA, DNA methylation of the Crf promoter region was not 
consistently found to be affected by ELS x 5-HTT genotype interaction in the BNSTov and 
PVN. This is not entirely unexpected, as previous studies have shown that chronic stress 
exposure (early/adult life) can differentially affect DNA methylation of the Crf promoter in 
the BNSTov, PVN and CeA (Mueller and Bale, 2008; Sterrenburg et al., 2011). A recent study 
suggests that the use of more prolonged maternal separations could have induced ELS x 
5-HTT genotype alterations of Crf promoter methylation in the PVN (Chen et al., 2012). In 
the BNSTov of the adult naïve cohort, we observed higher methylation of CpG_-226 in 
5-HTT-/- rats compared to 5-HTT+/+ rats (5-HTT genotype effect), which however was not 
present in cohort 2. This is most likely explained because of a general downregulation 
CpG_-226 methylation by the repeated exposure to foot shock stress, as chronic stress has 
previously been shown to lead to a decrease in Crf CpG_-226 methylation in the BNSTov 
(Sterrenburg et al., 2011). In line with the absence of consistent alterations of Crf promoter 
methylation in the BNSTov and PVN, we did not find significant effects of ELS x 5-HTT 
genotype interaction on CRF expression in these areas, although DNA methylation of the 
Crf promoter methylation did show a significant negative correlation with CRF mRNA 
levels in the PVN. 
 From this study, together with previous studies that have employed a similar maternal 
separation paradigm, the picture emerges that the genetic background (strain) of rats 
modulates the effects of ELS exposure on CRF expression in the BNSTov, PVN and CeA, 
supporting the importance of considering GxE interactions in psychopathology. For 
Long-Evans rats, it has been reported that ELS induces increased CRF expression in the 
BNST, PVN and CeA (Francis et al., 2002; Huot et al., 2004; Plotsky et al., 2005, but also see 
Ladd et al., 2005). In Sprague-Dawley and Wistar rats however, CRF expression in the BNST/
PVN/CeA is unaltered or even lower following exposure to ELS (this study, as well as 
Desbonnet et al., 2008; Bravo et al., 2010; Chen et al., 2012, but also see Aisa et al., 2007). 
Together, these studies suggest that the effects of ELS (maternal separation) on the basal 
expression levels of CRF in the adult brain are moderated by the genomic differences 
between rat strains. However, it should be noted that this concerns only a limited number 
of studies of which none have directly compared rat strains for their sensitivity to ELS to 
induce alterations in CRF expression.
Technical note
It should be noted that in the current study, as well as in previous studies (Mueller and 
Bale, 2008; Elliott et al., 2010; Sterrenburg et al., 2011; Chen et al., 2012), DNA methylation of 
the Crf promoter has been examined in micropunches of brain areas. As these samples 
contain a large fraction of non-CRF expressing cells, the resulting DNA methylation 
IJzendoorn, 2011; Ellis et al., 2011). Indeed, the 5-HTLLPR S-allele is very common, with an 
allele frequency of approximately 40% in Caucasians (Lesch et al., 1996; Noskova et al., 
2008; Eisenberg and Hayes, 2010), and S-allele carriers have repeatedly been shown to 
display increased benefit from positive environments in comparison to LL homozygotes 
(Kaufman et al., 2004; Pluess et al., 2010; Van IJzendoorn et al., 2012).
 In the current study, we have found a neural correlate (CeA CRF mRNA levels) of 
coping behaviour and thus, as pointed out above, differential susceptibility. Firstly, we 
found that ELS and 5-HTT genotype interact to affect DNA methylation of the Crf promoter 
specifically in the CeA. Of the investigated CpG sites, CpG_-36 showed a highly significant 
negative correlation with CeA CRF mRNA levels, which itself showed a correlation with 
coping behaviour (escape latencies) in the LH paradigm.
 Passive coping responses across a variety of rodent stress models have been 
associated with increased activity of 5-HT neurons in the dorsal raphe nucleus (DRN) 
(Valentino et al., 2010; Hammack et al., 2012, but also see Wood et al., 2013). The DRN is 
densely innervated by CRF-containing fibers, which are in part derived from the CeA 
(Peyron et al., 1998; Lowry et al., 2000; Retson and Van Bockstaele, 2013). Interestingly, phar-
macological manipulations have shown that CRF can both stimulate and inhibit the 
activity of DRN 5-HT neurons, via corticotropin-releasing factor receptor 1 (CRF1R) and 
corticotropin-releasing factor receptor 2 (CRF2R), respectively (Waselus et al., 2009; 
Valentino et al., 2010). CRF has high affinity for CRF1R, but only low affinity for CRF2R, in 
contrast to the CRF peptide family members urocortin 1, 2 and 3, which have therefore 
been proposed to be the endogenous ligands for CRF2R (Vaughan et al., 1995; Hsu and 
Hsueh, 2001; Lewis et al., 2001; Reyes et al., 2001). Given the correlation we identified here 
of CeA CRF mRNA levels with increased active coping (decreased escape latencies), we 
hypothesize that increased CeA-CRF input to the DRN could strengthen CRF1R over CRF2R 
activation associated with lower DRN 5-HT activity and increased active coping responses. 
There is likely an optimum to increased CeA-CRF input though, as increasingly higher 
doses of CRF would start to activate CRF2R (Hammack et al., 2003a, 2003b). Furthermore, 
the consequences of increased DRN 5-HT neuron activity depend on the recruited 
forebrain projections, as CeA-stimulated 5-HT release in the medial prefrontal cortex has 
actually been associated with reduced passive coping behaviour (Forster et al., 2006, 
2008).
 It should be pointed out that although DNA methylation (CpG_-36) correlated 
significantly with CRF mRNA levels in the CeA, only the adult naïve cohort showed GxE 
regulation of CpG_-36, while the adult stress cohort showed GxE regulation of CpG_-226 
and CpG_-147. Furthermore, CeA CRF mRNA levels were not significantly affected by the 
interaction of ELS and 5-HTT genotype, and CpG_-36 methylation did not show a 
significant correlation with escape latencies unlike CeA CRF mRNA levels. Therefore, 
whereas our findings are suggestive of an ELS x 5-HTT genotype effect on CeA Crf 
promoter methylation that moreover could possibly be linked to stress coping behaviour, 
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Supplementary Methods
RNA isolation and cDNA synthesis 
From the micropunches of the BNSTov, PVN and CeA, total RNA was isolated by a single 
step of guanidinium isothiocyanate/phenol extraction using PureZol RNA isolation 
reagent (Bio-Rad, Hercules, CA, USA) according to manufacturer’s instructions. RNA 
concentrations were measured and RNA purity checked (A260/280 ratio between 1.8 and 
2.0) with a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, 
USA). Samples were treated with DNase to avoid DNA contamination. First strand cDNA 
synthesis was performed by incubating 40 ng of RNA dissolved in 12 µl of RNase-free 
water containing 0.25 mU random hexamer primers (Roche Applied Science, Penzberg, 
Germany) at 70 °C for 10 min, followed by double-strand synthesis in 1st strand buffer with 
10 mM DTT, 100 U Superscript II (Life Technologies), 0.5 mM dNTPs (Roche Applied Science) 
and 20 U of rRNasin (Promega Corp., Fitchburg, WI, USA) at 37 °C for 75 min. The cDNA 
samples were stored at -20 °C.
Quantitative real-time PCR
Quantitative real-time PCR (qRT-PCR) was performed with the ABI Prism® 7900 HT 
Sequence Detection System (Applied Biosystems, Foster City, CA, USA). For the reactions 
a total volume of 25 µl of buffer solution was used containing 5 µl of template cDNA, 12.5 
µl Power SYBR Green Master mix (Applied Biosystems), 1.5 µl RNase-free DEPC and 0.6 µM 
of each primer. Prior to analysis of the relative expression of Crf, it was evaluated whether 
Rn18S, Gapdh or Hprt1 would be the best internal control gene and all primer pairs were 
tested for reaction efficiency. Primers and probe sequences were purchased from Biolegio 
B.V. (Nijmegen, The Netherlands). The following primer sequences were used: Crf-Fw: 
5’-CCGGGCAGAGCAGTTAGC-‘3, Crf-Rev: 5’- CAACATTTCATTTCCCGATAATCTC-‘3, Gapdh-Fw: 
5’-GGTGTGAACGGATTTGGC-‘3, Gapdh-Rev: 5’- CTGGAAGATGGTGATGGGTT-‘3, Rn18S-Fw: 
5’-GTAACCCGTTGAACCCCATT-‘3, Rn18S-Rev: 5’-CCATCCAATCGGTAGTAGCG-‘3, Hprt1-Fw: 
5’-CAGACCGCTTTTCCCGC-‘3, Hprt1-Rev: 5’-CCCCCTTCAGCACACAGAG-‘3. The cycling 
protocol started with 10 min at 95 °C, followed by 39 reaction cycles with 15 s at 95 °C and 
1 min at 60 °C. For each reaction, the cycle threshold (Ct) was determined, i.e. the number 
of cycles needed to detect fluorescence above the arbitrary threshold. The procedure was 
concluded with a melting curve protocol, from 65 °C to 95 °C, measuring fluorescence 
every 0.5 °C, to control for product specificity. All RT-PCR analyses were carried out in 
triplicate, with newly synthesized cDNA. Relative target gene expression was calculated 
by the 2-ΔCt method (Schmittgen and Livak, 2008).
Immunohistochemistry
Immunohistochemistry targeted at CRF was carried out on free-floating sections of the 
BNSTov, PVN and CeA with the combined diaminobenzidine (DAB) and avidin-biotin-com-
patterns are ‘condensed’ and the effects of ELS, 5-HTT genotype and their interaction are 
likely underestimated. 
Conclusions
In conclusion, we report here that ELS and 5-HTT genotype interact to affect DNA 
methylation of the Crf promoter region in the CeA. Furthermore, methylation of CpG_-36 
was found to significantly correlate with CRF mRNA levels in the CeA, suggesting that 
there is a functional relationship between DNA methylation and Crf transcription. In 
addition, we found that CeA CRF mRNA levels correlated with behavioural resilience to 
inescapable stress. Therefore, our findings are suggestive of an ELS x 5-HTT genotype 
effect on CeA Crf promoter methylation, which is possibly linked to stress coping 
behaviour. As discussed above, our results warrant replication, as well as further experi-
mentation to connect the dots between Crf promoter methylation, expression of CRF and 
behavioural changes that are relevant for psychopathology.
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plex (ABC) method. The sections were rinsed in PBS, treated with 0.5% Triton X-100 (Sigma-
Aldrich, Zwijndrecht, The Netherlands) in PBS for 30 min to enhance antibody penetration, 
1% H2O2 in PBS for 45 min to quench endogenous peroxidase activity, and pre-incubated 
in PBS with 2% normal donkey serum (NDS) for 1 h. Incubation with the primary antiserum, 
rabbit polyclonal anti-CRF (1:2000, kindly provided by the late Dr. Wylie Vale, Salk Institute, 
La Jolla, CA, USA) was performed with 2% NDS in PBS for 16 h. The high specificity of the 
CRF antiserum has been described on the basis of preabsorption with the homologous 
synthetic peptide (Rivier et al., 1983; Sawchenko et al., 1984). Following rinses in PBS, the 
sections were incubated for 2 h with the secondary antiserum, biotinylated donkey 
anti-rabbit IgG (1:200, Jackson Immunoresearch, West Grove, PA, USA) and 2% NDS in PBS. 
Following rinses in PBS, the sections were incubated for 1 h with ABC of the Vectastain 
Elite ABC kit (1:200, Vector Laboratories, Burlingame, CA, USA) in PBS, after which they were 
again rinsed with PBS. The immunostaining was visualized by incubating the sections 
with 0.5% DAB (Sigma-Aldrich) and 0.005% H2O2 in Tris-HCl buffer (pH 7.4) for 11 min. 
Following rinses in Tris-HCl buffer, the sections were mounted on gelatin-coated glasses, 
left to dry overnight at 37 °C, dehydrated by an ethanol-xylene sequence and coverslipped 
with Entellan (Merck, Darmstadt, Germany).
Image analysis
For each immunohistochemical reaction, image analysis was performed bilaterally in 3 
sections of the BNSTov, PVN and CeA, interspaced by 125 µm. Digital images of the brain 
sections were taken at a resolution of 2592 x 1944 pixels with a DMBRE microscope 
equipped with a DC 500 digital camera (Leica microsystems, Wetzlar, Germany). The 
images were analyzed with ImageJ software (NIH, Bethesda, MD, USA), which was used to 
count CRF-immunoreactive (CRF-ir) neurons and boutons, as well as to quantify the 
specific signal density (SSD) of the CRF immunostaining of neurons and boutons. The 
analyses were performed by using the Analyze Particles-tool of ImageJ, which enables the 
selection of neurons and boutons by setting thresholds in the pixel size of particles. The 
measures were averaged, providing for each parameter and brain nucleus one value per 
animal.
Figure S1 Cytosine-phosphate-guanine (CpG) sites in the proximal promoter of the rat Crf gene. 
The cyclic AMP-response element (CRE) has been shown to be involved in the stress-induced 
elevation of CRF expression (Yao and Denver, 2007; Kovács, 2013) and is located upstream (-229_-221) 
of the transcription start site (TSS). In addition, CpG_-79 is located in a putative binding site for 
activator protein 1 (AP-1). Furthermore, 24-30 base pairs upstream of the TSS a TATA box is located, 
surrounded by several CpGs (Yao and Denver, 2007). The TATA box sequence is a core promoter 
sequence involved in the recruitment of RNA polymerase II (Lee and Young, 2000). Furthermore, 
DNA methylation of CpGs that surround TATA box sequences has been linked to the regulation of 
gene transcription (Kitazawa and Kitazawa, 2007; Matsumoto et al., 2013).
Figure S2 Cohort 1: Corticotropin-releasing factor (CRF) mRNA levels. CRF mRNA levels in the oval 
subdivision of the bed nucleus of the stria terminalis (BNSTov) and the central amgydala (CeA) of 
serotonin transporter (5-HTT) homozygous knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) 
and wild-type (5-HTT+/+) rats exposed to daily 3 h separations (MS180) or a control treatment (MS0) 
from postnatal day 2 to 14. CRF mRNA levels were not found to be significantly affected by early life 
stress, 5-HTT genotype or their interaction. Data were normalized to the average of the MS0-5-HTT+/+ 
group.
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Figure S3 Cohort 2: Corticotropin-releasing factor (CRF) mRNA levels. CRF mRNA levels in the oval 
subdivision of the bed nucleus of the stria terminalis (BNSTov), the paraventricular nucleus of the 
hypothalamus (PVN) and the central amgydala (CeA) of serotonin transporter (5-HTT) homozygous 
knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) rats exposed to daily 
3 h separations (MS180) or a control treatment (MS0) from postnatal day 2 to 14. In addition, this 
cohort of rats was exposed on three consecutive days to footshocks in a learned helplessness 
paradigm (Van der Doelen et al., 2013). CRF mRNA levels were not found to be significantly affected 
by early life stress, 5-HTT genotype or their interaction. Data were normalized to the average of the 
MS0-5-HTT+/+ group.
Figure S4 Cohort 1: Oval subdivision of the bed nucleus of the stria terminalis (BNSTov): immuno-
histochemistry of corticotropin-releasing factor (CRF). The BNSTov contains CRF-immunoreactive 
(CRF-ir) neurons and boutons (A). In the magnification-inset B (white box in A) an arrow indicates a 
CRF-ir neuron, while arrowheads point out CRF-ir boutons. The number (#) and specific staining 
density (SSD) of CRF-ir neurons (C, D) and boutons (E, F) were quantified for serotonin transporter 
(5-HTT) homozygous knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) 
rats exposed to daily 3 h separations (MS180) or a control treatment (MS0) from postnatal day 2 to 14. 
The number and SSD of CRF-ir neurons and boutons were not found to be significantly affected by 
early life stress, 5-HTT genotype or their interaction. Scale bar = 50 µm.
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Figure S4 Continued.
Figure S5 Cohort 1: Central amygdala (CeA): immunohistochemistry of corticotropin-releasing 
factor (CRF). The CeA contains contains CRF-immunoreactive (CRF-ir) neurons and boutons (A). In 
the magnification-inset B (white box in A) an arrow indicates a CRF-ir neuron, while arrowheads 
point out CRF-ir boutons. The number (#) and specific staining density (SSD) of CRF-ir neurons (C, D) 
and boutons (E, F) were quantified for serotonin transporter (5-HTT) homozygous knockout 
(5-HTT-/-), heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) rats exposed to daily 3 h 
separations (MS180) or a control treatment (MS0) from postnatal day 2 to 14. The number and SSD of 
CRF-ir neurons and boutons were not found to be significantly affected by early life stress, 5-HTT 
genotype or their interaction. Scale bar = 50 µm.
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Figure S5 Continued. Figure S6 Continued.
Figure S6 Cohort 1: Paraventricular nucleus (PVN): immunohistochemistry of corticotropin- 
releasing factor (CRF). The PVN contains CRF-immunoreactive (CRF-ir) neurons (A), of which the 
number (#) and specific staining density (SSD) were quantified for serotonin transporter (5-HTT) 
homozygous knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) rats 
exposed to daily 3 h separations (MS180) or a control treatment (MS0) from postnatal day 2 to 14. The 
number of CRF-ir neurons in the PVN (B) was found to be significantly affected by 5-HTT genotype 
(G: p < 0.01), with 5-HTT-/- rats showing a higher number of CRF-ir neurons in the PVN compared to 
5-HTT+/+ rats. The SSD of CRF-ir neurons in the PVN (C) was also found to be significantly influenced 
by 5-HTT genotype (G: p < 0.05), and in an opposite way as the number of CRF-ir neurons. However, 
post-hoc analysis did not reveal significant intergroup differences. Scale bar = 50 µm, *: p < 0.05.
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Supplementary material: group sizes
Group sizes of analyzed variables: cohort 1
BNSTov MS0 MS180
5-HTT+/+ 5-HTT+/- 5-HTT-/- 5-HTT+/+ 5-HTT+/- 5-HTT-/-
# CRF-ir neurons 6 6 5 6 6 6
SSD CRF-ir neurons 6 6 5 6 6 6
# CRF-ir boutons 6 6 5 6 6 6
SSD CRF-ir boutons 6 6 5 6 6 6
CRF mRNA 8 7 5 6 6 4
DNA methylation 8 8 6 7 8 5
PVN MS0 MS180
5-HTT+/+ 5-HTT+/- 5-HTT-/- 5-HTT+/+ 5-HTT+/- 5-HTT-/-
# CRF-ir neurons 5 5 5 4 4 4
SSD CRF-ir neurons 5 5 5 4 4 4
DNA methylation 8 7/8 5/6 7 9 5
CeA MS0 MS180
5-HTT+/+ 5-HTT+/- 5-HTT-/- 5-HTT+/+ 5-HTT+/- 5-HTT-/-
# CRF-ir neurons 6 5 4 5 6 6
SSD CRF-ir neurons 6 5 4 5 6 6
# CRF-ir boutons 6 5 4 5 6 6
SSD CRF-ir boutons 6 5 4 5 6 6
CRF mRNA 7 5 5 5 6 5
DNA methylation 8 8 6 7 9 5
Group sizes of analyzed variables: cohort 2
BNSTov MS0 MS180
5-HTT+/+ 5-HTT+/- 5-HTT-/- 5-HTT+/+ 5-HTT+/- 5-HTT-/-
CRF mRNA 13 22 16 14 20 14
DNA methylation 9 21 16 14 17 12
PVN MS0 MS180
5-HTT+/+ 5-HTT+/- 5-HTT-/- 5-HTT+/+ 5-HTT+/- 5-HTT-/-
CRF mRNA 13 21 16 14 20 14
DNA methylation 13 18 16 14 16 14
CeA MS0 MS180
5-HTT+/+ 5-HTT+/- 5-HTT-/- 5-HTT+/+ 5-HTT+/- 5-HTT-/-
CRF mRNA 13 22 16 15 20 14
DNA methylation 12 20 15 14 19 13
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Introduction
Vulnerability to stress-related psychiatric disease is largely determined by a complex 
interplay between genetic and environmental factors. A common polymorphism in the 
serotonin (5-hydroxytrypamine; 5-HT) transporter (5-HTT, SLC6A4) gene has been shown 
to moderate the impact of stressful life events on the occurrence of major depression 
(Caspi et al., 2003; Karg et al., 2011, but also see Risch et al., 2009). Individuals with the short 
(S) allele of the of the 5-HTT-linked polymorphic region (5-HTTLPR) seem to be especially 
sensitive to the experience of early life stress (ELS) (Karg et al., 2011), but importantly, also to 
positive environments (Van IJzendoorn et al., 2012). To understand the (neuro)physiological 
underpinnings of the interaction of 5-HTTLPR with psychopathogenic environmental 
factors such as ELS is pivotal for progression towards rationale-based therapy.
 Corticotropin-releasing factor (CRF) is a key neuropeptide involved in the stress 
response due to its control of the hypothalamo-pituitary-adrenal (HPA) axis and its 
initiating and coordinating role of HPA, autonomic and behavioural responses to stress 
(Bale and Vale, 2004; Joëls and Baram, 2009). We have shown before that ELS and 5-HTT 
genotype interact to program the adult HPA-axis (Van der Doelen et al., 2014a) as well as 
DNA methylation of the Crf promoter region in the amygdala (Van der Doelen et al., 
2014b). Over the last decade, evidence has accumulated suggesting that other members 
of the CRF family of neuropeptides, certainly urocortin 1 (Ucn1), but also urocortin 2 and 
urocortin 3, complement the actions of CRF in the regulation of the stress response 
(Kuperman and Chen, 2008; Kozicz et al., 2011a; Ryabinin et al., 2012). These complementary 
functions are facilitated by differences in anatomical distribution and receptor 
pharmacology (Janssen and Kozicz, 2013). The actions of CRF and the urocortins are 
mediated by two G-protein coupled receptors, corticotropin-releasing factor receptor 1 
and 2 (CRF1R, CRF2R). Ucn1 binds both receptors with high affinity, while CRF has low 
affinity for CRF2R, and Ucn2 and Ucn3 selectively bind to CRF2R (Vaughan et al., 1995; Hsu 
and Hsueh, 2001; Lewis et al., 2001; Reyes et al., 2001).
 Ucn1 is a 40 amino acid-peptide, that is highly conserved across species (Vaughan et 
al., 1995; Donaldson et al., 1996; Zhao et al., 1998; Cepoi et al., 1999; Hauger et al., 2006). In 
the mammalian brain, Ucn1 is most abundantly expressed by neurons of the centrally 
projecting Edinger-Westphal nucleus (EWcp) in the midbrain (Vaughan et al., 1995; Kozicz 
et al., 1998, 2011b; Bittencourt et al., 1999; Iino et al., 1999). The EWcp-Ucn1 neurons have 
been shown to be recruited by various but selective stressors (Weninger et al., 2000; 
Gaszner et al., 2004; Korosi et al., 2005; Rouwette et al., 2011) with activity (measured by 
expression of the immediate early gene cFos) in some cases lasting up to 18 hours (Kozicz 
et al., 2001). Furthermore, in contrast to the HPA-axis, EWcp-Ucn1 neurons do not show 
habituation upon chronic stress exposure (Viau and Sawchenko, 2002; Korosi et al., 2005; 
Xu et al., 2010). Interestingly, Ucn1 expression is increased in CRF-knockout mice (Weninger 
et al., 2000) and decreased in mice overexpressing neuronal CRF (Kozicz et al., 2004). Based 
Abstract
The interaction of early life stress (ELS) and the serotonin transporter (5-HTT) gene-linked 
polymorphic region (5-HTTLPR) has been associated with increased risk to develop 
depression in later life. We have used the maternal separation paradigm as a model for ELS 
exposure of homozygous and heterozygous 5-HTT knockout rats. Previously, we have 
reported altered stress coping behaviour and activity of the hypothalamo-pituitary-adre-
nal (HPA) axis in this ELS x 5-HTT genotype model. Next to corticotropin-releasing factor 
(CRF), the related peptide urocortin 1 (Ucn1) has been implicated in the behavioural and 
HPA response to stress. Ucn1 is abundantly expressed by neurons of the centrally 
projecting Edinger-Westphal (EWcp) nucleus, which are known to project to the dorsal 
raphe (DR) nucleus. The DR is involved in the behavioural and physiological stress response 
and is a major source of forebrain-projecting 5-HT neurons. Interestingly, the EWcp 
displays a dense innervation of 5-HT fibers as well. Therefore, it is hypothesized that the 
reciprocal relationship of EWcp-Ucn1 and DR-5HT neurons is of interest for stress-related 
psychiatric disorders. In this study, we found that ELS and 5-HTT genotype increased the 
number of 5-HT neurons in specific DR subdivisions, and that 5-HTT knockout rats showed 
decreased 5-HT innervation of EWcp-Ucn1 neurons. Furthermore, ELS was associated with 
increased DNA methylation of the promoter region of the Ucn1 gene and increased 
expression of 5-HT receptor 1A in the EWcp. In contrast, 5-HTT deficiency was associated 
with site-specific increases and decreases of DNA methylation of the Ucn1 promoter, and 
heterozygous 5-HTT knockout rats showed decreased expression of CRF receptor 1 in the 
EWcp. Together, our findings reveal a reciprocal relationship between EWcp-Ucn1 and 
DR-5-HT neurons, which were found to be affected by exposure to ELS and 5-HTT 
genotype. These findings at the molecular level are hypothesized to contribute to ELS x 
5-HTTLPR-linked psychopathology. 
118 119
CHAPTER 6 THE EWCP AND THE DR
6
has been shown to be stimulated by glucocorticoid hormones through the glucocorticoid 
receptor (GR) (Zhang et al., 2012; Lau et al., 2013). Furthermore, behavioural responses to 
stress have been shown to be significantly affected by GR signaling in DR 5-HT neurons 
(Espallergues et al., 2012; Vincent and Jacobson, 2014).
 Rodents with a knockout of the 5-HTT transporter (5-HTT-/-) display increased 
extracellular 5-HT levels across the brain, decreased excitability of DR 5-HT neurons, 
decreased 5-HT tissue levels, and an almost complete absence of 5-HT re-uptake (Bengel 
et al., 1998; Gobbi et al., 2001; Lira et al., 2003; Mathews et al., 2004; Kim et al., 2005; Homberg 
et al., 2007). Furthermore, 5-HTT-/- mice and rats have been shown to exhibit decreased 
pre- and postsynaptic 5-HT1A expression and functioning (Li et al., 1999, 2000; Fabre et al., 
2000; Homberg et al., 2008a; Olivier et al., 2008b).
 From experiments with the maternal separation (MS) paradigm, the perspective has 
risen that the genetic background of rat strains can have strong modulatory effects on the 
phenotypic outcome of exposure to ELS. The expression of 5-HT1A and 5-HTT have for 
instance been reported to be decreased in Sprague-Dawley rats (Lee et al., 2007; Bravo et 
al., 2014), but unaltered or increased (5-HTT mRNA) in Lister hooded and Long-Evans rats 
that were subjected to MS (Neumaier et al., 2002; Gartside et al., 2003; Arborelius et al., 
2004; Gardner et al., 2009). For Ucn1 expression in the EWcp, exposure to ELS has been 
shown not to affect wildtype (5-HTT+/+) Wistar rats (Gaszner et al., 2009), while 5-HTT-/- 
mice display decreased Ucn1 expression in the EWcp (Fabre et al., 2011). In contrast, a 
human postmortem study reported that male (but not female) suicide victims with major 
depression exhibited highly increased Ucn1 mRNA levels in the EWcp (Kozicz et al., 2008).
 For the present study, we hypothesized that ELS and 5-HTT gene variation would 
interact to affect the reciprocal relationship between the EWcp-Ucn1 and DR-5-HT 
populations. Specifically, we exposed heterozygous (5-HTT+/-) and homozygous (5-HTT-/-) 
5-HTT knockout rats, and their wild-type (5-HTT+/+) littermates to ELS, i.e. maternal 
separation, and examined the EWcp-Ucn1 neurons at the epigenetic, mRNA and protein 
level. Furthermore, we assessed the reciprocal innervation of Ucn1 and 5-HT, as well as the 
expression levels of 5-HT1A, CRF1R, CRF2R and GR in the EWcp and DR. Previously, we have 
shown differential stress coping behaviour and HPA-axis activity in our ELS x 5-HTT 
genotype model (Van der Doelen et al., 2013, 2014a).
Materials and Methods
Animals
The experimental procedures were approved by the Committee for Animal Experiments of 
the Radboud University Nijmegen, The Netherlands, and all efforts were made to minimize 
animal suffering and to reduce the number of animals used. Serotonin transporter knockout 
rats (Slc6a41Hubr) were generated by N-ethyl-N-nitrosurea (ENU)-induced mutagenesis (Smits 
on these findings and the differential activation of PVN-CRF and EWcp-Ucn1 neurons in 
the stress response, it has been proposed that the dynamics of Ucn1 are important for the 
adaptive phase of the central stress response (Kozicz et al., 2011a; Ryabinin et al., 2012).
 The EWcp-Ucn1 neurons have been shown to innervate the lateral septum in the 
forebrain, but predominantly project to the brainstem and spinal cord (Kozicz et al., 1998; 
Bittencourt et al., 1999; Weitemier et al., 2005). In the brainstem, a major site of innervation 
by Ucn1-positive fibers is the dorsal raphe (DR) nucleus nucleus (Bittencourt et al., 1999; 
Bachtell et al., 2004; Weitemier et al., 2005), where lesions of the EWcp have been shown 
to lead to a significant reduction of Ucn1-positive fibers (Bachtell et al., 2004). The EWcp on 
the other hand exhibits a dense innervation of 5-HT-positive fibers, and the DR has been 
shown to send projections to the EWcp (Clements et al., 1985; Morin and Meyer-Bernstein, 
1999). Therefore, EWcp-Ucn1 neurons are hypothesized to contribute to the regulation of 
DR 5-HT activity, and vice versa (Kozicz et al., 2011a).
 The DR and median raphe (MR) nuclei contain the majority of forebrain-projecting 
5-HT neurons. The DR especially has been implicated in the behavioural and physiological 
stress response (Hale et al., 2012), and receives denser Ucn1-positive innervation compared 
to the MR (Bittencourt et al., 1999; Weitemier et al., 2005). The DR is topographically 
organized in subregions encompassing the rostral, dorsal, ventral, lateral, interfascicular 
and caudal portions. Interestingly, 5-HT interneurons from the lateral wings of the DR 
(DRLW) innervate the dorsal and ventral parts of the DR (DRD, DRV), and have been 
proposed, based on a collection of evidence, to have a tonic inhibitory control over the 
DRD and DRV via postsynaptic 5-HT1A receptors (Jasinska et al., 2012). In addition, 5-HT1A 
autoreceptors are crucially involved in the inhibitory regulation of DR 5-HT neuron activity 
(Savitz et al., 2009). In depressed subjects, 5-HT1A binding in the DR (positron emission 
tomography) has been reported to be both elevated and reduced (Drevets et al., 1999; 
Parsey et al., 2006b), with postmortem binding studies suggesting that this discrepancy 
might be explained by considering the rostrocaudal extent of the DR (Boldrini et al., 2008).
 The activity of DR 5-HT neurons can furthermore be regulated by CRF and urocortins. 
Activation of CRF1R has been associated with repression, while CRF2R mediates excitation 
of DR 5-HT neurons (Lukkes et al., 2008). Exposure to stress influences the relative 
contributions of CRF1R and CRF2R by affecting internalization and plasma membrane 
recruitment (Waselus et al., 2009; Wood et al., 2013). It has been postulated that 
CRF1R-mediated inhibition of 5-HT release in DR projection areas is associated with active 
coping responses, and CRF2R-mediated stimulation with passive stress coping (Valentino 
et al., 2010). However, 5-HT-linked behavioural responses may depend on the involved 
projection area(s), as well as the type and duration of the stressor (Forster et al., 2006; 
Wood et al., 2013).
 The neurotransmission of 5-HT is not only affected by the regulation of the activity of 
5-HT neurons, but also by the functioning of the 5-HT transporter (5-HTT), which serves to 
re-uptake 5-HT from the extracellular space. The expression of 5-HTT by DR 5-HT neurons 
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fixated brains were immediately isolated, postfixated in fresh 4% PFA and transferred to a 
30% sucrose solution (PBS). The sucrose solution was refreshed every two days until the 
brains were completely submerged. Then, the brains were frozen by use of dry ice and 
were cut in 25 µm-thick coronal slices on a freezing microtome (Microm, Walldorf, 
Germany). The sections were stored in a sterile antifreeze solution (0.05 M PBS, 30% 
ethylene glycol, 20% glycerol) at -20 °C.      
 For decapitations, rats were taken from their home cage into a separate room and 
decapitated within 10 s. Immediately after decapitation, the brains were isolated, frozen in 
aluminum foil on dry ice and stored at -80 °C. In a cryostat (-15 °C), the brains were prepared 
in 420 µm-thick coronal slices in order to obtain punches from the EWcp (Bregma -5.28 
and -5.70 mm, coordinates based on Paxinos and Watson, 2007) and DR (Bregma -7.08 and 
-7.50 mm). The brain areas were punched out with a Miltex 1.5 mm biopsy puncher (Integra 
Miltex, York, PA, USA), collected in sterile vials, immediately placed on dry ice and stored at 
-80 °C.
 Half of the punches were used for RNA isolation, the other half for the isolation of 
genomic DNA. The punches were distributed by systematic randomization, accounting 
for lateralization and Bregma position. 
Immunohistochemistry
For dual immunofluorescence labelling of Ucn1 and 5-HT (n = 6-7), free-floating sections 
containing the EWcp and DR were used. The EWcp sections were rinsed in PBS, incubated 
for 30 min with 0.5% Triton X-100 (Sigma-Aldrich, Zwijndrecht, The Netherlands) in PBS to 
enhance antibody penetration, and pre-incubated in PBS with 2% normal donkey serum 
(NDS) for 1 h. Incubation with the primary antisera, polyclonal rabbit anti-Ucn1 (1:2000, 
kindly provided by the late Dr. Wylie Vale, Salk Institute, La Jolla, CA, USA) and monoclonal 
mouse anti-5-HT (1:20.000, kindly provided by Dr. Lucienne Léger, Université Claude 
Bernard, Lyon, France), was performed with 2% NDS in PBS for 16 h. The high specificities 
of rabbit anti-Ucn1 (Bittencourt et al., 1999; Turnbull et al., 1999) and mouse anti-5-HT 
(Léger et al., 1998, 2001) have been reported previously. Following rinses in PBS, the 
sections were incubated for 3 h with the secondary antisera, cyanine2-conjugated donkey 
anti-rabbit IgG and cyanine3-conjugated donkey anti-mouse IgG (both 1:100, Jackson 
Immunoresearch, West Grove, PA, USA), with 2% NDS in PBS.    
 The DR sections were treated in a similar fashion, but with the use of tyramide signal 
amplification (TSA fluorescence system kit, PerkinElmer, Boston, MA, USA) for the 
visualization of Ucn1-immunoreactivity. The DR sections were rinsed in PBS and were 
incubated for 30 min with 0.5% Triton X-100 (Sigma-Aldrich, Zwijndrecht, The Netherlands) 
in PBS to enhance antibody penetration. Next, the sections underwent heat-induced 
epitope retrieval by incubation for 10 min in 0.01 M sodium citrate buffer at 85 °C, were 
rinsed with PBS, and incubated with 1% H2O2 in PBS for 45 min to quench endogenous 
peroxidase activity. Following rinses with PBS, the sections were pre-incubated in PBS-BTSA 
et al., 2006). Experimental animals (5-HTT+/+, 5-HTT+/- and 5-HTT-/- rats) were derived from 
crossing 3 month old 5-HTT+/- rats that were outcrossed for at least twelve generations 
with commercial (Harlan, Ter Horst, The Netherlands) wild-type Wistar rats. The pregnant 
dams were housed in standard polypropylene cages (40 x 20 x 18 cm) with sawdust 
bedding and ad libitum access to water and rodent chow (Sniff Spezialdiäten, Soest, 
Germany) in a temperature (21 ± 1 °C) and humidity-controlled room (45-60% relative 
humidity), with a 12 : 12 h light : dark cycle (lights on at 07.00 a.m.). The dams were inspected 
daily at 5.00 p.m. for delivery of pups and day of birth was designated as postnatal day 
(PND) 0. At PND1, two paper towels (22,5 x 24,5 cm) were supplied to the mother for nest 
construction. Further, the litters were culled to a maximum of 10 pups, with gender ratios 
in favor of a male majority to maximally 7 : 3.
Early life stress
We used repeated and prolonged maternal separation as a model for ELS. Litters were 
randomly allocated to one of two rearing conditions (from PND 2 to 14): maternal 
separation for 180 min (MS180) or a control treatment with immediate reunion of mother 
and pups (MS0). MS180/MS0 was started daily between 08.30 and 09.00 a.m., and was 
performed as follows: The mother was removed from the home cage and placed into an 
identical cage until the end of the separation period. Pups were then removed from the 
nest as complete litters and placed into a cage (24 x 15 x 14 cm) with only sawdust 
bedding, after which they were transferred to an adjacent room. The cages were placed 
on heat pads, which were set to maintain a bedding temperature of 31-33 °C for PND 2-7 
and 29-31 °C for PND 8-14. At the end of the separation period, litters were returned to 
their home cage by first rolling them in the home cage bedding material and then placing 
them in the nests. This was followed by reunion with the mothers. During PND 0-22, half 
of the bedding material of the home cages was refreshed every week. At PND 14, ear 
punches were taken of the pups for identification and genotyping, which was performed 
by Kbiosciences (Hoddesdon, United Kingdom). The procedure of genotyping has been 
described previously (Homberg et al., 2007). At PND 22, the pups were weaned and 
housed in groups of 2-3 littermates of the same sex and rearing, under the same conditions 
as mentioned above. 
Tissue collection and preparation
For the collection of tissues only adult (PND85-95) male rats were used. At this point, the 
sample was split into a group of rats that was sacrificed by perfusion and a group of rats 
that was sacrificed by decapitation. Of every litter, where possible, a single rat was selected 
of all three genotypes. Prior to transcardial perfusion, rats received an intraperitoneal 
injection of sodium pentobarbital (50 mg/kg body weight). The perfusion was performed 
with phosphate-buffered saline (PBS, pH 7.4) and a clamp on the abdominal aorta, 
followed by fixation of the brain with ice-cold 4% paraformaldehyde (PFA) in PBS. The 
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RNA isolation and cDNA synthesis 
From the micropunches of the EWcp and DR, total RNA was isolated by use of the 
Nucleospin® RNA II kit (Macherey-Nagel, Düren, Germany) according to manufacturer’s 
instructions. Samples were treated with rDNase to avoid DNA contamination. RNA 
concentrations were measured and RNA purity checked (A260/280 ratio between 1.8 and 
2.0) with a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, 
USA). First strand cDNA synthesis was performed by incubating 40 ng of RNA dissolved in 
12 µl of RNase-free water containing 0.25 mU random hexamer primers (Roche Applied 
Science, Penzberg, Germany) at 70 °C for 10 min, followed by double-strand synthesis in 1st 
strand buffer with 10 mM DTT, 100 U Superscript II (Life Technologies), 0.5 mM dNTPs 
(Roche Applied Science) and 20 U of rRNasin (Promega Corp., Fitchburg, WI, USA) at 37 °C 
for 75 min. The cDNA samples were stored at -20 °C.
Quantitative real-time PCR
Quantitative real-time PCR (qRT-PCR, n = 5-8) was performed with the CFX96 Touch 
Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA). For the reactions a total 
volume of 25 µl of buffer solution was used containing 5 µl of template cDNA, 12.5 µl Power 
SYBR Green Master mix (Applied Biosystems, Foster City, CA, USA), 1.5 µl RNase-free DEPC 
and 0.6 µM of each primer. Primers were designed using NCBI Primer-Blast (www.ncbi.nlm.nih.
gov/tools/primer-blast/) and synthesized by Biolegio BV (Nijmegen, The Netherlands). 
With standard curve analysis all primer pairs were confirmed to have reaction efficiencies of 
> 1.8. Prior to analysis of the relative expression of the genes of interest (GOI), for each tissue 
it was evaluated whether Rn18S, Gapdh or Hprt1 would be the best internal control gene. 
The following primer sequences were used; Crhr1-Fw: 5’-TGCCAGGAGATTCTCAACGAA-‘3, 
Crhr1-Rev: 5’-AAAGCCGAGATGAGGTTCCAG-‘3, Crhr2-Fw: 5’-TTCCTGCTG CAACTCATCGA-‘3, 
Crh2r-Rev: 5’-CCTCCACAAACATCCAGAAGAAG-‘3, Gapdh-Fw: 5’-GGTGTGAACGGATTTGGC-‘3, 
Gapdh-Rev: 5’-CTGGAAGATGGTGATGGGTT-‘3, Hprt1-Fw: 5’-CAGACCGCTTTTCCCGC-‘3, 
Hprt1-Rev: 5’-CCCCCTTCAGCACACAGAG-‘3, Htr1a-Fw: 5’- TTTCTCATCTCCATCCCGCC-‘3, 
Htr1a-Rev: 5’-GCCTGCTCCCTTCTTTTCCA’-3, Nr3c1-Fw: 5’-TCGTCAAAAGGGAAGGGAACT-‘3, 
Nr3c1-Rev: 5’-TGGAAGCAGTAGGTAAGGAGA-‘3, Rn18S-Fw: 5’-GTAACCCGTTGAACCCCATT-‘3, 
Rn18S-Rev: 5’-CCATCCAATCGGTAGTAGCG-‘3, Slc6a4-Fw: 5’-CCCTCTGTTTCTCCTGTTCATC-‘3, 
Slc6a4-Rev: 5’-TAGCCCAAGACGATACTCCA-‘3, Ucn-Fw: 5’-ACTGGGCAGACACTCCGATAAC-‘3, 
Ucn-Rev: 5’-TCCACTGGCTGCTCTCCG-‘3. The cycling protocol started with 10 min at 95 °C, 
followed by 39 reaction cycles with 15 s at 95 °C and 1 min at 60 °C. For each reaction, the 
cycle threshold (Ct) was determined, i.e. the number of cycles needed to detect 
fluorescence above the arbitrary threshold. Relative expression of the GOI was calculated 
by the 2-ΔCt method (Schmittgen and Livak, 2008). The procedure was concluded with a 
melting curve protocol, from 65 °C to 95 °C, measuring fluorescence every 0.5 °C, to control 
for product specificity. All qRT-PCR analyses were carried out in triplicate, with newly 
synthesized cDNA. 
with 2% NDS for 1 h. Incubation with the primary antisera, rabbit anti-Ucn1 (1:50.000) and 
mouse anti-5-HT (1:2000), was performed with 2% NDS in PBS-BTSA for 16 h. With in-between 
rinses in PBS, the sections were then incubated for 1 h with biotinylated donkey anti-rabbit 
IgG (Jackson Immunoresearch) in PBS-BTSA, for 30 min with a conjugate of streptavidine 
and horseradish peroxidase (1:100, TSA kit) in PBS-BTSA, and for 1 h with cyanine3-tyramide 
(1:200, TSA kit) and AlexaFluor488-conjugated donkey anti-mouse IgG (Jackson Immuno-
research) in amplification diluent (TSA kit).
 The EWcp and DR sections were mounted on gelatin-coated glasses, air-dried and 
coverslipped with Fluorsave (Calbiochem, San Diego, CA, USA). Digital images of the 
sections (1024 x 1024 dpi) were obtained with the use of a Leica DM IRE2 confocal laser 
scanning microscope (TCS SP2 AOBS system, Leica Microsystems, Leica, Wetzlar, Germany) 
and 488 nm Argon and 561 nm yellow diode lasers.     
 
Image analysis
The images were analyzed with the use of ImageJ software (NIH, Bethesda, MD, USA) and 
by observers that were blind for experimental grouping. In the EWcp, the number and 
mean staining intensity of Ucn1-immunoreactive (Ucn1-ir) neurons were quantified by 
manually encircling Ucn1-ir neurons in three serial sections, interspaced by 125 µm. The 
analysis of 5-HT-immunoreactive (5-HT-ir) fibers in the EWcp was automated by the use of 
the Analyze Particles-tool of ImageJ, which enables the selection of particles by pixel size 
thresholding. The mean staining intensities were corrected with a measurement of the 
background intensity in the same section, and expressed as specific signal density (SSD, 
arbitrary units).
 For the quantification of the number and SSD of 5-HT-ir neurons in the DR, a distinction 
was made on the basis of the topographical organization of the DR (Lowry, 2002; Hale 
et al., 2012). Firstly, three images were selected of every animal that contained the DRD, 
DRV and DRLW. The rostrocaudal extent of the selected DR images was in correspondence 
to the micropunches of the DR (approximately -7.08 to -7.92 mm from Bregma). Each image 
was subdivided by placing straight lines over the image, based on the extent of the 
cellular groups and specific landmarks (Roche et al., 2003). Next, the number of 5-HT-ir 
neurons was counted manually per section, and the mean SSD was obtained as described 
above for the EWcp images.
 In addition, overlay images were created from the Ucn1-ir and 5-HT-ir signals of each 
EWcp and DR section (Photoshop, Adobe, San José, CA, USA), which were used to manually 
count the number of 5-HT-ir fibers that were juxtaposed to Ucn1-ir neurons in the EWcp 
and the number of Ucn1-ir fibers juxtaposed to 5-HT neurons in the different subdivisions 
of the DR. The total number and SSD of Ucn1-ir fibers in the DR subdivisions were not 
quantified. All obtained measures were averaged, providing for each parameter one value 
per brain area and animal. 
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the DR, a log-transformation was applied to achieve a normal distribution. For the SSD of 
5-HT-ir fibers in the EWcp, the DNA methylation measurements and DR 5-HTT mRNA 
levels, log-transformation did not achieve a normal distribution. For these parameters, 
bootstrap analysis was applied to confirm if the results from the factorial ANOVA were 
robust, and non-parametric post-hoc testing was used. For correlational analysis, Bonferroni 
correction was applied to correct for multiple comparisons. Furthermore, Pearson or 
Spearman correlations were performed in the case of parametric or non-parametric 
variables, respectively. Statistical significance was set at p < 0.05. 
Results
Immunohistochemistry of Ucn1 and 5-HT in the EWcp
In the EWcp, immunohistochemistry with the Ucn1 and 5-HT antisera revealed the 
presence of Ucn1-ir somas, as well as a dense network of 5-HT-ir fibers (Figure 2A, B). We 
quantified the number and SSD of both Ucn1-ir neurons and 5-HT-ir fibers using ImageJ 
(Figure 2). Furthermore, overlay images were created (Figure 2C) to quantify the number 
of Ucn-ir neurons that were found to be juxtaposed with 5-HT-ir, as well as the average 
number of juxtaposed 5-HT-ir fibers per Ucn-ir neuron.
 The number and SSD of Ucn-ir neurons were not found to be significantly affected by 
ELS, 5-HTT genotype or their interaction. In contrast, 5-HTT deficiency, but not ELS or ELS 
x 5-HTT genotype interaction, was found to significantly affect the number (F2,34 = 10.09, 
p < 0.001) and SSD (F2,34 = 7.82, p = 0.001) of 5-HT-ir fibers in the EWcp. Post-hoc testing 
indicated that 5-HTT-/- rats display a significantly lower number and SSD of 5-HT-ir fibers in 
the EWcp compared to 5-HTT+/+ rats (p ≤ 0.01) and 5-HTT+/- rats (p ≤ 0.001). Moreover, the 
number of Ucn1-ir neurons that were juxtaposed to 5-HT-ir fibers was also found to be 
significantly affected by 5-HTT genotype (F2,34 = 6.65, p < 0.01), with 5-HTT
-/- rats showing 
a decreased number of Ucn1-ir neurons with 5-HT contacts compared to both 5-HTT+/+ 
rats (p < 0.01) and 5-HTT+/- rats (p < 0.05). Interestingly, the average number of 5-HT-ir 
contacts per single Ucn1-ir neuron was not found to be significantly affected by 5-HTT 
genotype, nor by ELS or the interaction between ELS and 5-HTT genotype (Figure 2).
Gene expression in the EWcp
The mRNA levels of Ucn1, CRF2R and GR in the EWcp were found not to be significantly 
affected by ELS, 5-HTT genotype or their interaction. In contrast, CRF1R mRNA levels were 
found to be significantly affected by 5-HTT genotype (F2,35 = 4.03, p < 0.05). Post-hoc 
analysis indicated that CRF1R mRNA levels in the EWcp were significantly lower for 5-HTT
+/- 
rats compared to 5-HTT+/+ rats (p < 0.05). In addition, 5-HT1A mRNA levels were found to be 
affected by ELS (F1,35 = 4.91, p < 0.05), with the MS180 group displaying significantly higher 
5-HT1A mRNA levels than the MS0 group (Figure 3).
DNA methylation assay
DNA methylation is an epigenetic mechanism that occurs at cytosine-phosphate- guanine 
(CpG) sites and is associated with the repression of gene transcription (Moore et al., 2013). 
The DNA methylation assay (n = 5-8) was performed as described previously (Sterrenburg 
et al., 2011). Briefly, genomic DNA was isolated from punches of the EWcp and DR by use 
of the DNeasy blood & tissue kit (Qiagen, Valencia, CA, USA) and according to the 
manufacturer’s instructions. Bisulfite conversion of the DNA samples and pyrosequencing 
of the promoter region of the Ucn gene were performed by EpigenDX (Hopkinton, MA, 
USA) (Kim et al., 2007). The promoter region of the Ucn gene contains important sites for 
the regulation of transcription, such as a cyclic-AMP response element (CRE), and putative 
binding sites for transcription factors such as GATA (Vaughan et al., 1995; Zhao et al., 1998). 
All but one of the examined CpG sites are found upstream of the transcription start site 
of the gene, indicated by a minus sign (Figure 1).
Statistical analysis
All statistical tests have been carried out using SPSS (version 20, IBM corporation, Armonk, 
NY, USA)). The results are presented as the mean with the standard error of the mean 
(SEM). The qRT-PCR 2-ΔCt data have been expressed as a ratio compared to the average of 
the MS0-wild-type group. All data have been examined with factorial ANOVA. If a 
significant main effect (“genotype”, “early life stress”) or interaction (“genotype x early life 
stress”) was found, post-hoc testing was performed. For the number of Ucn-ir neurons in 
the EWcp, the mRNA levels of CRF1R, CRF2R, Ucn1, 5-HT1A in the EWcp and CRF1R mRNA in 
Figure 1 Cytosine-phosphate-guanine (CpG) sites in the proximal promoter of the rat Ucn gene. 
The cyclic AMP-response element (CRE) has been functionally characterized for the mouse and 
human (Ucn, UCN) genes (Zhao et al., 1998). Furthermore, 77-83 base pairs upstream of the 
transcription start site (TSS) a TATA-like sequence (TATATAA) is located, surrounded by several CpGs. 
There are multiple putative binding sites for transcription factors in the 5’-flanking region, but these 
remain to be experimentally followed up on (Zhao et al., 1998).
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DNA methylation of the Ucn1 gene promotor region in the EWcp
Overall, the DNA methylation levels of the promoter region of the Ucn gene in the EWcp 
were found to be remarkably low (Figure 4). Across the promoter region, only at CpG_-171 
and CpG_+27 the methylation levels were found to be above 5%, while at CpG_-89 there 
was a complete absence of methylation.
 Factorial ANOVA revealed that DNA methylation of CpG_-171 (F2,35 = 4.55, p < 0.05) 
and CpG_-24 (F2,35 = 4.46, p < 0.05) was significantly affected by 5-HTT genotype (Figure 
4). Post-hoc analysis indicated that CpG_-171 methylation was significantly higher in 
5-HTT-/- rats compared to 5-HTT+/- rats (p < 0.05) and 5-HTT+/+ rats (p < 0.01). Furthermore, 
CpG_-24 methylation was completely absent in 5-HTT-/- rats, resulting in a significant 
difference from 5-HTT+/- rats (p < 0.05) (Figure 5). In addition, DNA methylation of CpG_-156 
(F1,35 = 7.01, p < 0.05) and CpG_-49 (F1,35 = 9.08, p < 0.01) was found to be significantly 
affected by ELS, with the MS180 group displaying significantly higher methylation levels at 
these CpG sites compared to the MS0 group (Figure 4).
 DNA methylation of the other CpG sites was not found to be significantly regulated 
by ELS, 5-HTT genotype or their interaction. Furthermore, we found no significant 
correlations between Ucn1 mRNA levels and the methylation of individual CpG sites or the 
average methylation of the Ucn promotor region.
Immunohistochemistry of 5-HT and Ucn1 in the DR
In the DR, immunohistochemistry with the Ucn1 and 5-HT antisera revealed the abundant 
presence of 5-HT-ir somas in the different subdivisions of the DR, but only a sparse 
innervation by Ucn1-ir fibers. The number and SSD of 5-HT-ir neurons was quantified 
using ImageJ (Figure 6A), as well as the number of contacts (juxtapositions) between 
5-HT-ir neurons and Ucn1-ir fibers (Figure 6B, C).
 Interestingly, we found a highly significant positive correlation between CRF1R and 
GR mRNA levels in the EWcp (rs = .73, p = 0.000), that remained significant after (Bonferroni) 
correction for multiple comparisons (Figure 3). 
Figure 3  Edinger-Westphal nucleus: mRNA levels of urocortin 1 (Ucn1), corticotropin-releasing 
factor receptor 1 (CRF1R) and 2 (CRF2R), serotonin receptor 1A (5-HT1A) and the glucocorticoid 
receptor (GR). Quantitative real-time PCR was used to analyze these mRNA levels in serotonin 
transporter (5-HTT) homozygous knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and 
wild-type (5-HTT+/+) rats exposed to daily 3 h separations (MS180) or a control treatment (MS0). CRF1R 
mRNA levels were found to be significantly lower in 5-HTT+/- compared to 5-HTT+/+ rats (G: p < 0.05), 
while 5-HT1A mRNA levels were found to be significantly higher in the MS180 compared to the MS0 
group (E: p < 0.05). Furthermore, CRF1R and GR mRNA levels were found to show a highly significant 
positive correlation (p < 0.001). Data were normalized to the average of the MS0-5-HTT+/+ group.
Figure 3  Continued.
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 The number of 5-HT-ir neurons in the DRLW were found to be significantly affected 
by ELS (F1,35 = 8.40, p < 0.01) with the MS180 group displaying a higher number of 5-HT-ir 
neurons in the DRLW compared to the MS0 group (Figure 6). In addition, in the DRV the 
number of 5-HT-ir neurons were found to be significantly affected by 5-HTT genotype 
(F2,35 = 3.52, p < 0.05). Post-hoc analysis indicated that 5-HTT
-/- rats exhibit a significantly 
higher number of 5-HT-ir neurons in the DRV compared to 5-HTT+/- and 5-HTT+/+ rats (both 
p < 0.05) (Figure 6). For the DRD, no effect of ELS, 5-HTT genotype or their interaction was 
found regarding the number of 5-HT-ir neurons (Figure 6). The SSD of 5-HT-ir neurons in 
all three subdivisions was not found to be significantly affected by ELS, 5-HTT genotype 
or their interaction (Figure 6).
 Furthermore, the number of juxtaposed Ucn1-ir fibers and 5-HT-ir neurons in the 
studied subregions of the DR was also not found to be affected by ELS, 5-HTT genotype 
or their interaction (Figure 6). 
    
Gene expression in the DR
As for the EWcp, the mRNA levels of Ucn1, 5-HT1A, CRF1R, CRF2R and GR were assessed in 
punches of the DR (Figure 7). Furthermore, we took the opportunity to include an analysis 
of Slc6a4 expression to validate the impact of heterozygous and homozygous 5-HTT 
knockout on 5-HTT mRNA levels. Indeed, we found that 5-HTT mRNA levels in the DR 
were affected by 5-HTT genotype (F2,34 = 23.43, p = 0.000), with highly significant 
differences between 5-HTT-/- rats and the other genotypes; 5-HTT+/- and 5-HTT+/+ rats (p = 
0.000). Furthermore, as expected, 5-HTT+/- rats showed a significant, approximate 50% 
reduction in DR 5-HTT mRNA levels compared to 5-HTT+/+ rats (p < 0.01) (Figure 7).
Figure 4  DNA methylation of the promoter region of the Ucn gene in the Edinger-Westphal 
nucleus of serotonin transporter (5-HTT) homozygous knockout (5-HTT-/-), heterozygous knockout 
(5-HTT+/-) and wild-type (5-HTT+/+) rats exposed to daily 3 h separations (MS180) or a control treatment 
(MS0). Methylation of the cytosine-phosphate-guanine (CpG) sites positioned 171 bp and 24 bp 
upstream of the transcription start site (CpG_-171, CpG_-24) were found to be significantly regulated 
by 5-HTT genotype (G: p < 0.05). Furthermore, methylation levels of CpG_-156 and CpG_-49 were 
found to be significantly higher in the MS180 compared to the MS0 group (E: p < 0.05).
Figure 5  Edinger-Westphal nucleus: DNA methylation of the cytosine-phosphate-guanine (CpG) 
sites located 171 and 24 bp (CpG_-171, CpG_-24) upstream of the transcription start site of the Ucn 
gene of serotonin transporter (5-HTT) homozygous knockout (5-HTT-/-), heterozygous knockout 
(5-HTT+/-) and wild-type (5-HTT+/+) rats. *: p < 0.05.
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Figure 6  Dorsal raphe (DR) nucleus: immunohistochemistry of serotonin (5-HT, A) and urocortin 
1 (Ucn1) in the dorsal (DRD) and ventral (DRV) parts, as well as the lateral wings (LW) of the DR. The 
number (#) and specific staining density (SSD) of 5-HT-ir neurons were quantified in the different 
subdivisions of the DR for serotonin transporter (5-HTT) homozygous knockout (5-HTT-/-), 
heterozygous knockout (5-HTT+/-) and wild-type (5-HTT+/+) rats exposed to daily 3 h separations
(MS180) or a control treatment (MS0). In the LW, the number of 5-HT-ir neurons was found to be 
increased in the MS180 compared to the MS0 group (E: p < 0.05). In the DRV, the number of 5-HT-ir 
neurons was found to be significantly higher in 5-HTT-/- rats compared to 5-HTT+/- and 5-HTT+/+ rats 
(G: p < 0.05). In addition, overlay images were created to quantify the number Ucn1-ir fibers that 
were juxtaposed (B) or co-localized (C) with 5-HT-ir neurons, which was not found to be significantly 
affected. Scale bar = 150 µm.
Figure 7  Dorsal raphe nucleus: mRNA levels of serotonin transporter (5-HTT), urocortin 1 (Ucn1), 
corticotropin-releasing factor receptor 1 (CRF1R) and 2 (CRF2R), serotonin receptor 1A (5-HT1A) and 
the glucocorticoid receptor (GR). Quantitative real-time PCR was used to analyze these mRNA levels 
in serotonin transporter homozygous knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and 
wild-type (5-HTT+/+) rats exposed to daily 3 h separations (MS180) or a control treatment (MS0). 5-HTT 
mRNA levels were found to be significantly different between 5-HTT-/-,5-HTT+/- and 5-HTT+/+ rats (G: 
p < 0.01). Data were normalized to the average of the MS0-5-HTT+/+ group.
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 Although no other significant effects were found of ELS, 5-HTT genotype or their 
interaction on gene expression in the DR, there were a number of correlations that 
remained significant after Bonferroni correction for multiple comparisons. Interestingly, 
DR Ucn1 mRNA levels showed highly significant negative correlations with the mRNA 
levels of both 5-HT1A (rs = -.60, p = 0.000) and CRF2R (rs = -.78, p = 0.000). As would 
consequently be expected, the mRNA levels of 5-HT1A and CRF2R showed a highly 
significant positive correlation (rs = .72, p = 0.000) (Figure 8).
Discussion
In this study, ELS x 5-HTT genotype interaction was not found to significantly affect the 
EWcp-Ucn1 and DR-5-HT populations in terms of neuronal expression or reciprocal 
innervation. Yet, DNA methylation of the Ucn promoter region in the EWcp was found to 
be altered at specific CpG sites by main effects of ELS and 5-HTT genotype. Furthermore, 
exposure to ELS was associated with increased EWcp 5-HT1A mRNA levels and an increased 
number of 5-HT neurons in the DRLW. In addition, 5-HTT+/- rats showed significantly 
decreased CRF1R mRNA levels in the EWcp, while 5-HTT
-/- rats displayed a significant 
reduction of 5-HT innervation of EWcp-Ucn1 neurons, as well as an increased number of 
5-HT neurons in the DRV. Altogether, we identified a number of potentially interesting 
effects of ELS exposure and 5-HTT genotype at the molecular level, which are hypothesized 
to contribute to ELS x 5-HTTLPR behavioural findings, as discussed below. In addition, we 
obtained correlational evidence suggesting the importance of 1) balanced CRF1R/GR 
signaling in the EWcp and 2) Ucn1 in the modulation of 5-HT neuron activity, via the 
balanced expression of 5-HT1A and CRF2R in the DR.
 
EWcp-Ucn1 neurons
In the EWcp, DNA methylation of the Ucn promoter region was found to be increased by 
ELS exposure at CpG_-156 and CpG_-49 and by 5-HTT deficiency at CpG_-171, while 
5-HTT-/- rats exclusively showed an absence of CpG_-24 methylation. Remarkably, DNA 
methylation of the Ucn promoter region overall was very low, in stark contrast with the 
high methylation that is observed in the Crf promoter region in the PVN and the extended 
amygdala (Elliot et al., 2010; Sterrenburg et al., 2011, Van der Doelen et al., 2014b). It is 
tempting to speculate that these strikingly different promoter methylation patterns, 
together with the complementary dynamics of PVN-CRF and EWcp-Ucn1 neurons, could 
be related to their proposed roles in controlling the stress response (Kozicz et al., 2011a; 
Janssen and Kozicz, 2013). It should be noted that the Ucn promoter methylation 
differences did not translate into altered expression levels of Ucn1 (mRNA, protein) in the 
EWcp. Further (in vitro) studies are therefore needed to directly assess the functionality of 
DNA methylation of the Ucn promoter region. Previously, in line with the current study, 
Figure 7  Continued.
Figure 8  Dorsal raphe nucleus: correlations of mRNA levels of urocortin 1 (Ucn1), serotonin 
receptor 1A (5-HT1A) and corticotropin-releasing factor receptor 2 (CRF2R). Ucn1 mRNA showed a 
significant negative correlation with both 5-HT1A and CRF2R (p < 0.001), while the latter two showed 
a significant positive correlation (p < 0.001). For Ucn1 mRNA, a logarithmic scale was applied for 
visualization purposes.
136 137
CHAPTER 6 THE EWCP AND THE DR
6
maternal separation (MS) of Wistar 5-HTT+/+ rats was shown not to lead to alterations in 
Ucn1 expression in the EWcp (Gaszner et al., 2009). In contrast to our study, 5-HTT-/- mice 
have been shown to display decreased Ucn1 expression in the EWcp (Fabre et al., 2011). 
Possibly, this discrepancy could indicate a species difference for the consequences of 
5-HTT knockout, which is for instance also known for the sensitivity for MDMA (3,4-meth-
ylenedioxymethamphetamine or ‘ecstasy’) (Trigo et al., 2007; Oakly et al., 2014).
 Furthermore, we observed that 5-HTT-/- rats displayed significantly reduced co-local-
ization (juxtaposition) of 5-HT fibers and Ucn1 neurons and decreased overall 5-HT 
innervation of the EWcp, consistent with the reduced 5-HT tissue levels across the brain of 
5-HTT-/- mice and rats (Bengel et al., 1998; Kim et al., 2005; Homberg et al., 2007). At this 
point, it is not yet known how 5-HT contributes to the regulation of EWcp-Ucn1 neurons. 
The actions of 5-HT in the EWcp could be mediated by one of the many 5-HT receptors 
(Hoyer et al., 2002). One of them is likely the 5-HT1A receptor, which we could reliably 
detect with real-time PCR in the EWcp. As 5-HT1A couples to inhibitory Gi/Go proteins 
(Barnes and Sharp, 1999; Albert et al., 2014), stimulation of 5-HT1A would be expected to 
inhibit the activity of EWcp-Ucn1 neurons. Previously, we found that ELS exposure was 
associated with reduced stress-induced activation (cFos expression) of Ucn1 neurons in 
the EWcp (Gaszner et al., 2009). Interestingly, the present study shows that ELS exposure 
was associated with increased 5-HT1A mRNA levels in the EWcp. Therefore, increased 
5-HT1A expression could be involved in the ELS-induced decreased recruitment of 
EWcp-Ucn1 neurons by acute stress (Gaszner et al., 2009). Together, the decreased 5-HT 
innervation of EWcp-Ucn1 neurons displayed by 5-HTT-/- rats and the increased 5-HT1A 
expression in the EWcp of ELS-exposed rats, could constitute an ELS x 5-HTT genotype 
interaction at the level of stress-induced activity of EWcp-Ucn1 neurons. We hypothesize 
that 5-HTT+/+ rats and 5-HTT+/- rats display decreased activity of EWcp-Ucn1 neurons 
(increased 5-HT1A expression) upon adult stress exposure, while this effect of ELS exposure 
is diminished or absent in 5-HTT-/- rats (increased 5-HT1A expression, but decreased 5-HT 
innervation).
 Next to Ucn1 and 5-HT1A, the expression of CRF1R, CRF2R, and GR was examined at the 
mRNA level in the EWcp. We found a highly significant correlation between CRF1R mRNA 
and GR mRNA levels, indicative for the importance of balanced CRF1R/GR signal 
transduction in EWcp-Ucn1 neurons. This is not surprising given the complementary 
homeostatic functions in which these receptors are involved. While CRF1R activation is 
central to the initiation of HPA activity and the behavioural fight-flight response, GR 
activation is crucial for the termination of HPA responses and the facilitation of recovery 
from the stress response (De Kloet et al., 2005; Joëls and Baram, 2009). In 5-HTT+/- rats, we 
found that EWcp CRF1R mRNA levels were significantly decreased. Stimulation of CRF1R 
leads to the activation of cAMP response element binding protein (Arzt and Holsboer, 
2006), which has the capacity to stimulate Ucn1 expression via its binding (CRE) site in the 
Ucn gene. Therefore, the decreased expression of CRF1R in 5-HTT
+/- rats might compromise 
CRF-induced Ucn1 expression in the EWcp, which could lead to an imbalance in the 
actions of CRF and Ucn1 during responses to stress (Kozicz et al., 2011a). As we did not find 
a significant correlation of CRF1R and Ucn1 mRNA levels in the EWcp, the decreased CRF1R 
mRNA levels in 5-HTT+/- rats might only have functional consequences when the animals 
would be exposed to additional stress later in life (De Kloet, 2008; Gaszner et al., 2009). In 
this regard, the altered DNA methylation of the Ucn promoter could modulate 
stress-induced Ucn1 expression. 
DR-5-HT neurons
In the DR, we found that ELS exposure was associated with an increased number of 5-HT 
neurons in the DRLW, while 5-HTT-/- rats displayed an increased number of 5-HT neurons 
specifically in the DRV. Interestingly, based on a collection of evidence, it has recently been 
proposed that DRLW-5-HT neurons have an inhibitory influence on the 5-HT projection 
neurons in the DRD and DRV (Jasinska et al., 2012). Therefore, the ELS-induced increase in 
DRLW-5-HT neurons is expected to increase inhibitory influence on 5-HT projection 
neurons. The inhibition of 5-HT release in DR projection areas has been linked with active 
coping behaviour and resilience to learned helplessness (LH) (Valentino et al., 2010; 
Hammack et al., 2012; Warden et al., 2012). We have previously applied a LH paradigm to 
our ELS x 5-HTT genotype model. The LH paradigm induces an escape deficit (passive 
coping) in vulnerable rats by pre-exposure to inescapable shock stress. We found that 
exposure to ELS was associated with increased expression of active coping behaviour and 
thus resilience to inescapable stress (Van der Doelen et al., 2013). These behavioural 
findings support the recently postulated match/mismatch hypothesis, which states that 
exposure to ELS is not necessarily pathological, but can be used to adaptively respond to 
future stress exposure (Gluckman et al., 2007; Champagne et al., 2009; Nederhof and 
Schmidt, 2012). Importantly, it remains to be elucidated which specific combinations of 
early and later life stressful events have adaptive and maladaptive consequences. Here, we 
suggest that the ELS-induced increase in DRLW-5-HT neurons may contribute to the 
ELS-induced increase in active coping behaviour in the LH paradigm (Van der Doelen et 
al., 2013).
 In 5-HTT-/- rats, we found an increased number of 5-HT neurons in the DRV compared 
to both 5-HTT+/- and 5-HTT+/+ rats. This molecular phenotype would be consistent with a 
behavioural phenotype of increased passive coping behaviour (Jasinska et al., 2012). 
Indeed, 5-HTT-/- mice and rats have been shown to express higher levels of passive coping 
behaviour in inescapable contexts, by displaying increased immobility in the forced swim 
test, as well as decreased exploration in tests for anxiety-like behaviour as the elevated 
plus maze and the open field (Holmes et al., 2002, 2003a; Lira et al., 2003; Olivier et al., 
2008a). Yet, despite previous exposure to inescapable shocks, we have observed that 
5-HTT-/- rats show higher levels of active coping behaviour in a context where stress has 
become escapable (Van der Doelen et al., 2013). Overall, these behavioural findings are 
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consistent with the hypervigilant phenotype of 5-HTT-/- rodents, as they display increased 
sensitivity for environmental factors (Homberg and Van den Hove, 2012). Further studies 
are needed to address how the role of the subdivisions of the DR contribute to stress 
coping behaviour with differential 5-HTT availability. Previously, the number of 5-HT 
neurons was found to be decreased in the DR of 5-HTT-/- mice (Lira et al., 2003) and 
unaltered in 5-HTT-/- rats (Olivier et al., 2008a). These studies did not distinguish the 
different subdivisions of the DR, which may explain the novelty of our present findings.
 In addition, we have examined the mRNA levels of 5-HTT, 5-HT1A, GR, CRF1R and CRF2R 
in micropunches of the DR. We confirmed the approximate 50% reduction of 5-HTT 
expression in 5-HTT+/- rats (Homberg et al., 2007). The mRNA levels of 5-HT1A, GR, CRF1R 
and CRF2R were however not found to be significantly affected by 5-HTT genotype, nor 
by ELS exposure or ELS x 5-HTT genotype interaction. In Sprague-Dawley rats, ELS 
exposure has been found to lead to increased CRF1R and decreased 5-HTT, 5-HT1A and 
CRF2R mRNA levels in the DR (Lee et al., 2007; Bravo et al., 2011, 2014). In Long-Evans and 
Lister-Hooded rats however, 5-HT1A mRNA was not affected by ELS exposure (Neumaier et 
al., 2002; Gartside et al., 2003; Arborelius et al., 2004), while 5-HTT expression was reported 
to be unaltered or increased in the DR of Long-Evans rats (Arborelius et al., 2004; Gardner 
et al., 2009). It would be interesting to elucidate whether genomic differences between 
these rat strains may explain the differential effects of ELS exposure on gene expression in 
the DR.
 In depressed subjects, exposure to childhood abuse has been associated with 
decreased 5-HTT binding in the midbrain (positron emission tomography) (Miller et al., 
2009), and adolescent rhesus monkeys exposed to ELS have been shown to display 
decreased 5-HTT binding across the brain, including the raphe (Ichise et al., 2006). In 
contrast, 5-HT1A binding in the raphe was not found to be affected by ELS exposure in 
juvenile rhesus monkeys (Spinelli et al., 2010). Furthermore, depressed subjects have been 
reported to exhibit both elevated and reduced 5-HT1A in vivo binding in the DR (Drevets 
et al., 1999; Parsey et al., 2006b), while postmortem binding studies suggest that this 
discrepancy might be explained by considering the rostrocaudal extent of the DR (Boldrini 
et al., 2008). A limitation of our current study is therefore that we have only collected 
micropunches of the mid-DR (approximately 7 to 8 mm caudal to Bregma) and could 
therefore not asses gene expression along the rostrocaudal axis of the DR.
 An interesting observation is that both 5-HT1A and CRF2R mRNA levels in the DR were 
found to both show highly significant negative correlations with Ucn1 mRNA levels. These 
correlations suggest that locally translated Ucn1 might contribute to the regulation of 
5-HT1A and CRF2R expression. Both receptors are expressed on 5-HT neurons (Day et al., 
2004; Kiyasova et al., 2013), and the activation of 5-HT1A in the DR is associated with au-
to-inhibition of 5-HT neurons, while stimulation of CRF2R is associated with excitation of 
5-HT neurons in the DR (Valentino et al., 2010; Albert et al., 2014). Furthermore, CRF has 
only low affinity for CRF2R, in contrast to the urocortins, which have therefore been 
proposed to be the endogenous ligands for CRF2R (Vaughan et al., 1995; Hsu and Hsueh, 
2001; Lewis et al., 2001; Reyes et al., 2001; Kozicz, 2010). Interestingly, double knockout of 
Ucn1 and 2 was found to be associated with reduced anxiety-like behaviour and altered 
5-HT activity in DR projection areas (Neufeld-Cohen et al., 2010). The current findings 
suggest that Ucn1 could be involved in the homeostatic regulation of 5-HT neurons by 
balancing the expression of 5-HT1A and CRF2R. Possibly, this effect is mediated directly by 
CRF2R activation, as direct protein-protein interactions have been shown to underlie the 
altered expression of 5-HT2 receptors after CRF1R stimulation in the medial prefrontal 
cortex (Magalhaes et al., 2010). It should be noted that Ucn1 mRNA levels and Ucn1 
innervation (juxtaposition) of DR 5-HT neurons were not found to be affected in our ELS x 
5-HTT genotype model. Possibly, as mentioned above, differential Ucn1 expression might 
only become apparent after exposure to a ‘third hit’; a stressful event in adolescence or 
adulthood (Daskalakis et al., 2013).
Conclusions
In conclusion, we report here that exposure to ELS is associated with increased 5-HT1A 
expression in the EWcp and an increased number of 5-HT neurons in specifically the 
DRLW. Furthermore, 5-HTT deficiency was found to be associated with decreased CRF1R 
expression in the EWcp and an increased number of 5-HT neurons in the DRV. Moreover, 
both ELS exposure and 5-HTT genotype had an impact on DNA methylation of the Ucn 
promoter in the EWcp, which potentially affects stress-induced expression of Ucn1. In 
addition, we found correlative evidence suggestive of the importance of balanced CRF1R/
GR signaling in the EWcp and a role for Ucn1 in the regulation of DR 5-HT neuron activity. 
Together, these effects of ELS and 5-HTT genotype at the molecular level could constitute 
ELS x 5-HTT genotype interaction effects at the level of stress-induced activity of 
EWcp-Ucn1 and DR-5-HT neurons, which are linked to behavioural changes (Van der 
Doelen et al., 2013) that are relevant for human ELS x 5-HTTLPR effects at the epidemiolog-
ical level (Caspi et al., 2003; Karg et al., 2011). Our results however foremost warrant further 
experimentation in order to elucidate the links between DNA methylation, gene 
expression, EWcp-DR functional connectivity and stress coping behaviour.
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Introduction
The response to an adverse event is significantly affected by the genetic background, 
suggesting that gene-environment interaction represents a key feature in psychiatry 
(Caspi et al., 2010). One of the most investigated human polymorphisms in gene-environ-
ment interaction is the serotonin transporter (5-HTT/SERT)-linked polymorphic region 
(5-HTTLPR), which comes in two variants, the long (L) and the short (S) allele (Lesch et al., 
1996; Murphy and Lesch, 2008). Specifically, the S-allelic variant is directly associated with 
neuroticism (Lesch et al., 1996) and may enhance depression susceptibility following 
interaction with stressful events (Caspi et al., 2003; Munafo et al., 2009; Karg et al., 2011). 
Since this polymorphism is not found in rodents, 5-HTT mutant animals have been 
generated in which the function and the expression of the gene has been altered (Caspi 
et al., 2010). We have shown that adult 5-HTT knockout rats, characterized by depression- 
and anxiety-related behaviours (Olivier et al., 2008a), have reduced levels of neuroplastic 
molecules in brain regions involved in depression and anxiety-related disorders (Calabrese 
et al., 2010, 2013; Molteni et al., 2010; Guidotti et al., 2012). In particular, we demonstrated 
that the reduction of the expression of the neurotrophin brain-derived neurotrophic 
factor (BDNF) was specific to the ventral part of the hippocampus, whereas no change 
was observed in the dorsal hippocampus (Calabrese et al., 2013). This distinction is relevant, 
because the ventral hippocampus is involved in emotion regulation, and the dorsal 
hippocampus in spatial memory (Fanselow and Dong, 2010). Moreover, the impairment 
in neuronal plasticity that follows genetic inactivation of 5-HTT originates early in 
development and worsens during the first 2-3 weeks of postnatal life (Calabrese et al., 
2013).
 It has now been well-established that the effect of stress exposure on brain function 
depends on the timing and duration of the adverse experience. In particular, the negative 
influences exerted by early life events on brain development is relevant to later psychopa-
thology since they will affect brain structures that are not yet mature (Fumagalli et al., 
2007). Indeed, humans exposed to maltreatment early in life show an increased risk of 
developing psychiatric diseases (Heim et al., 2004; Fisher et al., 2014).
 Among the animal models developed to study the effects of early perinatal 
adversities, the maternal separation (MS) model is of interest since it triggers anxiety and 
depression-related behaviours as well as deficits in cognitive functions in later life (Ladd et 
al., 2000; Sanchez et al., 2001; Gutman and Nemeroff, 2002; Newport et al., 2002). 
Furthermore, MS has been demonstrated to be associated with alterations in the 
functioning of the hypothalamo-pituitary-adrenal (HPA) axis (Weaver et al., 2004; Van der 
Doelen et al., 2014) and impaired function of neuroplastic mechanisms (Fumagalli et al., 
2007; Lippmann et al., 2007; Calabrese et al., 2011). In this regard, previous studies conducted 
in our lab have demonstrated that single or repeated MS produces a significant reduction 
in the expression of BDNF in adulthood (Roceri et al., 2002, 2004).
Abstract
Although the causes of psychiatric disorders are not fully understood, it is well established 
that mental illness originates from the interaction between genetic and environmental 
factors. In this regard, compelling evidence demonstrates that depression can be the 
consequence of altered, and often maladaptive, response to adversities during pre- and 
early post-natal life. In this study, we investigated the impact of chronic maternal separation 
on the expression of the neurotrophin brain-derived neurotrophic factor (BDNF) in 
serotonin transporter (5-HTT) knockout rats in the ventral and dorsal hippocampus as well 
as the ventral and dorsal medial prefrontal cortex (mPFC). We found that both 5-HTT 
deletion and maternal separation led to an overall reduction of Bdnf expression in the 
ventral hippocampus and the ventral mPFC, whereas in the dorsal hippocampus and the 
dorsal mPFC we observed a significant increase in the neurotrophin gene expression after 
MS exposure, specifically in heterozygous 5-HTT knockout rats. In summary, we show that 
the modulation of Bdnf expression in 5-HTT mutant rats exposed to maternal separation 
reflects the complex functional consequences of this gene-environment interaction with 
a clear distinction between the ventral and the dorsal subfields of the hippocampus and 
the mPFC.
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Brain tissue collection
For the collection of brain tissue, adult (postnatal day (PND85-95) male rats were used. Of 
every litter, where possible, a single rat was selected of all three genotypes. The rats were 
sacrificed between 9.00 a.m. and 2.00 p.m. by acute decapitation. Across this time period, 
the rats were randomized for their genotype and early life treatment. Immediately after 
decapitation, the brains were isolated, frozen in aluminum foil on dry ice and stored at -80 
°C. In a cryostat (-15 °C), the brains were prepared in 420 μm-thick coronal slices in order to 
obtain punches from dorsal and ventral parts (prelimbic, infralimbic respectively) of the 
mPFC (Bregma +3.72 and +3.30 mm) and dorsal (Bregma -2.14 and -2.56 mm) and ventral 
hippocampus (Bregma -4.80 and -5.22 mm). The brain areas were bilaterally punched out 
with a Miltex 1.5 (hippocampal samples) or 1.0 mm (medial prefrontal cortex) biopsy 
puncher (Integra Miltex, York, PA, USA), collected in sterile vials, immediately placed on dry 
ice and stored at -80 °C.
RNA preparation and gene expression analysis by quantitative real 
time RT-PCR
Total RNA was isolated by a single step of guanidinium isothiocyanate/phenol extraction 
using PureZol RNA isolation reagent (Bio-Rad Laboratories s.r.l. Italia) according with the 
manufacturer’s instructions, and quantified by spectrophotometric analysis. Following 
total RNA extraction, the samples were processed for real time retrotranscriptase 
polymerase chain reaction (RT-PCR) to assess: total Bdnf, long 3’-UTR Bdnf and Bdnf exon IV, 
and VI mRNA levels. An aliquot of each sample was treated with DNase to avoid DNA 
contamination. RNA was analyzed by TaqMan qRT-PCR instrument (CFX384 real time 
system, Bio-Rad Laboratories, Italy) using the iScriptTM one-step RT-PCR kit for probes 
(Bio-Rad Laboratories). Samples were run in 384 well formats in triplicate as multiplexed 
reactions with a normalizing internal control (36B4). Probe and primer sequences used 
(Table 1) were purchased from Eurofins MWG-Operon (Germany) and Life Technologies.
 Thermal cycling was initiated with an incubation at 50°C for 10 min (RNA retrotrans-
cription) and then at 95°C for 5 min (TaqMan polymerase activation). After this initial step, 
39 cycles of PCR were performed. Each PCR cycle consisted of heating the samples at 95°C 
for 10 s to enable the melting process and then for 30 s at 60°C for the annealing and 
extension reactions. A comparative cycle threshold (Ct) method was used to calculate the 
relative target gene expression.
Statistical analysis
The effects of 5-HTT genotype and maternal separation were analyzed with a two-way 
analysis of variance (ANOVA) followed by Single Contrast Post Hoc Testing (SCPHT). 
Significance for all tests was assumed at p < 0.05. Data are presented as means ± standard 
error of the mean (SEM). For graphic clarity, results are presented as mean percent of 
5-HTT+/+/No Stress rats.
 On these bases, the purpose of this study was to investigate the impact of chronic 
maternal separation on the expression of Bdnf in the ventral and dorsal parts of the 
hippocampus, as well as the medial prefrontal cortex (mPFC) of animals with partial or 
total deletion of the 5-HTT gene. We aimed to evaluate if the anatomical selectivity 
observed under basal conditions is found also after stress exposure, or whether the 
differential basal deficits in neuroplasticity influence the response to an early life 
manipulation.
Materials and Methods
Animals
Serotonin transporter knockout Wistar rats (Slc6a41Hubr) were generated by ENU-induced 
mutagenesis (N-ethyl-N-nitrosourea) (Smits et al., 2006). Briefly, high-throughput 
resequencing of genomic target sequences in progeny from mutagenized rats revealed 
an ENU-induced premature stop codon in exon 3 of the 5-HTT gene in a female rat (Wistar/
Crl background). The heterozygous mutant animal was outcrossed for at least six 
generations to a Wistar background to eliminate confounding effects from other 
mutations that may have been induced by the ENU mutagenesis. Under the used 
mutagenesis conditions the mean mutation frequency was roughly 1 in 1.2 million base 
pairs (about 1 cM). Although the chance for the occurrence of a strongly linked mutation 
with a phenotypic effect is very small, this possibility should be taken into account in the 
design and interpretation of experiments. To control for this possibility as much as 
possible, experimental animals were always generated by incrosses between outcrossed 
heterozygous 5-HTT knockout (5-HTT+/−) rats (Homberg et al., 2007). All subjects were 
bred and reared in the Central Animal Laboratory of the Radboud University Nijmegen 
Medical Centre in Nijmegen, The Netherlands. At the age of 14 days, ear cuts were taken 
for genotyping. Animals were supplied with food and water ad libitum and were kept on 
a 12 h: 12 h dark–light cycle (lights on at 6:00 a.m.). From postnatal day 2 to postnatal day 
14, 5-HTT+/+, 5-HTT+/-, and homozygous 5-HTT knockout (5-HTT-/-) rats were separated from 
their mothers for 3 hours a day (maternal separation; ‘Stress’). The pups that underwent 
the control treatment received the exact same handling, but were immediately reunited 
with their mother (‘No Stress’). After this manipulation, all the animals underwent normal 
animal care and were sacrificed at adulthood. Although it should be acknowledged that 
Bdnf is differently expressed and regulated in males compared to females (Chourbaji et al., 
2008, 2011, 2012), for the present study, we have only used male rats. All experiments were 
carried out in accordance with the Guidelines laid down by the European Communities 
Council Directive of 24 November 1986 (86/609/EEC).
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 In the ventral mPFC (Figure 1C), a region structurally and functionally linked to the 
ventral hippocampus, we found a significant modulation due to 5-HTT genotype (F1,36 = 
3.29, p < 0.05) as well as exposure to MS (F1,36 = 6.48, p < 0.05). Indeed, total Bdnf expression 
was decreased in 5-HTT+/- (-39%, p < 0.01) and 5-HTT-/- rats (-33%, p < 0.05), compared to 
5-HTT+/+ rats under control conditions. Following exposure to MS, total Bdnf mRNA levels 
were significantly reduced in 5-HTT+/+ animals (-46%, p < 0.001 vs 5-HTT+/+/No Stress), 
whereas the decreased neurotrophin expression in 5-HTT+/- and 5-HTT-/- animals was not 
exacerbated by stress exposure.
Results
Modulation of total Bdnf expression in 5-HTT (/SERT) mutant rats 
after exposure to maternal separation
We initially investigated total Bdnf mRNA levels in the hippocampus and mPFC (Figure 1) 
of 5-HTT+/+, 5-HTT+/- and 5-HTT-/- rats exposed (or not) to MS from PND2 to PND14.
 In the ventral part of the hippocampus, which is involved in anxiety, fear and stress 
responses (Figure 1A), the total Bdnf mRNA levels were modulated by the genotype (F1,33 
= 4.91, p < 0.05) as well as by the stress exposure (F1,33 = 11.22, p < 0.01). Indeed, the single 
contrast post hoc test revealed a statistically significant reduction of total Bdnf levels in 
5-HTT-/- (-43%, p < 0.05 vs 5-HTT+/+/No Stress). Similarly, exposure to MS significantly 
decreased Bdnf expression in 5-HTT+/+ (-43%, p < 0.05 vs 5-HTT+/+/No Stress) as well as in 
5-HTT+/- (-44%, p < 0.05 vs 5-HTT+/-/No Stress) animals. However, this did not occur in 
5-HTT-/- rats since the reduction due to the genetic background was not exacerbated by 
the manipulation early in life.
 Conversely, in the dorsal part of the hippocampus, which is mainly involved in spatial 
learning and memory (Figure 1B), we observed a significant effect of exposure to MS (F1,37 
= 8.96, p < 0.01), whereas 5-HTT genotype did not affect the expression of the neurotrophin 
(F1,37 = 2.19, p > 0.05). Indeed, the exposure to MS led to an increase in total Bdnf gene 
expression in 5-HTT+/- animals (+64%, p < 0.05 vs 5-HTT+/-/No Stress), without affecting its 
mRNA levels in 5-HTT+/+ rats, nor significantly in 5-HTT-/- rats.
Figure 1  Modulation of total Bdnf expression by maternal separation in serotonin transporter 
(5-HTT/SERT) wild-type (SERT+/+), heterozygous (SERT+/-) and homozygous (SERT-/-) knockout rats. 
Total Bdnf mRNA levels were measured in the ventral hippocampus (A), dorsal hippocampus (B), 
ventromedial prefrontal cortex (C) and dorsomedial prefrontal cortex (D). The data, expressed as a 
percentage of SERT+/+/No Stress (set at 100%), reflect the mean ± SEM from at least 5 independent 
determinations. *p < 0.05, **p < 0.01, ***p < 0.001 vs SERT+/+/No Stress; #p < 0.05 vs SERT+/-/No Stress.
a: forward and reverse primers and probes purchased from Eurofins MWG-Operon
Gene Forward primer Reverse Primer Probe
Total Bdnf 5’-AAGTCTGCATTACAT-
TCCTCGA-3’
5’-GTTTTCTGAAAGAG-
GGACAGTTTAT-3’
5’-TGTGGTTTGTTGC-
CGTTGCCAAG-3’
Bdnf exon VI 5’- CTGGCAGGCTTT-
GATGAGAC -3’
5’- GTCATCACTCTTCT-
CACCTGG -3’
5’- AGCTTTGTGTGGAC-
CCTGAGTTCC -3’
36B4 5’-TTCCCACTGGCT-
GAAAAGGT-3’
5’-CGCAGCCGCAAAT-
GC-3’
5’-AAGGCCTTCCTGGC-
CGATCCATC-3’
b: forward and reverse primers and probes purchased from Life Technologies
Gene Accession number Assay ID
Long 3’UTR Bdnf EF125675 Rn02531967_s1
Bdnf exon IV EF125678 Rn01484927_m1
Table 1  Sequences of forward and reverse primers used in Real-Time PCR analysis and 
purchased from Eurofins MWG-Operon (Germany).
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p > 0.05). It was found that MS only significantly decreased long 3’-UTR Bdnf mRNA levels 
in 5-HTT+/- animals (-36%, p < 0.01 vs 5-HTT+/-/No Stress). In contrasty, in the dorsal 
hippocampus (Figure 2B), the expression of long 3’-UTR Bdnf was specifically increased by 
MS (F1,31 = 7.22, p < 0.05) in both 5-HTT
+/- (+30%, p < 0.05 vs 5-HTT+/-/No Stress) and in 
5-HTT-/- animals (+44%, p < 0.05 vs 5-HTT-/-/No Stress).
 In the ventral mPFC (Figure 2C), long 3’-UTR Bdnf mRNA levels were significantly 
reduced in 5-HTT-/- animals under control conditions (-40%, p < 0.05 vs 5-HTT+/+/No Stress), 
whereas MS decreased long 3’-UTR Bdnf mRNA levels only in 5-HTT+/+ rats (-29%, p < 0.05 
vs 5-HTT+/+/No Stress). Differently, in the dorsal mPFC (Figure 2D) the expression of the 
 Similarly to what was observed in the dorsal part of the hippocampus, in the dorsal 
mPFC (Figure 1D) we found a significant effect only of MS exposure (F1,39 = 3.15, p < 0.05). 
In this brain region, total Bdnf mRNA levels were up-regulated by the early life stress 
procedure specifically in 5-HTT+/- animals (+33%, p < 0.05 vs 5-HTT+/-/No Stress).
Modulation of long 3’-UTR Bdnf expression in 5-HTT(/SERT) mutant 
rats after exposure to maternal separation
In the ventral hippocampus (Figure 2A), the levels of long 3’-UTR Bdnf mRNAs were 
significantly affected by MS (F1,37 = 11.46, p < 0.01) but not by 5-HTT genotype (F1,37 = 0.28, 
Figure 3  Modulation of Bdnf exon IV expression by maternal separation in serotonin transporter 
(5-HTT/SERT) wild-type (SERT+/+), heterozygous (SERT+/-) and homozygous (SERT-/-) knockout rats. 
Bdnf exon IV mRNA levels were measured in the ventral hippocampus (A), dorsal hippocampus (B), 
ventromedial prefrontal cortex (C) and dorsomedial prefrontal cortex (D). The data, expressed as a 
percentage of SERT+/+/No Stress (set at 100%), reflect the mean ± SEM from at least 5 independent 
determinations. *p < 0.05, **p < 0.01, ***p < 0.001 vs SERT+/+/No Stress; #p < 0.05, ###p < 0.001 vs 
SERT+/-/No Stress.
Figure 2 Modulation of long 3’-UTR Bdnf expression by maternal separation in serotonin 
transporter (5-HTT/SERT) wild-type (SERT+/+), heterozygous (SERT+/-) and homozygous (SERT-/-) 
knockout rats. Long 3’-UTR Bdnf mRNA levels were measured in the ventral hippocampus (A), dorsal 
hippocampus (B), ventromedial prefrontal cortex (C) and dorsomedial prefrontal cortex (D). The 
data, expressed as a percentage of SERT+/+/No Stress (set at 100%), reflect the mean ± SEM from at 
least 5 independent determinations. *p < 0.05, vs SERT+/+/No Stress; #p < 0.05, ##p < 0.01 vs SERT+/-/
No Stress; $ p < 0.05 vs SERT-/-/No Stress.
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reduced its expression only significantly in 5-HTT+/- rats (-31%, p < 0.05 vs 5-HTT+/-/No Stress).
 Differently, in the dorsal part of the hippocampus (Figure 3B) we observed only an 
effect of 5-HTT genotype (F1,34 = 5.02, p < 0.05) with an up-regulation of exon IV gene 
expression in 5-HTT+/-/No Stress rats (+38%, p = 0.05 vs 5-HTT+/+/No Stress).
 In the ventral mPFC (Figure 3C), we found a significant effect of 5-HTT genotype (F1,38 
= 13.60, p < 0.001). Indeed, exon IV mRNA levels were significantly reduced in 5-HTT+/- and 
5-HTT-/- rats compared to 5-HTT+/+ rats under control conditions (-47%, p < 0.001; -30%, p 
< 0.01, respectively). Moreover, MS influenced the expression of this transcript in 5-HTT+/+ 
rats (-25%, p < 0.05 vs 5-HTT+/+/No Stress), without increasing the reduction already present 
in mutant animals.
 Exposure to MS significantly influenced the expression of exon IV also in the dorsal 
mPFC (Figure 3D) (F1,37 = 7.57, p < 0.01). Here, the levels of exon IV were significantly reduced 
in 5-HTT+/+ rats (-30%, p < 0.05 vs 5-HTT+/+/No Stress) while an increase was detected in 
5-HTT+/- rats (+43%, p < 0.001 vs 5-HTT+/-/No Stress).
 For exon VI, we found that MS exposure (F1,36 = 5.79, p < 0.05) only significantly 
decreased its expression in the ventral hippocampus (Figure 4A) of 5-HTT+/- rats (-32%, p < 
0.01 vs 5-HTT+/-/No Stress). In the dorsal part of the hippocampus (Figure 4B), both 5-HTT 
genotype (F1,36 = 3.41, p < 0.05) and exposure to MS significantly influenced exon VI mRNA 
levels (F1,36 = 3.97, p < 0.05). Indeed, the levels of exon VI were significantly reduced in the 
5-HTT+/- rats (-40%, p < 0.01 vs 5-HTT+/+/No Stress) under control conditions, whereas MS was 
associated with increased expression in these rats only (+90%, p < 0.01 vs 5-HTT+/-/No Stress).
 In the ventral mPFC (Figure 4C) we found a significant effect of 5-HTT genotype (F1,37 
= 8.03, p < 0.01). Indeed, both 5-HTT+/- and 5-HTT-/- animals showed reduced exon VI mRNA 
levels compared to 5-HTT+/+ rats under control conditions (-45%, p < 0.01; -38%, p < 0.05, 
respectively). In the dorsal mPFC, no effects of 5-HTT genotype or exposure to MS were 
observed (Figure 4D).
Discussion
Our results demonstrate that early life stress affects the expression of Bdnf in an anatomically 
distinct manner as a function of 5-HTT genotype. Indeed, we found brain region specificity 
with marked differences between the ventral and the dorsal parts of the brain regions 
considered. Specifically, we found that both 5-HTT deletion and exposure to MS led to an 
overall reduction of Bdnf expression in the ventral hippocampus and in the ventral mPFC, 
whereas in the dorsal hippocampus and in the dorsal mPFC we observed a significant 
increase in the neurotrophin gene expression after MS exposure specifically in 5-HTT+/- rats.
 We confirm previous results showing that the total form of Bdnf was reduced in the 
ventral hippocampus (Calabrese et al., 2013), as well as the ventral mPFC of 5-HTT-/- and 
5-HTT+/- rats, compared to 5-HTT+/+ rats under control conditions, with the latter in line 
with previous observations with the whole prefrontal cortex (Molteni et al., 2010).
long 3’-UTR Bdnf transcript was up-regulated significantly only in 5-HTT+/- rats (+33%, p < 0.05 
vs 5-HTT+/+/No Stress) under control conditions, while exposure to MD was without effect.
Modulation of Bdnf exon IV and VI expression in 5-HTT(/SERT) mutant 
rats after exposure to maternal separation
Next we investigated the expression levels of the main neurotrophin transcripts, namely 
exon IV (Figure 3) and VI (Figure 4). In the ventral hippocampus (Figure 3A) the expression 
levels of exon IV were influenced by 5-HTT genotype (F1,35 = 6.18, p < 0.01) as well as by MS 
(F1,35 = 11.00, p < 0.01). Indeed, we observed a significant reduction of exon IV mRNA levels 
in 5-HTT-/- animals under control conditions (-35%, p < 0.01 vs 5-HTT+/+/No Stress), while MS 
Figure 4  Modulation of Bdnf exon VI expression by maternal separation in serotonin transporter 
(5-HTT/SERT) wild-type (SERT+/+), heterozygous (SERT+/-) and homozygous (SERT-/-) knockout rats. 
Bdnf exon VI mRNA levels were measured in the ventral hippocampus (A), dorsal hippocampus (B), 
ventromedial prefrontal cortex (C) and dorsomedial prefrontal cortex (D). The data, expressed as a 
percentage of SERT+/+/No Stress (set at 100%), reflect the mean ± SEM from at least 5 independent 
determinations. *p < 0.05, **p < 0.01 vs SERT+/+/No Stress; #p < 0.05, ###p < 0.001 vs SERT+/-/No Stress.
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due to the putative ‘vulnerable’ 5-HTT genotype in the ventral and dorsal hippocampus 
and mPFC. This may be due to the fact that the MS paradigm used in our study is already 
sufficient to produce behavioural (Meaney, 2001; Fumagalli et al., 2007) as well as molecular 
alterations (reduction of Bdnf in wild-type animals) (Roceri et al., 2004), putatively leading 
to a floor effect in 5-HTT mutant rats, which could hinder the identification of a gene x 
environment (GxE) interaction.
 Moreover, the reduction of neurotrophin levels in 5-HTT mutant rats occurs already 
between the first and second weeks of life (Calabrese et al., 2013), suggesting that this 
period may be critical for the correct development of neuroplastic mechanisms. If 
unaltered, changes in neurodevelopment may in turn underlie the “for better and for 
worse” phenotypes in adult 5-HTT mutant rats. Since MS was carried out exactly during 
this vulnerable developmental time window, it may be inferred that the alteration due to 
the manipulated genotype was maximal. Hence, any further effect of MS would be 
overshadowed by the developmental changes in 5-HTT mutant rats.
 In an attempt to assess whether the mechanism underlying the modification of Bdnf 
expression induced by 5-HTT genotype and early life stress are comparable or distinctive, 
we measured the mRNA levels of the long 3’-UTR pool of transcripts, and of the type IV 
and VI 5’-exons. The Bdnf gene is characterized by the presence of two different polyade-
nylation sites at the 3’-UTR (Pruunsild et al., 2011) giving rise to a short and a long transcript 
form. While the short 3’-UTR mRNAs are restricted to the somata, the long 3’-UTR mRNAs 
are also localized in dendrites (An et al., 2008), suggesting that they may subserve different 
physiological roles within the cell (Lau et al., 2010; Waterhouse et al., 2012; Orefice et al., 
2013). The effect observed in the dorsal hippocampus on total Bdnf gene expression was 
paralleled by a similar modulation of the long 3’-UTR Bdnf and exon VI, two subpopulations 
of Bdnf mRNA that can be targeted to dendrites (An et al., 2008; Baj et al., 2013). Interestingly, 
in the ventral part of the hippocampus, a more comparable pattern between total Bdnf 
and the specific expression of exon IV was found. This would suggest that 5-HTT deletion 
and MS exposure not only affect the expression of Bdnf in an anatomy-specific manner, 
but also that the mechanisms through which this modulation is achieved are possibly 
specific for the considered brain region. Moreover, alterations in different pools of the 
neurotrophin may be translated in different modulation of downstream pathways.  
In summary, we show that the modulation of Bdnf expression in 5-HTT mutant rats 
exposed to MS reflects the complex functional consequences of this GxE interaction with 
a clear distinction between the ventral and the dorsal subfields of the hippocampus and 
mPFC. The further characterization of these mechanisms may provide novel cues for 
modulating neurotrophin function, which is dysregulated in several psychiatric conditions.
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 In addition to 5-HTT genotype, MS differentially affected Bdnf transcript levels in the 
ventral vs the dorsal parts of the hippocampus and mPFC. Indeed, in the ventral 
hippocampus as well as in the ventral mPFC, exposure to MS substantially reduced total 
Bdnf expression in a manner that corresponds to that exerted by 5-HTT deletion, without 
any MS x 5-HTT genotype interaction. Conversely, within the dorsal hippocampus as well 
as in the dorsal mPFC, we found a MS x 5-HTT genotype interaction; Bdnf gene expression 
was up-regulated selectively in 5-HTT+/- rats after exposure to MS.
 Behavioural characterization of the 5-HTT-/- rat model has shown these animals to 
display anxiety- and depression-like behaviour in the elevated plus maze, open field, 
forced swim test and sucrose consumption tests (Olivier et al., 2008a). Yet, we have also 
demonstrated that 5-HTT+/- rats show an improved stress coping response in the learned 
helplessness (LH) test after exposure to MS (Van der Doelen et al., 2013). These “for better 
and for worse” phenotypes are in line with the concept of the predictive adaptive response 
(PAR) (Gluckman et al., 2007). PAR entails that stressful experiences in the past can be 
useful for responding to a subsequent challenging situation (the performance is optimal 
when early and later life environment match). Moreover, recent findings have demonstrated 
that humans and nonhuman primates carrying the S variant of the 5-HTTLPR outperform 
subjects carrying the L-allele in a wide array of cognitive tasks (Homberg and Lesch, 2011). 
It is tempting to speculate that the differential modulation of Bdnf in the dorsal and ventral 
hippocampus and mPFC underlies the “for better and for worse” phenotypes in 5-HTT 
mutant rats. Reduced Bdnf levels in the ventral regions due to MS or 5-HTT deficiency 
could contribute to the anxiety- and depression-related phenotypes (“for worse”). 
Conversely, increased Bdnf levels in dorsal regions after exposure of 5-HTT+/- rats could 
exert beneficial effects on cognition and may explain the “for better” phenotype shown 
by these rats at the behavioural level (Van der Doelen et al., 2013). Indeed, by applying the 
LH paradigm to MS x 5-HTT genotype experiments, we have previously reported increased 
expression of adaptive, active coping behaviour. When stratifying for 5-HTT genotype, we 
found that the adaptive effect of MS exposure was only significant for 5-HTT+/- rats (Van 
der Doelen et al., 2013). These behavioural findings support the postulated match/
mismatch hypothesis, which states that exposure to ELS is not necessarily pathological, but can 
be used to adaptively respond to future stress exposure (Schmidt, 2011; Homberg, 2012).
 The effects observed in 5-HTT mutant rats under control conditions, as well as in 
5-HTT+/+ rats exposed to MS, confirm our previous results that juvenile and adult 5-HTT 
mutants rats exhibit a decrease in Bdnf levels in the hippocampus and prefrontal cortex 
(Molteni et al., 2010; Calabrese et al., 2013), and match the finding that early life stress 
exposure leads to a reduction in BDNF levels in adult animals (Roceri et al., 2004). Dissecting 
the brain regions more precisely, we could reveal that early life stress has a specific impact 
on neuroplasticity in the ventral hippocampus and the ventral mPFC.
 Conversely, considering the fact that gene-environment interactions increase the risk 
for psychiatric disorders, we found that MS did not worsen the neuroplastic alterations 
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1. ELS, 5-HTT genotype and stress coping behaviour
In the literature, a dominant view has been that the exposure to (early life) stress 
predisposes individuals to increased vulnerability to subsequent periods of stress 
(cumulative stress hypothesis; CSH), and with that the adaptive value of coping with life’s 
challenges has been underrecognized (Bonanno and Mancini, 2008; Heim and Binder, 
2012). Yet, many individuals show resilience in the face of chronic stress or traumatic events 
(Feder et al., 2009; Schmidt et al., 2010; Russo et al., 2012) and exposure to moderate, 
predictable stressors could even be beneficial (Parihar et al., 2011; Suo et al., 2013). Recently, 
the match/mismatch hypothesis has been advocated, which states that exposure to ELS 
(and stressors in other phases of life) may not necessarily have negative consequences for 
the individual. Moreover, this model postulates that the individual may use the experience 
of past stressors in order to improve his/her adaptive fitness and successfully cope with 
later life challenges (Champagne et al., 2009; Oitzl et al., 2010; Schmidt, 2011; Homberg, 
2012; Nederhof and Schmidt, 2012; Daskalakis et al., 2013). In line with this hypothesis, in 
chapter 2 we found that ELS-exposed rats showed improved stress coping behaviour, as 
expressed by decreased escape latencies in a shuttle-box test, despite of exposure to 
inescapable foot shocks the days before. We do emphasize that replication of our findings 
(including those presented in the other chapters) is warranted, preferably by other 
laboratories.
1.1 The match/mismatch hypothesis (MMH) 
In addition to our study, an increasing body of experimental data from animal models is 
present in the literature that is supportive of the MMH (e.g. Abraham and Gruss, 2010; 
Daskalakis et al., 2012; Ricon et al., 2012; Santarelli et al., 2014; Zalosnik et al., 2014). 
Experiments by Danielle Champagne, Harm Krugers and colleagues have been an 
important starting point for the experimental support for the MMH. In these studies, rats 
that were exposed to ELS were found to show decreased cognitive performance under 
basal conditions, but superior cognitive performance under stressful conditions, 
compared to control rats (Champagne et al., 2008; Oomen et al., 2010). This was paralleled 
with the finding that exposure of hippocampal slices to glucocorticoid (CORT) levels 
reminiscent of stress impaired long-term potentiation (LTP; synaptic correlate of learning) 
in control rats, but enhanced LTP in ELS rats (Champagne et al., 2008; Bagot et al., 2009), 
involving alterations in glutamate neurotransmission in the hippocampus (Bagot et al., 
2012a, 2012b). The improved learning performance of ELS-exposed rats in the fear 
conditioning paradigm (stressful condition) was furthermore found to be associated with 
increased spontaneous recovery of the memory (Xiong et al., 2014). 
 Despite the evidence from animal studies, two recent studies with depressive 
subjects, which directly addressed the match/mismatch as well as the classical cumulative 
stress hypothesis (CSH), concluded that the observed interaction between stressors across 
The risk to develop depression after exposure to early life stress (ELS) is significantly 
increased in individuals with the 5-hydroxytryptamine (5-HT) transporter (5-HTT)-linked 
polymorphic region (5-HTTLPR) S-allele (Caspi et al., 2003; Karg et al., 2011, Sharpley et al., 
2014, but also see Risch et al., 2009). In this thesis, we have aimed to come to a further 
understanding of how this gene x environment (GxE) interaction affects stress coping 
behaviour (chapter 2), hypothalamo-pituitary-adrenal (HPA)-axis activity (chapter 3) and 
gene expression of related factors in the brain (chapters 4-7) in adulthood. In chapter 2, 
we found that rats that experienced repeated maternal separation (MS) during the early 
postnatal period (rodent model of ELS) do not necessarily develop a phenotype that is 
reminiscent of maladaptation or disease vulnerability. Rather, we found that ELS increased 
the degree of active coping behaviour as expressed by decreased escape latencies in the 
learned helplessness (LH) paradigm. As increased escape performance directly decreases 
the exposure to foot shocks in the third day of this paradigm, active coping can 
unequivocally be interpreted as an adaptive behavioural response in this specific context. 
Moreover, heterozygous 5-HTT knockout (5-HTT+/-) rats seemed to be especially sensitive 
to the effect of ELS, suggesting that 5-HTTLPR S-allele carriers do not necessarily develop 
vulnerability to stress-related psychiatric diseases like depression following ELS exposure, 
but that this is dependent on the congruence between the early and later life environment. 
In chapter 3, we presented another major finding: we confirmed the hypothesis that ELS 
and 5-HTT genotype interact to program the basal activity of the adult HPA-axis. 
Specifically, the data from postmortem gene expression and adrenal in vitro analyses 
suggest that this ELS x 5-HTT genotype effect is largely programmed at the level of 
adrenal gene expression, leading to differential adrenocorticotropic hormone (ACTH) 
sensitivity of the adrenals. In addition, in chapters 4 and 7 we identified a complex 
change in medial prefrontal cortex (mPFC) and hippocampal mRNA levels of the 
glucocorticoid receptor (GR), mineralocorticoid receptor (MR), FK506-binding protein 51 
(FKBP5), and different transcripts of brain-derived neurotrophic factor (BDNF) in response 
to ELS and 5-HTT genotype. Finally, we found altered DNA methylation of the promoter 
regions of the genes encoding corticotropin-releasing factor (CRF) and urocortin 1 (Ucn1) 
as a function of ELS and 5-HTT genotype (chapter 5 and 6).
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behaviour in 5-HTT+/- mice (Spinelli et al., 2013). Therefore, the context was found to 
determine the level of anxiety-like behaviour displayed by 5-HTT+/- mice after exposure to AS.
 With regard to 5-HTTLPR, the results of our study and Spinelli et al. (2013) suggest that 
carrying the S-allele is not invariably related to increased stress vulnerability. Rather, in the 
case of matching early and adult life environmental conditions, S-allele carriers may exhibit 
increased adaptive fitness compared to LL homozygotes. The increased sensitivity of 
5-HTT+/- rodents to benefit from a positive, adaptive match between the early and adult 
life environment is also in support of the differential susceptibility hypothesis (DSH) (Belsky 
et al., 2009; Ellis et al., 2011). The DSH suggests that common ‘vulnerability’ genes do not 
only confer increased sensitivity to adverse, but also positive environmental events. As 
such, the DSH provides a theoretical framework for the evolutional survival for these 
‘plasticity’ genes (Belsky et al., 2007; Ellis et al., 2011; Bakermans-Kranenburg and Van 
IJzendoorn, 2011). 
2.  Learned helplessness; uncontrollable vs  
inescapable stress
The labs of Steven Maier, Martin Seligman and Linda Watkins have shown that the potency 
of electric shock stress to affect subsequent escape behaviour - but also social interaction, 
fear conditioning and anxiety-like behaviour - involves the (lack of) perception of control 
over the situation. In their experiments, rats receive electric shocks to their tails while 
being restrained in boxes which have a wheel that can be turned to terminate the shock 
(controllable shocks). Coupled to these boxes are identical setups in which rats receive an 
identical amount of tail shocks, but cannot control the duration or onset of the shocks by 
wheel turning (yoked, uncontrollable shocks). In the controllable shock situation, the 
number of wheel turns required to terminate each shock is increased as the rats started to 
learn to use the wheel. With this setup, it could be shown that rats that were subjected to 
uncontrollable stress (US) subsequently failed to learn to escape foot shocks in a shuttle 
box, which was therefore termed as LH. In contrast, rats that received an equal amount of 
tail shocks but that learned to control the shocks by turning the wheel show an unaffected 
phenotype in comparison to unstressed controls. Hence, the experience of control seems 
to prevent the induction of LH by US. Furthermore, the effects of US were found to be 
‘trans-situational’, as the tail shocks were administered in a different context than the 
shuttle box, where foot shocks were applied (Maier and Seligman, 1976; Maier and Watkins, 
2005). In our design, we have not looked at controllability and we have therefore chosen 
to use the term inescapable stress (IS). Furthermore, the escape test and IS were both 
administered in the shuttle box, and we therefore, cannot speak of trans-situational effects 
of IS. Nevertheless, we observed in pilot studies that IS-exposed rats show a highly 
significant escape deficit (increased escape latencies and escape failures) in comparison 
to unstressed rats. The failure to escape shocks in two-thirds of the trials is generally 
the life span was more in line with the CSH, instead of the MMH (Power et al., 2013; Vinkers 
et al., 2014). Yet, it has been proposed that the CSH and MMH models may co-apply in 
varying degrees, dependent on the individual programming sensitivity and the severity 
of stressful life events (Nederhof and Schmidt, 2012).
1.2 Context-dependence  
In chapter 1, we already introduced a prominent example of experimental studies that 
support the MMH; the stress inoculation (SI) treatment of squirrel monkeys by David M. 
Lyons and co-workers. In summary, social separations as juveniles were found to be 
associated with resilience to a moderate stressor in adulthood (Parker et al., 2004; Lyons 
and Parker, 2007). The similarity between the juvenile and adult treatment (type and 
severity of stressors) likely underlies the reduced sensitivity to the adult stressor in the 
SI-treated monkeys. In the case of our study, it would be interesting to further examine 
which properties of the MS treatment and the LH paradigm are instrumental for their 
putative match, as these stressors are not very similar at first sight.
 It is increasingly recognized that the outcome of the interaction between the 
environments of different (early postnatal, juvenile, pubertal, adolescent and adult) 
developmental time windows is context-dependent (Santarelli et al., 2014). This makes 
sense, as different types and durations of stressors require different responses of the 
individual (Myers et al., 2014). Therefore, if the early life environment would not lead to 
adequate predictive programming of behavioural and physiological coping mechanisms 
for later life challenges, maladaptation and disease vulnerability could arise if stressors are 
not efficiently dealt with. The context-dependence of phenotypic programming in 
response to certain environments has been illustrated by Igor Branchi and colleagues. In 
their study, mice were reared in a communal nesting (CN) condition, which is regarded as 
an enrichment of the early environment, or in standard animal facility rearing (AFR) 
conditions. It was confirmed that CN was associated with social enrichment, as increased 
interactions with the mother and peers were observed compared to the AFR condition. At 
adulthood, the mice were exposed for 4 weeks to the forced swim test (FST), a physical 
stressor, or a social stressor (social instability), and stress-induced anhedonia was assessed. 
Consistent with the hypothesis of context-dependence, the CN mice showed increased 
resilience to the social, but not the physical stressor, in comparison to the AFR mice 
(Branchi et al., 2013). Furthermore, another recent study showed that readouts of stress 
vulnerability can depend on the behavioural test that is used. In this study, adolescent 
5-HTT+/- mice and wildtype (5-HTT+/+) mice were exposed to nine sessions of exposure to 
electric shocks. Anxiety-like behaviour was assessed by re-exposure to the shock context 
(RESC) or the elevated plus maze (EPM). Significant interactions of adolescent stress (AS) 
and 5-HTT genotype were found for both tests. In the RESC however, AS-5-HTT+/- mice 
showed increased freezing compared to control-5-HTT+/- mice, which was not found for 
5-HTT+/+ mice, while in the EPM, AS was found to selectively decrease anxiety-like 
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of CRF1R and CRF2R has shown that CRF1R activation is associated with inhibition, and 
CRF2R activation with stimulation of DR 5-HT neuron activity (Valentino et al., 2010). As CRF 
has high affinity for CRF1R compared to CRF2R, at first instance CRF would be expected to 
inhibit DR 5-HT neuron activity. However, increasingly higher doses of CRF activate CRF2R 
in the DR (Hammack et al., 2003a, 2003b), and stressors have been found to induce CRF1R 
internalization paralleled with CRF2R plasma membrane recruitment in the DR (Waselus et 
al., 2009). In chapter 5, we found that CRF mRNA levels in the central amygdala (CeA) 
show a significant positive correlation with escape performance in rats that had been 
subjected to the LH paradigm. The DR is densely innervated by CRF-containing fibers, 
which are in part derived from the CeA (Peyron et al., 1998; Lowry et al., 2000; Retson and 
Van Bockstaele, 2013). Therefore, we hypothesize that increased CeA-CRF input to the DR 
is associated with increased CRF1R over CRF2R activation that leads to lower DR 5-HT 
neuron activity and increased active coping responses. Yet, it should be noted that although 
ELS and 5-HTT genotype both affected escape latencies in the LH paradigm, CeA CRF 
mRNA levels were not found to be significantly altered in our ELS x 5-HTTLPR model.
 In addition to the dual CRF-mediated control via CRF1R and CRF2R, the regulation of 
DR 5-HT neurotransmission is further complicated by the topographical organization of 
the DR, which is subdivided in regions encompassing the rostral, dorsal, ventral, lateral, 
interfascicular and caudal portions of the DR (Lowry, 2002; Fox and Lowry, 2013). The 5-HT 
interneurons of the lateral wings of the DR (DRLW) innervate the dorsal and ventral parts 
of the DR (DRD, DRV) and are thought to have a tonic inhibitory control over DRD and DRV 
5-HT projection neurons (Jasinska et al., 2012). In chapter 6, we found that ELS exposure is 
associated with an increased number of 5-HT neurons in the DRLW, while homozygous 
5-HTT (5-HTT-/-) knockout rats displayed an increased number of 5-HT neurons in the DRV. 
Therefore, ELS exposure may be associated with increased DRLW-inhibition of 5-HT 
projection neurons, which may contribute to the ELS-induced increase in active coping 
behaviour in the LH paradigm. The increased number of 5-HT neurons in the DRV of 
5-HTT-/- rats would, according to the same model, be predicted to be associated with 
increased escape latencies. Although 5-HTT-/- mice and rats indeed show higher levels of 
passive coping in inescapable contexts as the EPM and FST, the 5-HTT-/- rats showed a 
better performance in the shuttle box escape test compared to 5-HTT+/+ and 5-HTT+/- rats, 
despite the previous exposure to IS (chapter 2). Overall, the behavioural findings are 
consistent with a hypervigilant phenotype of 5-HTT-/- rodents (Homberg and Van den 
Hove, 2012). On the other hand, the inconsistence of increased active coping behaviour in 
the escape test and an increased DRV 5-HT neuron number as displayed by 5-HTT-/- rats 
questions the validity of the DRLW-DRD/DRV model of 5-HT neurotransmission.
2.1.2. The contribution of contextual fear 
Along this line, it has been observed that raphe 5-HT lesions do not prevent escape 
deficits if IS and escape testing occur in the same context (Soubrie et al., 1986; Siegel and 
accepted as a criterion of what is termed LH, and the percentage (15-20%) of helpless 
5-HTT+/+ rats is consistent with what is typically observed for wild-type rats (Vollmayr and 
Henn, 2001).
2.1 The biology of learned helplessness
In addition to their demonstration of the importance of the lack of controllability for the 
behavioural consequences of IS exposure, the Maier lab and others have also provided 
insights into the underlying neurobiology. Accordingly, the activity of the dorsal raphe 
(DR) 5-HT neurons has been shown to inhibit active coping responses by projections to 
the dorsolateral periaqueductal gray (PAG), while potentiating fear/anxiety via projections 
to the amygdala. The exposure to IS was shown to lead to sensitization of DR 5-HT neurons 
for subsequent stressor exposure and consequently leading to increased passive coping 
responses to a variety of stressors (Maier and Watkins, 2005, 2010). Downstream of the DR 
5-HT neurons, resilience to IS was found to be associated with activation of ΔFosB 
(immediate early gene) in the ventrolateral PAG. In this study, the experimental setup was 
similar to ours with IS exposure and escape testing both occurring in the shuttle box 
(Berton et al., 2007). Interesting in this regard is that dorsolateral PAG activity has been 
linked to unconditioned fear responses, while the ventrolateral PAG seems to be exclusively 
involved in contextual fear conditioning (Vianna et al., 2001).
 Upstream of DR 5-HT neurons, input from the mPFC has been shown to be instrumental 
for the role of controllability. It is thought that control over the stressor is detected by (so 
far unknown) cortical areas which convey this information to the mPFC. Then, glutamatergic 
projections of the mPFC activate y-aminobutyric acid (GABA) interneurons in the DR that 
in turn inhibit the DR 5-HT neurons. Via this mechanism, the mPFC can prevent the 
sensitization of the DR 5-HT neurons to subsequent stress responses (Amat et al., 2005; 
Maier and Watkins, 2010). By probing metabolic activity in the brain in vivo, it was recently 
shown that the IS-induced escape deficit is associated with activity of a neurocircuitry that 
extends beyond the mPFC, DR, PAG and amygdala. Interestingly, it appeared that the 
lateral septum and the habenula were central nodes in this ‘LH-network’ (Mirrione et al., 
2014). Indeed, the habenula has been shown to regulate stress coping behaviour by 
modulation of DR neurons; by use of optogenetics, selective stimulation of habenula 
input to the DR was shown to stimulate passive coping in the FST, while stimulation of 
mPFC input to the DR was shown to increase active coping behaviour (Warden et al., 2012).
2.1.1. CRF and the regulation of DR 5-HT neurons
Next to the above discussed brain areas, the activity of DR 5-HT neurons is known to be 
regulated by CRF and its related neuropeptides urocortin 1, 2 and 3 (Ucn1, Ucn2, Ucn3), via 
the G-protein coupled CRF receptors 1 and 2 (CRF1R, CRF2R). Although it is not yet 
elucidated which of these neuropeptides are endogenously involved in the modulation 
of CRF1R and CRF2R in the DR, the exogenous administration of agonists and antagonists 
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to context alone. Therefore, in subsequent experiments it would be instrumental to assess 
freezing behaviour during the intertrial interval of the escape test, which was unfortunately 
not possible retrospectively because of the technical limitations of the video camera 
setup.
3. ELS, 5-HTT genotype and physiology
Next to the assessment of stress coping behaviour, the main aim of this thesis has been to 
elucidate the physiological changes that are associated with ELS x 5-HTT genotype 
interactions. Specifically, we have studied the adult HPA-axis and central expression of GR, 
MR and FKBP5, the epigenetic (DNA methylation) regulation of the expression of the 
related neuropeptides CRF and Ucn1 as well as the expression of the neurotrophin BDNF 
in the brain. Before discussing these findings in further detail, we would like to point out 
that one could expect that the depressogenic interaction of ELS and 5-HTTLPR first 
described at the epidemiological level (Caspi et al., 2003; Karg et al., 2011; Sharpley et al., 
2014), at the physiological/molecular level would not necessarily only constitute of ELS x 
5-HTT genotype effects, but also various physiological changes that are (statistically) 
independent effects of ELS and 5-HTT genotype. These together, however, could give rise 
to a significant interaction of ELS and 5-HTT genotype at the behavioural (epidemiologi-
cal) level. In all of the chapters of the thesis, we indeed found main effects of ELS and 
5-HTT genotypes on several parameters, next to interaction effects.
3.1 ELS x 5-HTT genotype: the HPA-axis
In the case of the HPA axis (chapter 3), we found that basal plasma levels of CORT were 
affected by a significant interaction of ELS and 5-HTT genotype. This GxE interaction 
comprised an opposite effect of 5-HTT genotype depending on the early life treatment; 
5-HTT-/- rats displayed the highest CORT levels in the control group, but not after exposure 
to ELS. In contrast, 5-HTT+/+ rats showed an up-regulation of plasma CORT levels due to 
ELS, such that the 5-HTT+/+ rats showed the highest plasma CORT levels in the ELS group. 
5-HTT+/- rats, in contrast to their stress coping behaviour (chapter 2), were not affected by 
ELS exposure in their basal HPA activity. Therefore, for the HPA-axis the 5-HTT-/- rats may 
represent a better model of the 5-HTTLPR S-allele than the 5-HTT+/- rats, which is associated 
with increased basal CORT levels in healthy controls (O’Hara et al., 2007; Wüst et al., 2009; 
Wankerl et al., 2010). Furthermore, our results resonate with the finding that 5-HTTLPR S/S 
individuals displayed the highest basal CORT levels with a low-risk for depression group 
(family history and environment), while within a high-risk group S/S subjects showed the 
lowest and L/L individuals the highest CORT levels (Jabbi et al., 2007).
 In addition, the HPA axis has also been studied for the interaction of 5-HTTLPR with 
stressful life events (SLE) across the life span. Firstly, Alexander et al. (2009) reported that 
basal CORT levels were unaffected, while Mueller et al. (2011) unfortunately did not analyze 
Brown, 1988; Maier and Watkins, 2005), which was the case in our experimental setup. 
While this does not rule out a role for DR 5-HT neurons in the modulation of escape 
behaviour in our experiments, it is suggestive of the importance of additional mechanisms, 
which are likely related to contextual fear memory. The conditioning of contextual fear is 
the learning of the association of an adverse stimulus with certain environmental 
(contextual) features; rats that receive foot shocks in a certain environment will later show 
increased levels of freezing in that environment compared to unshocked rats (Maren et al., 
2013). Contextual fear, but also other stress-related memories, are modulated by 
stress-induced release of CORT, and this modulation consists of immediate and delayed 
effects on various aspects of memory. Post-training application of CORT or GR agonists 
promotes the consolidation of information, while retrieval of memory and working 
memory are negatively affected by increased CORT levels. Importantly, the effects of 
CORT on learning and memory are a matter of timing, and furthermore depend on the 
degree of CORT release, and the level of arousal, as activation of the noradrenergic system 
interacts with central CORT effects in the formation of emotional memory (Het et al., 2005; 
De Quervain et al., 2009; Roozendaal et al., 2009; Henckens et al., 2011; Joëls et al., 2011; 
Roozendaal and McGaugh, 2011; Schilling et al., 2013; Van Ast et al., 2013). Administration of 
CORT immediately after fear conditioning increases freezing 24 h later, while the same 
dose administered 1 h before the test decreases freezing 24 h later. The application of GR 
antagonists and blockade of CORT synthesis by pre-administration of metyrapone have 
been associated with the opposite effects (Roozendaal et al., 1996; Cordero and Sandi, 
1998; Cordero et al., 1998; Abrari et al., 2009; Atsak et al., 2012). With regard to the LH 
paradigm (with IS exposure and escape testing in the same context), administration of 
metyrapone before IS exposure has been shown to decrease the IS-induced escape 
deficit. In contrast, adrenalectomy has been reported to have no effect, or to potentiate 
the IS-induced escape deficit. An explanation that has been proposed for this discrepancy 
is that bilateral adrenalectomy induces compensatory changes different from those 
associated with acute blockade of CORT synthesis (Edwards et al., 1990; Báez et al., 1996; 
Kademian et al., 2005). We hypothesize that increased levels of IS-induced CORT release 
partially mediate the IS-induced escape deficit by enhancing contextual fear. Experiments 
targeted at this hypothesis may also reveal the possible contribution of IS-induced CORT 
levels to the differential escape performance displayed by ELS-exposed 5-HTT+/+ and 
5-HTT+/- rats. From our study of the HPA-axis in chapter 3, we would suggest that after ELS 
exposure 5-HTT+/+ rats show greater IS-induced CORT release compared to 5-HTT+/- rats. 
This may explain why 5-HTT+/+ rats seem to display a less pronounced improvement of 
escape performance associated with ELS in comparison to 5-HTT+/- rats. Given the 
association of ELS with improved fear conditioning (Champagne et al., 2008; Oomen et al., 
2010) as well as improved escape performance (chapter 2) however, it remains to be seen 
whether increased contextual fear actually would be associated with increased passive 
coping behaviour during escape testing (electric shock exposure), as well as in response 
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unaffected, suggesting that the identified ELS x 5-HTT genotype interaction selectively 
affects the adrenal cortex. Moreover, in an in vitro study we found that 5-HTT genotype 
was associated with altered adrenal ACTH sensitivity, at least in animals reared in AFR 
conditions. For future experiments, an ELS x 5-HTT genotype experiment with an in vitro 
adrenal assay would be envisaged, which could furthermore address the involvement of 
epigenetic mechanisms in the regulation of gene expression. An advantage here is that 
the adrenal cortex and medulla likely provide higher tissue homogeneity compared to 
the brain. Nonetheless, the adrenal gland comprises many cell types, sympathetic nerve 
endings and many intra-adrenal systems that regulate steroidogenesis (Nussdorfer, 1996; 
Ehrhart-Bornstein et al., 1998). The chromaffin cells of the rat medulla contain for instance 
5-HT, which potently stimulates the release of aldosterone and CORT (Contesse et al., 
1998). We were notified by Dr. Hervé Lefebvre that next to 5-HT receptor 4 (5-HT4) (chapter 3), 
we should also have considered 5-HT receptor 7 (5-HT7) to subserve this function in the 
rat adrenal, based on two studies that we had not yet identified in the literature (Lenglet 
et al., 2002; García-Iglesias et al., 2013). At the mRNA level, both receptors were however 
not found to be affected by ELS, 5-HTT genotype or their interaction (data not shown). To 
further assess the intra-adrenal 5-HT system, pharmacological manipulations (including 
5-HT4 and 5-HT7 agonists/antagonists) of the in vitro adrenal assay could be most helpful 
at this point.
3.3 GR, MR, FKBP5
Despite the marked ELS x 5-HTT genotype programming of adrenocortical activity, we 
found little to no changes in gene expression at the level of the pituitary and paraventric-
ular nucleus (PVN) of the hypothalamus. Numerous studies have shown that areas as the 
mPFC, hippocampus and extended amygdala are involved in the regulation of HPA 
activity (Ulrich-Lai and Herman, 2009). Therefore, we hypothesized that the extrahypotha-
lamic expression of GR, MR and their co-chaperone FKBP5 would be affected by ELS, 
5-HTT genotype or their interaction. Indeed, we found a complex adaptation, including 
ELS x 5-HTT genotype effects, of GR, MR and FKBP5 mRNA levels in the mPFC and 
hippocampus (chapter 4). The altered expression of GR and MR, in conjunction with 
FKBP5, could potentially lead to a functional GR/MR disbalance in the mPFC and 
hippocampus, which has been proposed to contribute to increased vulnerability to 
stress-related psychopathology (De Kloet et al., 1998, 2005). It has to be acknowledged 
that the stability of the identified transcriptional GR/MR disbalances remains to be further 
examined. In chapter 4, we have furthermore discussed in detail the possible functional 
consequences (regulation of the HPA-axis, stress-related behavioural and mnemonic 
functioning) of the differences we observed in GR, MR and FKBP5 mRNA levels between 
5-HTT+/+, 5-HTT+/- and 5-HTT-/- rats that received a control treatment or were exposed to ELS. 
basal activity of the HPA-axis (correspondence with Dr. Anett Mueller). Both studies, 
however, did report that the CORT response following public speaking was significantly 
affected by 5-HTTLPR x SLE interaction. Furthermore, both studies indicate that an 
increasing number of SLEs leads to increased HPA reactivity in S-allele carriers, but 
decreased CORT responses to stress in L/L individuals. The study by Mueller et al. (2011) 
also reported that only SLEs up to 5 years of age interact with 5-HTTLPR, and that this GxE 
interaction only manifests itself in young adults. These studies do not seem to directly fit 
our findings on the influence of ELS x 5-HTT genotype on basal HPA activity, which we 
hypothesize to be predictive of HPA reactivity to stress. In this regard, it should be 
considered that in our study ELS was likely applied in an earlier developmental stage. 
Furthermore, the studies of Alexander, Mueller and colleagues included a multitude of 
SLEs, which were not evaluated for their possible interactive effects on the programming 
of the HPA-axis. Other studies have indicated that the effects of ELS on adult HPA activity 
are highly dependent on the later life environment (Essex et al., 2011; Goldman-Mellor et 
al., 2012; Jaffee et al., 2014).
 From the perspective of pathophysiology, altered basal HPA activity seems to be an 
endophenotype that is relevant to a number of psychiatric diseases, with lower CORT 
levels consistently reported in atypical depression and post-traumatic stress disorder, and 
elevated plasma CORT levels in melancholic depression (Checkley, 1996; Gold and 
Chrousos, 2002; Yehuda, 2009). As discussed above, animal studies suggest that the 
adaptive- or maladaptiveness of altered HPA activity is highly dependent on the specific 
demands and context of a given stressor (Oitzl et al., 2010; Myers et al., 2014). Hence, 
successful programming of physiology and behaviour is dependent on the prediction of 
later life environmental challenges (Belsky and Pluess, 2009; Heiming and Sachser, 2010; 
Schmidt, 2011). Therefore, it would be highly relevant to further characterize our animal 
model of ELS x 5-HTTLPR interaction by assessing behaviour in conjunction with HPA 
responses to different types of acute and chronic stressors. In addition, it would be highly 
recommended to extend the study of basal HPA activity by considering circadian and 
ultradian rhythmicity.
3.2 Adrenal ELS x 5-HTT genotype programming
Beyond the assessment of HPA activity under various conditions and variables, it would be 
interesting to further explore the regulation of adrenocortical gene expression. The 
starting point here was the observation that ACTH levels were not found to be significantly 
affected, while plasma CORT levels were associated with ELS x 5-HTT genotype interaction, 
suggesting altered adrenal sensitivity for ACTH. Indeed, we found an equivalent and 
highly significant ELS x 5-HTT genotype programming of adrenal mRNA levels of the 
ACTH receptor and a number of factors involved in the synthesis of CORT (chapter 3). To 
rule out an overall altered activity of the adrenal glands we measured plasma adrenalin, 
adrenal tyroxine hydroxylase mRNA levels and adrenal weight, which were all found to be 
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the BDNF gene (Kaufman et al., 2006; Wichers et al., 2008). The BDNFVal66Met polymorphism 
impairs the dendritic trafficking, synaptic localization and secretion of BDNF (Egan et al., 
2003). Therefore, we expected and indeed found that ELS and 5-HTT genotype interact to 
affect central expression levels of BDNF (chapter 7). Similar to GR, MR and FKBP5 mRNA 
levels, the effect of ELS x 5-HTT genotype interaction on the expression of different Bdnf 
transcripts in the mPFC and hippocampus was found to depend on the dorsoventral 
subdivision. Specifically, ELS and 5-HTT genotype were both associated with decreased 
BDNF mRNA levels in the ventral mPFC and hippocampus, while ELS was observed to 
selectively increase Bdnf expression in the dorsal mPFC and hippocampus of 5-HTT+/- rats. 
Moreover, by assessing differential exon usage (the main Bdnf transcripts include exon IV 
versus VI) and polyadenylation of the 3’-untranslated region (UTR) (An et al., 2008; Lubin et 
al., 2008; Molteni et al., 2009; Orefice et al., 2013), our study indicates that the differential 
effects of ELS x 5-HTT genotype on total BDNF mRNA levels in the dorsal versus ventral 
areas include effects on specific, functionally different (cellular localization), Bdnf transcripts 
(chapter 7). Our investigation of altered expression of Bdnf has been preceded by a study 
with an alternative ELS x 5-HTT genotype model. In this study by Carola et al. (2008), a 
model of ELS was obtained by intercrossing two inbred mouse strains, C57BL/6J (B6, 
5-HTT+/-) and BALB/cByJ (C), that exhibit large differences in maternal care (MC). Females 
derived from these crosses – B6 x C and C x B6 – are genetically identical but provide high 
and low levels of maternal care (licking and grooming, L/G), respectively. A significant ELS 
x 5-HTT genotype interaction was found, with increased dorsal hippocampal BDNF mRNA 
levels as well as anxiety-like behaviour displayed by low L/G-5-HTT+/- mice compared to 
the 5-HTT+/+ and high L/G groups. Furthermore, the BDNF mRNA levels showed a nearly 
significant positive correlation with anxiety-like behaviour in the open field test (Carola et 
al., 2008). Our data suggest that this ELS-induced upregulation of BDNF mRNA levels in the 
dorsal hippocampus of 5-HTT+/- rodents constitutes a long 3’-UTR and exon VI Bdnf 
transcript (chapter 7). 
4.  Possible future avenues for ELS x 5-HTT genotype 
rodent studies
In the above sections we have already discussed important research questions that have 
arisen as a consequence of the findings presented in this thesis. In addition, we would like 
to propose three broader avenues for further studies with our ELS x 5-HTTLPR model. The 
first would be to study the effects of MS across different developmental stages (prenatal, 
juvenile, pubertal, adolescence, senescence) in addition to adulthood. With this approach, 
it could be elucidated at which age certain features arise and how stable they are across 
development. For instance, in rat pups, repeated MS as well as 24 h deprivation of maternal 
contact have been shown to induce increased adrenal expression of the ACTH receptor 
(Schmidt et al., 2004; Daskalakis et al., 2011); therefore, it would be interesting to assess the 
3.4 CRF and Ucn1
The CRF family of neuropeptides (CRF, urocortins) is involved in the regulation of HPA 
activity, as well as the behavioural stress response (Binder and Nemeroff, 2010). In the 
central amygdala (CeA) and the oval subdivision of the bed nucleus of the stria terminalis 
(BNSTov), and the centrally-projecting Edinger-Westphal nucleus (EWcp), we found that 
ELS x 5-HTT genotype affected the DNA methylation of the promoter regions of the 
genes encoding CRF, and Ucn1, respectively (chapter 5 and 6). Moreover, DNA methylation 
of the Crf promoter was found to show highly significant negative correlations with CRF 
mRNA levels in the PVN and the CeA. Furthermore, despite ELS x 5-HTT genotype 
interaction effects on DNA methylation of the promoter regions of these genes, the 
mRNA and protein levels of CRF in the PVN, BNSTov and CeA, and Ucn1 in the EWcp, were 
comparable between experimental groups. Therefore, additional epigenetic mechanisms 
(e.g. miRNAs, histone modifications) should be considered to be involved in the regulation 
of Crf and Ucn expression. In addition, we hypothesize that the effects of ELS x 5-HTT 
genotype on DNA methylation of these genes may represent an early programming that 
would regulate stress-induced expression of CRF and Ucn1 in response to later adverse life 
events. Therefore, the inclusion of exposure to acute or chronic stressors in adolescence/
adulthood in our ELS x 5-HTTLPR model (as proposed above) could represent a ‘third hit’ 
(De Kloet, 2008; Daskalakis et al., 2013), which may reveal functional consequences of the 
altered DNA methylation of the Crf and Ucn promoter regions.
 Interestingly, the levels of DNA methylation of Crf, which were consistent with 
previous reports (Elliott et al., 2010; Sterrenburg et al., 2011), were far higher than those 
observed for Ucn (chapter 5 and 6). We hypothesize that these differential promoter 
region DNA methylation patterns may be associated with the complementary dynamics 
of PVN (BNSTov, CeA)-CRF and EWcp-Ucn1 neurons (Kozicz et al., 2011a; Janssen and 
Kozicz, 2013). Furthermore, we obtained correlative evidence in chapter 6 suggestive of a 
role of EWcp-Ucn1 neurons in the regulation of DR 5-HT neurons. Specifically, Ucn1 mRNA 
levels in the DR showed highly significant negative correlations with mRNA levels of CRF2R 
and the inhibitory autoreceptor 5-HT receptor 1A (5-HT1A). As CRF2R (stimulation) and 
5-HT1A (inhibition) have opposite roles in the regulation of DR 5-HT neurons, locally 
translated Ucn1 might contribute to the balanced expression of CRF2R and 5-HT1A. It could 
be highly relevant to further address the role of Ucn1 in the regulation of DR 5-HT neuronal 
activity, since the dual CRF1R/CRF2R regulation is associated with potent effects on stress 
coping behaviour (Valentino et al., 2010; Wood et al., 2013).
3.5 BDNF
Besides the role of 5-HTT in the HPA-axis, 5-HTT has also been under scrutiny because of 
its tight connection with BDNF at the molecular level (Martinowich and Lu, 2008; Homberg 
et al., 2014). Indeed, epidemiological studies suggest the relation between ELS x 5-HTTLPR 
interaction and stress-related depression is moderated by the Val66Met polymorphism of 
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that the phenotypic correlates of 5-HTTLPR and ELS x 5-HTTLPR interaction are modulated 
by sex (Sjöberg et al., 2006; Brummett et al., 2008; Everaerd et al., 2012). As the heightened 
female vulnerability is limited to the period of postpuberty up to menopause, much 
attention has been paid to the role of estrogen (Krishnan and Nestler, 2010). Furthermore, 
animal studies confirm that a sexual dichotomy exists for many aspects of the stress 
response (Galea et al., 1997; Wood and Shors, 1998; Carvalho-Netto et al., 2011; Dalla et al., 
2011), and exposure to ELS has been described to have different effects in male and female 
rodents (Glover and Hill, 2012; Kundakovic et al., 2013; Davis and Pfaff, 2014; Fuentes et al., 
2014). Therefore, sex is a highly relevant factor and the underlying mechanisms of ELS x 
5-HTTLPR interaction may exhibit important differences between males and females.
 Although the primary objective of this thesis has been to provide mechanistic 
insights into the relation of 5-HTTLPR with major depression (Caspi et al., 2003; Karg et al., 
2011; Sharpley et al., 2014), this common genetic variant has also been associated with 
post-traumatic stress disorder (Xie et al., 2009; Gressier et al., 2013), anxiety disorders (Stein 
et al., 2008; Reinelt et al., 2013), and substance abuse (Feinn et al., 2005; Gerra et al., 2007). 
It is highly likely that this divergence is in part due to the modulation of ELS x 5-HTTLPR 
interaction by other genomic variants. In addition, we hypothesize that the systematic 
examination of ELS x 5-HTTLPR interaction by the study of sex differences, different types 
of ELS, and different developmental stages for phenotyping and additional (‘third hit’) 
stressors, may explain how a common genetic variant such as 5-HTTLPR is associated with 
such diverse psychopathology, and at the same time, could perhaps alleviate the 
controversy that has existed over the relation between 5-HTTLPR and psychiatric disease 
(Risch et al., 2009; Munafò et al., 2009; Margoob and Mushtaq, 2011; Navarro-Mateu et al., 
2014). 
5. Conclusions of this thesis
  
Overall, with this thesis we have come to a further understanding as well as additional 
questions about ELS x 5-HTTLPR interactions. With regard to physiology, we found that 
the effect of ELS x 5-HTTLPR interaction on activity of the HPA-axis (Jabbi et al.,, 2007; 
Alexander et al., 2009; Mueller et al., 2011) is likely to involve programming of the sensitivity 
of the adrenals to circulating levels of ACTH (chapter 3), which was associated with a 
complex adaptation of central expression levels of GR, MR and FKBP5 (chapter 4), CRF 
(chapter 5), and Ucn1 (chapter 6). For BDNF specifically, we extended the study by Carola 
et al. (2008) that indicated the involvement of altered dorsal hippocampal BDNF expression 
in increased anxiety/stress sensitivity of individuals with low 5-HTT availability, by showing 
that this altered BDNF expression likely constitutes the long 3’-UTR and exon VI BDNF 
transcript (chapter 7). With regard to behaviour, the findings presented in chapter 2 
suggest that 1) vulnerability to psychopathology is not necessarily increased after 
exposure to ELS, but is determined by the interaction between the early and later life 
ELS x 5-HTT genotype programming of adrenocortical gene expression from MS onwards 
to characterize its onset and stability. With such experiments, mechanisms underlying the 
long-term effects of MS could be studied in greater detail. Besides the HPA-axis, the focus 
could also be on other endocrine and metabolic factors (Schmidt et al., 2006; Lucassen et 
al., 2013), or the central CRF system (Ladd et al., 2000; Wang et al., 2011, 2012).
 Second, the use of different types of ELS exposure could be considered. As touched 
upon in chapter 1, the MS model may actually represent a model of human prenatal 
stress, with regard to maturation of the neocortex and the HPA-axis. From an ethological 
(rodent) perspective however, the MS model would evidently be a postnatal model, 
which furthermore seems to best approximate the human situation of early life neglect. In 
the laboratory setting, the mother rat is observed to be frequently away from the nest for 
periods of 20-25 minutes (Jans and Woodside, 1990), whereas in seminaturalistic 
conditions, subordinate mothers are often forced to build their nests far from nutritional 
sources, and this environmental challenge has been reported to lead to periods of 
separation for 2-3 h (Calhoun, 1962; Meaney, 2001). Therefore, the daily 3 h separations are 
considered to be an ethologically relevant stressor for the offspring, which results in a 
deprivation of maternal care. Furthermore, in chapter 3 we found that in our MS 
experiments, the mother rat seemed to compensate for nutritional deprivation (physical 
care), but did not show an increase in licking and grooming (emotional care) of the pups 
because of the separation period. To further characterize the immediate effects of MS, 
peer interaction (Branchi, 2009; Branchi and Cirulli, 2014) and within-litter variation of 
maternal care (Claessens et al., 2011; Van Hasselt et al., 2012) could be considered.
 From systematic analyses of human studies, it seems that emotional maltreatment is 
associated with increased risk for depression compared to physical or sexual abuse, which 
may predispose more to other psychiatric disorders (Boudewyn and Liem, 1995; Gibb et 
al., 2001; Hankin, 2005; Shapero et al., 2014). A recent study even reported that emotional 
abuse and not physical/sexual abuse moderated the relationship between later life stress 
and depressive episodes (Shapero et al., 2014). The vulnerability to depression conferred 
by emotional abuse and neglect is thought to be mediated by an insecure attachment 
style, negative cognitive styles, and additional adverse life events (Barnet et al., 2005; 
Hankin, 2005; Van Harmelen et al., 2010). Although the literature is thus far only indicative 
on this matter, we propose that the interaction of 5-HTTLPR with different types of ELS 
exposure in human as well as animal studies could be key in understanding/explaining 
how a common gene variant is associated with depression (Barnett et al., 1993; Manly et 
al., 2001).
 A third major possibility of follow-up could be to study sex differences in ELS x 5-HTT 
genotype interactions, as in our studies thus far, only male rats have been used for 
phenotypic analyses. Sex differences actually are a major issue, because females appear to 
have twofold higher risk compared to men to develop depression (Kendler et al., 2002; 
Holden, 2005; Wittchen and Jacobi, 2005). Indeed, a number of studies have also indicated 
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environment (match/mismatch hypothesis) (Champagne et al., 2009; Nederhof and 
Schmidt, 2012), and 2) these data best support the view that the 5-HTTLPR S-allele is 
associated with a plasticity, rather than a vulnerability phenotype (differential susceptibility 
hypothesis), namely environmental sensitivity (Kaufman et al., 2004; Belsky et al., 2007, 
Homberg and Van den Hove, 2012; Van IJzendoorn and Bakermans-Kranenburg, 2012).
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Summary
The aim of the research presented in this thesis has been to increase the understanding of 
the etiology of stress-related psychiatric disorders. Major depressive disorder, commonly 
referred to as (unipolar) depression, is a psychiatric disorder that inflicts a huge personal 
and societal burden, and, according to the World Health Organization, is among the 
leading causes of disability worldwide. The heritability of depression has been estimated 
to contribute to 30-50% of the risk to develop depression, with the remaining liability 
accounted for by non-genetic factors as stress and traumatic events, but also viral 
infections and even stochastic processes during brain development. Over the past decade 
it has becoming increasingly clear that vulnerability to depression consists of a complex 
interplay of genome and environment.
 Perhaps the most illustrative and well-known example of gene x environment 
interaction in psychiatry involves the serotonin (5-hydroxytryptamine; 5-HT) transporter 
gene. The 5-HT transporter (5-HTT) plays a critical role in the termination of 5-HT neuro-
transmission by the re-uptake of 5-HT into the presynaptic neuron, and is the target of the 
most widely prescribed class of antidepressants (selective serotonin reuptake inhibitors). 
The 5-HTT-linked polymorphic region (5-HTTLPR) is associated with two genetic variants 
of the 5-HTT gene: a short (S) and a long (L) allele. In 2003, Caspi and co-workers reported 
that the increased risk to develop depression after exposure to stress was 2-3 times higher 
in individuals with the S-allele compared to individuals without the S-allele. Further 
studies showed that this effect of the S-allele versus the L-allele is particularly evident for 
early life exposure to stress, and that, on the molecular level, the S-allele is associated with 
reduced expression of the 5-HTT gene.
 For the current thesis, we have studied the biological and behavioural consequences 
of the interaction between 5-HTT gene variation and early life stress (ELS) exposure. To 
perform these studies, we have subjected 5-HTT homozygous and heterozygous 
knockout rats during the early postnatal life to repeated and prolonged separations from 
their mothers. In chapter 2, the adult male offspring was assessed for their stress 
vulnerability by use of the learned helplessness paradigm. Remarkably, we found that the 
ELS exposure rendered the rats more stress resilient compared to control rats, as they 
displayed increased adaptive coping behaviour. These experimental findings have 
challenged the prevailing theory that postulates that ELS exposure invariably leads to 
adverse consequences. Rather, our results suggest that ELS exposure can lead to adaptive 
responses, depending on the challenges in later life. In addition, we found that the 
adaptive effect of ELS exposure was the strongest for heterozygous 5-HTT knockout rats 
(the S-allele model). This suggests that the S-allele does not only confer increased 
sensitivity to negative environmental programming, but that it is associated with differential 
susceptibility; an increased sensitivity for both adverse and beneficial environmental 
effects.
Zigmond RE, Schwarzschild MA and Rittenhouse AR (1989). Acute regulation of tyrosine hydroxylase by nerve 
activity and by neurotransmitters via phosphorylation. Annu Rev Neurosci 12, 415–461.
Zimmermann P, Brückl T, Nocon A, Pfister H, Binder EB, Uhr M et al. (2011). Interaction of FKBP5 gene variants and 
adverse life events in predicting depression onset: results from a 10-year prospective community study. 
Am J Psychiatry 168, 1107–1116.
204 205
SUMMARY SUMMARY
projecting Edinger-Westphal (EWcp) nucleus. We found that ELS was associated with 
increased DNA methylation of the urocortin 1 gene, and increased expression of 5-HT 
receptor 1A in the EWcp. In addition, urocortin 1 mRNA levels significantly correlated with 
CRF receptor 2 and 5-HT (auto)receptor 1A in the dorsal raphe. These findings suggest it 
could be worthwile to investigate the functional relationship between EWcp urocortin 1 
and dorsal raphe 5-HT neurons in the pathophysiology of depression as a function of ELS 
and 5-HTT gene variation.
 In chapter 7, we investigated the expression of different transcripts of the gene 
encoding brain-derived neurotrophic factor (BDNF). The relation between ELS and 
depression has been shown to be modulated by a number of genetic variants other than 
the 5-HTT polymorphism. Moreover, it is thought that the pathophysiology of depression 
arises from the interplay of a multitude of genetic and environmental factors, although 
evidence is still scarce. Yet, a polymorphism of the BDNF gene has been shown to interact 
with ELS and 5-HTT genotype to moderate the risk to develop depression. Therefore, it 
was perhaps not surprising to find that the interaction of ELS and 5-HTT genotype 
significantly affected the expression of BDNF in the hippocampus and medial prefrontal 
cortex. By assessing functionally different BDNF transcripts, our findings in chapter 7 
suggest that this BDNF transcript is constituted of a long 3’-untranslated region and the 
inclusion of exon VI.
 In chapter 8, we have provided an extensive discussion of the research findings 
summarized above and we furthermore propose that follow-up studies are needed to 
address the questions that have arisen from our work. To our opinion, the major 
conclusions of this thesis are 1) the S-allele can also be linked to stress resilience in the 
context of predictive adaptive programming, and 2) ELS and 5-HTT gene variation interact 
at the level of the adrenal gland to program HPA-axis activity. At the moment, further 
experiments are planned to elucidate the role of altered HPA-axis activity in stress network 
activation and behavioural stress responses, after ELS x 5-HTT genotype interaction. Next, 
the investigation of ELS x 5-HTT interactions could be advanced by including the 
evaluation of different developmental stages after ELS exposure, the use of different types 
of ELS exposure, and the evaluation of sex differences. Overall, we think that the research 
described in this thesis has contributed to a further understanding of the interaction of 
ELS and 5-HTT gene variation, and has provided new avenues for research aimed at 
elucidating the biological mechanisms involved in the etiology of depression.
 In chapter 3-4, we explored how the interaction of ELS and 5-HTT gene variation 
would affect the stressor-responsive hypothalamo-pituitary-adrenal (HPA) axis and related 
gene expression in the brain. The HPA-axis functions to regulate the cortex of the adrenal 
glands with regard to the synthesis and release of glucocorticoids in the bloodstream. In 
response to stress, glucocorticoids, mainly cortisol in primates and corticosterone in 
rodents (collectively referred to as CORT), mobilize energy resources by elevating 
circulating glucose levels, increasing heart rate and blood pressure, and decreasing the 
activity of the immune and digestive systems. Furthermore, as part of the stress response, 
CORT acts on the brain to affect neural plasticity, cognition and behaviour. The effects of 
CORT are mediated via the glucocorticoid and mineralocorticoid receptors (GR, MR), and 
GR-mediated feedback is instrumental for the termination of stress-induced CORT 
elevations. In depression, about 50% of patients display altered basal HPA activity and 
GR-mediated negative feedback. Altogether, the HPA-axis is an important regulatory 
system in the stress response, and we hypothesized that the interaction of ELS and 5-HTT 
gene variation could affect vulnerability to depression via altered activity and regulation 
of the HPA-axis. In chapter 3, we indeed found that ELS x 5-HTT genotype interaction 
significantly affected basal plasma CORT levels. Furthermore, we found evidence that 
strongly suggests that this effect was, at least in part, mediated by alterations of gene 
expression in the adrenal gland. In chapter 4, we found that ELS x 5-HTT genotype 
interaction also significantly affected the expression of GR and MR in the hippocampus 
and medial prefrontal cortex, brain areas known to be involved in stress coping behaviour 
and regulation of the HPA-axis.
 In chapter 5, we found that the mRNA levels of corticotropin-releasing factor (CRF) in 
the central amygdala showed a significant correlation with the levels of active coping 
behaviour displayed in the learned helplessness paradigm. Moreover, the interaction of 
ELS and 5-HTT gene variation was found to affect DNA methylation of the Crf gene 
promoter in the central amygdala, and the methylation levels of a specific site in the Crf 
promoter also significantly correlated with the CRF mRNA levels. As the selection of active 
stress coping responses has been associated with reduced activity of 5-HT neurons in the 
dorsal raphe nucleus, we hypothesize that increased CRF input to the dorsal raphe leads 
to lower 5-HT neuron activity via stimulation of CRF receptor 1, and therefore increased 
levels of active coping behaviour. At this point, further investigation is first needed to 
confirm the link of Crf promoter methylation with stress coping behaviour, which should 
for instance include the analysis of CRF protein levels.
 As referred to above, the dorsal raphe nucleus is known to be involved in a wide array 
of physiological and behavioural stress responses, via its serotonergic (5-HT) projections 
to other brain areas. And for behavioural responses the activity of 5-HT neurons is 
regulated by CRF receptors 1 and 2. Besides CRF itself, a number of related proteins, 
urocortins 1-3, are also endogenous ligands for CRF receptor 1 and 2. In chapter 6, we 
have examined the principal site of urocortin 1 expression in the brain, the centrally 
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Samenvatting
Het onderzoek dat in dit proefschrift is beschreven had het doel om het ontstaan van 
stress-gerelateerde, psychiatrische stoornissen beter te leren begrijpen. Depressie is een 
psychiatrische stoornis die een enorme persoonlijke en maatschappelijke last met zich 
meebrengt. Het risico om depressie te ontwikkelen heeft volgens (wetenschappelijke) 
schattingen een grote erfelijke component (zo’n 30 tot 50%), met daarnaast een belangrijke 
rol voor omgevingsfactoren als stress en traumatische gebeurtenissen, maar ook virale 
infecties en zelfs random gebeurtenissen tijdens de ontwikkeling van de hersenen. 
Gedurende het afgelopen decennium is het steeds duidelijker geworden dat het ontstaan 
van depressie het gevolg is van een complexe wisselwerking tussen genetische varianten 
en omgevingsfactoren.
 Misschien wel het bekendste voorbeeld van zo’n gen x omgevingsinteractie in de 
psychiatrie is die van het serotonine transporter polymorfisme. De serotonine transporter 
is betrokken bij het beëindigen van de communicatie tussen hersencellen via de neuro-
transmitter serotonine. Dit doet de serotonine transporter door serotonine terug de cel in 
te transporteren nadat het ter overbrenging van het signaal is afgegeven in de ruimte 
tussen een contactpunt van hersencellen; de zogenaamde synaps. De serotonine 
transporter is een bekend eiwit, omdat hierop de bekendste klasse van antidepressiva op 
inwerken; de SSRIs (serotonin transporter reuptake inhibitors). Het serotonine transporter 
polymorfisme bestaat uit twee varianten: een kort (short: S) en lang (L) allel. In 2003 werd 
een epidemiologisch onderzoek gepresenteerd waaruit bleek dat het risico om depressie 
te ontwikkelen na blootstelling aan bepaalde stressvolle gebeurtenissen twee tot drie 
keer zo groot was voor individuen met het S allel in vergelijking met individuen met het 
L allel. Studies die hierop volgden toonden aan dat dit effect van het S allel versus het 
L allel vooral erg groot was bij blootstelling aan stress in de vroege jeugd, en dat op 
moleculair niveau het S allel geassocieerd is met een lagere expressie van het serotonine 
transporter gen.
 In dit proefschrift hebben we de consequenties van de interactie tussen genetische 
variatie van het serotonine transporter gen, serotonine transporter genotype, en de 
vroege blootstelling aan stress onderzocht. Om zulk onderzoek tot op moleculair niveau 
te kunnen doen hebben we gebruik gemaakt van ratten waarbij de serotonine transporter 
volledig ontbrak, of maar voor de helft van het normale niveau aanwezig was. Deze ratten 
hebben we als pups vervolgens regelmatig gescheiden van hun moeders als een model 
voor vroege blootstelling aan stress. In hoofdstuk 2 hebben we vervolgens gekeken 
hoe goed de ratten met stress om konden gaan toen ze volwassen waren geworden. 
Opvallend genoeg bleken de op jonge leeftijd gestresste ratten minder kwetsbaar te zijn 
voor blootstelling aan stress in het volwassen leven in vergelijking met ratten die als pups 
enkel een controlebehandeling hadden gekregen. Deze experimentele bevindingen 
stroken niet met de heersende theorie dat vroege blootstelling aan stress enkel negatieve 
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niveaus correleerden met de expressie van de CRF receptor in de dorsale raphe. Dit zijn 
interessante aanknopingspunten om de relatie tussen de EW en de dorsale raphe verder 
te bestuderen,  om zo te zien of urocortine 1 in onze experimenten ook daadwerkelijk een 
functionele rol heeft, die bovendien beïnvloedt wordt door serotonine transporter 
genotype en vroege blootstelling aan stress.
 In hoofdstuk 7 zijn verschillende functionele transcripten van het gen dat codeert 
voor brain-derived neurotrophic factor (BDNF) onderzocht. Van de effecten van vroege 
blootstelling aan stress op het latere risico op depressie is namelijk aangetoond dat deze 
tegelijkertijd door polymorfismes van zowel het serotonine transporter als het BDNF gen 
wordt beïnvloed. De verwachting was daarom dat er ook een interactie op moleculair 
niveau zou zijn; en we vonden inderdaad dat de expressie van BDNF afhankelijk was van 
serotonine transporter genotype en vroege blootstelling aan stress. In een vergelijkbare 
studie was ook een verband aannemelijk gemaakt tussen angstgedrag en de expressie 
van BDNF in een bepaald hersengebied, de hippocampus. In hoofdstuk 7 vonden wij dat 
dit waarschijnlijk een specifiek transcript van het BDNF gen betreft.
 In hoofdstuk 8 hebben we alle resultaten uitvoerig bediscussieerd en nog eens 
kritisch onder de loep genomen. Daarnaast hebben we ook voorstellen tot vervolgonder-
zoek gedaan. Naar onze mening zijn de belangrijkste inzichten n.a.v. dit proefschrift dat 1) 
het polymorfisme van het serotonine transporter gen niet alleen geassocieerd is met een 
toegenomen gevoeligheid voor negatieve, maar juist ook voor positieve omgevings-
factoren, en dat 2) serotonine transporter genotype de effecten van de vroege blootstelling 
aan stress op de activiteit van de HHB-as beïnvloedt via de regulatie van genexpressie in 
de bijnieren. Alles tezamen denken wij dat dit proefschrift heeft bijgedragen aan een 
verbeterd inzicht in de gen x omgevingsinteractie van serotonine transporter genotype 
en vroege blootstelling aan stress, en dat het aanleiding biedt voor nieuw onderzoek naar 
de biologische mechanismen die betrokken zijn bij het ontstaan van depressie.
consequenties zou kunnen hebben. Onze resultaten suggereren juist dat dit ook geassocieerd 
kan zijn met adaptatie van het individu, en dat dit een voordeel t.o.v. anderen met zich 
mee kan brengen, afhankelijk van de uitdagingen die het latere leven biedt.
 In hoofdstuk 3 en 4 hebben we bestudeerd hoe de serotonine transporter genotype 
en vroege blootstelling aan stress de stressgevoelige hypothalamus-hypofyse-bijnier 
(HHB) as zouden kunnen beïnvloeden. De functie van de HHB-as is om de bijnierschors 
aan te sturen in diens productie en afgifte van glucocorticoïden aan de bloedbaan. Tijdens een 
stress respons zorgen glucocorticoïden ervoor dat energie beschikbaar komt, o.a. door 
stijging van de suikerspiegel en toename van de hartslag en bloeddruk. Daarnaast hebben 
glucocorticoïden belangrijke effecten in de hersenen, zoals op cognitie, geheugen en 
gedrag. Bij veel depressieve patiënten is er een afwijking in de activiteit en regulatie van 
de HHB-as, en daarom hadden wij de hypothese dat de effecten van serotonine transporter 
genotype en vroege blootstelling aan stress op het risico om depressie te ontwikkelen 
o.a. door veranderingen in de HHB-as zouden kunnen komen. In hoofdstuk 3 toonden wij 
aan dat de activiteit van de HHB-as inderdaad beïnvloed werd door zowel serotonine 
transporter genotype als door vroege blootstelling aan stress, en dat deze effecten 
waarschijnlijk voor een groot deel gemedieerd worden door veranderingen in genexpressie 
in de bijnieren. In hoofdstuk 4 toonden we daarnaast aan dat de expressie van de 
receptoren voor glucocorticoïden in het brein ook beïnvloed werden door zowel 
serotonine transporter genotype als door vroege blootstelling aan stress, en dat deze 
effecten bovendien sterk verschillen waren voor verschillende hersengebieden.
 In hoofdstuk 5 vonden we dat de mRNA niveaus van corticotropin-releasing factor 
(CRF) in de centrale amygdala een significante correlatie vertoonden met het gedrag dat 
bestudeerd was in hoofdstuk 2. Daarnaast bleek dat zowel de vroege blootstelling aan 
stress als het serotonine transporter genotype een effect hadden op de methylatie van 
het CRF gen in de centrale amygdala, en dat deze methylatieniveaus op hun beurt een 
significante correlatie vertoonden met de mRNA niveaus van CRF. Het specifieke gedrag 
dat in hoofdstuk 2 is bestudeerd is eerder al gelinkt aan de activiteit van serotonine 
neuronen in de dorsale raphe kern. Daarnaast weten we dat de activiteit van de serotonine 
neuronen gereguleerd kan worden door de receptoren voor CRF in de dorsale raphe. 
Onze hypothese is dat verhoogde input van CRF vanuit de centrale amygdala naar de 
dorsale raphe leidt tot lagere activiteit van serotonine neuronen, en daarmee een actievere 
manier van omgaan met stress. Op dit moment is nog verder onderzoek nodig om deze 
functionele connecties in ons onderzoeksmodel te bevestigen.
 In hoofdstuk 6 hebben we de dorsale raphe kern verder bestudeerd, net als de 
hersenkern die de grootste populatie neuronen herbergt die het eiwit urocortine 1 tot 
expressie brengen, de Edinger-Westphal (EW) kern. Urocortine 1 is een eiwit dat gerelateerd 
is aan CRF, en waarvan ook is aangetoond dat het de activiteit van serotonine neuronen in 
de dorsale raphe kan reguleren. We vonden dat de methylatie van het gen dat codeert 
voor urocortine 1 lager is na vroege blootstelling aan stress, en dat urocortine 1 mRNA 
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